sv1
As filed with the Securities and Exchange Commission on
April 15, 2010
Registration
No. 333-
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form S-1
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
GENESIS FLUID SOLUTIONS
HOLDINGS, INC.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Delaware
|
|
3531
|
|
98-0531496
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
830 Tender Foot Hill Road
#301
Colorado Springs, CO
80906
(719) 332-7447
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
Michael Hodges
Interim Chief Executive
Officer
830 Tender Foot Hill Road
#301
Colorado Springs, CO
80906
(719) 332-7447
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copies to:
Harvey J.
Kesner, Esq.
Benjamin S.
Reichel, Esq.
Sichenzia Ross Friedman Ference
LLP
61 Broadway, 32nd
Floor
New York, New York
10006
Telephone:
(212) 930-9700
Approximate date of commencement of proposed sale to the
public: As soon as practicable after the
effective date of this registration statement.
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, check the
following
box. þ
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act of
1933 registration statement number of the earlier effective
registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
Indicate by a check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check One):
|
|
|
|
Large
Accelerated
Filer o
|
Accelerated
Filer o
|
Non-Accelerated
Filer o
|
Smaller Reporting
Company þ
|
(Do not check if a smaller
reporting company)
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
|
Proposed Maximum
|
|
|
|
|
|
|
|
|
Amount to be
|
|
|
|
Offering Price
|
|
|
|
Aggregate Offering
|
|
|
|
Amount of
|
|
Title of Each Class of Securities to be Registered
|
|
|
Registered(1)
|
|
|
|
per Share
|
|
|
|
Price
|
|
|
|
Registration Fee
|
|
Common stock, par value $0.001 per share
|
|
|
|
7,027,500
|
|
|
|
$
|
3.40
|
(2)
|
|
|
$
|
23,893,500
|
|
|
|
$
|
1,703.61
|
|
Common stock, par value $0.001 per share, upon exercise of
warrants issued to investors
|
|
|
|
3,412,500
|
|
|
|
$
|
3.40
|
(3)
|
|
|
$
|
11,602,500
|
|
|
|
$
|
827.26
|
|
Common stock, par value $0.001 per share, currently being held
in escrow
|
|
|
|
1,300,000
|
|
|
|
$
|
3.40
|
(2)
|
|
|
$
|
4,420,000
|
|
|
|
$
|
315.15
|
|
Common stock, par value $0.001 per share, upon exercise of
warrants issued to the placement agents
|
|
|
|
107,500
|
|
|
|
$
|
3.40
|
(3)
|
|
|
$
|
365,500
|
|
|
|
$
|
26.06
|
|
Total
|
|
|
|
11,847,500
|
|
|
|
$
|
3.40
|
|
|
|
$
|
40,281,500
|
|
|
|
$
|
2,872.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Pursuant to Rule 416 under the
Securities Act, the shares of common stock offered hereby also
include an indeterminate number of additional shares of common
stock as may from time to time become issuable by reason of
anti-dilution provisions, stock splits, stock dividends,
recapitalizations or other similar transactions.
|
(2)
|
|
With respect to the shares of
common stock offered by the selling stockholders named herein,
estimated at $3.40 per share, the average of the high and low
prices of the common stock as reported on the OTC
Bulletin Board on April 12, 2010, for the purpose of
calculating the registration fee in accordance with
Rule 457(c) under the Securities Act.
|
(3)
|
|
Estimated at $3.40 per share, the
average of the high and low prices of the common stock as
reported on the OTC Bulletin Board on April 12, 2010,
for the purpose of calculating the registration fee in
accordance with Rule 457(g)(3) under the Securities Act.
|
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON
SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE
DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH
SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL
THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a)
OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION
STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION,
ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.
The
information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these
securities and we are not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
|
SUBJECT TO COMPLETION, DATED
APRIL 15, 2010
PRELIMINARY PROSPECTUS
11,847,500 Shares
Genesis Fluid Solutions
Holdings, Inc.
Common Stock
This prospectus relates to the sale by the selling stockholders
identified in this prospectus of up to 11,847,500 shares of
our common stock, which includes (i) 7,027,500 shares
issued to investors in a private placement;
(ii) 3,412,500 shares issuable upon the exercise of
warrants with an exercise price of $2.00 per share;
(iii) 1,300,000 shares issued in connection with the
Merger, which are being held in escrow for three years in order
to cover certain potential claims, indebtedness and liabilities,
including potential tax liabilities, of Genesis Fluid Solutions;
and (iv) 107,500 shares issuable upon the exercise of
warrants with an exercise price of $1.25 per share. All of these
shares of our common stock are being offered for resale by the
selling stockholders.
The prices at which the selling stockholders may sell shares
will be determined by the prevailing market price for the shares
or in negotiated transactions. We will not receive any proceeds
from the sale of these shares by the selling stockholders.
However, we will receive proceeds from the exercise of the
warrants if they are exercised for cash by the selling
stockholders.
We will bear all costs relating to the registration of these
shares of our common stock, other than any selling
stockholders legal or accounting costs or commissions.
Our common stock is quoted on the regulated quotation service of
the OTC Bulletin Board under the symbol
GSFL.OB. The last reported sale price of our common
stock as reported by the OTC Bulletin Board on
April 12, 2010, was $3.40 per share.
Investing in our common stock is highly speculative and
involves a high degree of risk. You should carefully consider
the risks and uncertainties described under the heading
Risk Factors beginning on page 8 of this
prospectus before making a decision to purchase our common
stock.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the accuracy or adequacy of this
prospectus. Any representation to the contrary is a criminal
offense.
The date of this prospectus
is ,
2010
TABLE OF
CONTENTS
You should rely only on the information contained in this
prospectus. We have not authorized any other person to provide
you with different information. If anyone provides you with
different or inconsistent information, you should not rely on
it. We are not making an offer to sell these securities in any
jurisdiction where an offer or sale is not permitted. You should
assume that the information appearing in this prospectus is
accurate only as of the date on the front cover of this
prospectus. Our business, financial condition, results of
operations and prospects may have changed since that date.
2
PROSPECTUS
SUMMARY
The following summary highlights information contained
elsewhere in this prospectus. This summary may not contain all
of the information that may be important to you. You should read
this entire prospectus carefully, including the sections
entitled Risk Factors and Managements
Discussion and Analysis of Financial Condition and Results of
Operations and our historical financial statements and
related notes included elsewhere in this prospectus. In this
prospectus, unless otherwise noted, the terms the
Company, we, us, and
our refer to Genesis Fluid Solutions Holdings, Inc.,
and its subsidiary, Genesis Fluid Solutions, Ltd.
Overview
We are engaged in the design and development of waterway
restoration and water remediation technologies for the
environmental, mining and paper industries. Our patented Rapid
Dewatering System (RDS) removes different types of debris,
sediments, and contaminates from waterways and industrial sites,
which assists in the recovery of lakes, canals, reservoirs and
harbors. The RDS system separates water from the solid materials
that are dredged, a process that is known as dewatering. Because
of the scalability of the equipment, the small footprint
required, and our own real time rapid dewatering capabilities,
our RDS can remove thousands of cubic yards of sediment per day,
and return clear water to waterways at rates of two thousand or
more gallons per minute. We believe we accomplish this at
significantly lower costs than our competitors.
After demonstrating proof of concept on a port restoration
project in California, we were acknowledged by the Water Board
for the State of California, the United States Environmental
Protection Agency and the United States Army Corps of Engineers
as having an innovative technology acceptable for the
restoration of both contaminated and non-contaminated waterways.
We believe our technologies have a variety of benefits for both
industry and the environment.
Our
History
Our wholly-owned subsidiary, Genesis Fluid Solutions, Ltd.,
began operations in 1994 as a sole proprietorship owned by our
founder, Michael Hodges, and was incorporated in Colorado in
2005. Genesis Fluid Solutions is engaged in the design and
development of waterway restoration and water remediation
technology and equipment for the environmental, mining and paper
industries. Genesis Fluid Solutions holds various United States
and international patents and patent applications on water
restoration and remediation technology, seeks to license the
technology and equipment to others, and seeks to enter into
contracts for the performance of water restoration and
remediation. To date, Genesis Fluid Solutions has not generated
material revenues or earnings as a result of its activities. As
a result of the Merger, Genesis Fluid Solutions became a
wholly-owned subsidiary of the Company and the Company succeeded
to the business of Genesis Fluid Solutions as its sole line of
business.
On October 30, 2009, we filed an Amended and Restated
Certificate of Incorporation in order to, among other things,
change our name from Cherry Tankers Inc. to
Genesis Fluid Solutions Holdings, Inc. and authorize
a class of blank check preferred stock.
On October 30, 2009, we entered into an Agreement of Merger
and Plan of Reorganization with Genesis Fluid Solutions, Ltd., a
privately held Colorado corporation (Genesis Fluid
Solutions), and Genesis Fluid Solutions Acquisition Corp.,
our newly formed, wholly-owned Delaware subsidiary
(Acquisition Sub). Upon closing of the transaction
contemplated under the Agreement of Merger and Plan of
Reorganization (the Merger), Acquisition Sub merged
with and into Genesis Fluid Solutions. Genesis Fluid Solutions,
as the surviving corporation, became a wholly-owned subsidiary
of the Company, and the Company succeeded to the business of
Genesis Fluid Solutions as its sole line of business.
At the closing of the Merger, each share of Genesis Fluid
Solutions common stock issued and outstanding immediately
prior to the closing of the Merger was exchanged for the right
to receive 10 shares of our common stock. To the extent
that there were fractional shares, the fractional shares were
rounded to the nearest whole share. Accordingly, an aggregate of
9,481,000 shares of our common stock were issued to the
holders of Genesis Fluid Solutions common stock. Of the
9,481,000 shares issued in the Merger,
1,300,000 shares issuable to Michael Hodges, the founder
and former chief executive officer of Genesis Fluid Solutions,
were agreed to be set aside in
3
escrow and held for three years in order to provide for certain
liabilities, including potential tax liabilities, of Genesis
Fluid Solutions (the Escrow Agreement, as more fully
described below).
Following the closing of the Merger, the Company issued
273 units in a private placement (the Private
Placement), consisting of an aggregate of
7,027,500 shares of the Companys common stock and
three-year callable warrants to purchase an aggregate of
3,412,500 shares of common stock exercisable at $2.00 per
share, for $25,000 per unit. Colorado Financial Service
Corporation, WFG Investments, Inc., Legend Merchant Group, and
Jesup & Lamont Securities Corp. (the Placement
Agents) served as the Companys placement agents for
certain of the investors in the Private Placement, and received
two-year warrants, exercisable at $1.25 per share, to purchase
33,000, 14,000, 8,000 and 2,500 shares of common stock,
respectively, equal to 2% of the number of shares investors
purchased through the respective Placement Agents. GarWood
Securities LLC received two-year warrants, exercisable at $1.25
per share to purchase 50,000 shares of common stock. All of
the shares issued in the Private Placement, as well as the
shares of common stock underlying the warrants issued to
investors and the Placement Agents, are subject to a
registration rights agreement under which we are obligated to
seek registration of the shares within 180 days of the
final closing date of the Private Placement. Holders of our
shares issued in the Private Placement also have the right to
seek piggyback registration of their shares in
certain circumstances, other than with respect to registration
of shares held under the Escrow Agreement.
Upon the closing of the Merger, Reuven Gepstein and Yael Alush
resigned as our officers and directors and, simultaneously with
the Merger, a new board of directors and new officers were
appointed. The new board of directors consists of Michael
Hodges, Mary Losty, John Freshman, and Robert Stempel.
On October 30, 2009, immediately following the closing of
the Merger and the initial closing of Private Placement, under
an Agreement of Conveyance, Transfer and Assignment of Assets
and Assumption of Obligations (the Conveyance
Agreement), we also transferred all of our pre-Merger
assets and liabilities to our wholly-owned subsidiary, Cherry
Tankers Holdings, Inc. (SplitCo). Thereafter,
pursuant to a stock purchase agreement (the Stock Purchase
Agreement), we transferred all of the outstanding capital
stock of SplitCo to certain of our stockholders in exchange for
the cancellation of 12,545,000 shares of our common stock
(the Split-Off), with 1,160,000 shares of
common stock held by persons who were stockholders of ours prior
to the Merger remaining outstanding. These 1,160,000 shares
constitute our public float, are our only shares of
registered common stock and, accordingly, are our only shares
available for resale without further registration.
The foregoing description of certain changes to our Certificate
of Incorporation, the Merger and the Split-Off does not purport
to be complete and is qualified in its entirety by reference to
the complete text of (i) the Amended and Restated
Certificate of Incorporation, which is filed as Exhibit 3.1
hereto, (ii) the Agreement of Merger and Plan of
Reorganization, which is filed as Exhibit 2.1 hereto,
(iii) the Escrow Agreement, which is filed as
Exhibit 10.19 hereto, (iv) the Conveyance Agreement,
which is filed as Exhibit 10.12 hereto, and (v) the
Stock Purchase Agreement, which is filed as Exhibit 10.13
hereto, each of which is incorporated herein by reference.
The foregoing description of the Private Placement does not
purport to be complete and is qualified in its entirety by
reference to the complete text of the (i) Form of
Subscription Agreement, which is filed as Exhibit 10.1
hereto, (ii) Form of Warrant, which is filed as
Exhibit 10.2 hereto, (iii) Form of Placement Agent
Warrant, which is filed as Exhibit 10.7 hereto, and
(iv) Form of Registration Rights Agreement, which is filed
as Exhibit 10.3 hereto, each of which is incorporated
herein by reference.
Following (i) the closing of the Merger, (ii) the
final closing of the Private Placement for an aggregate of
$6,825,000 (which includes the conversion of $675,000 of bridge
notes), and (iii) the cancellation of
12,545,000 shares in the Split-Off, there were
17,668,500 shares of common stock issued and outstanding.
Approximately 53.9% of the issued and outstanding shares were
held by the former stockholders of Genesis Fluid Solutions,
approximately 39.6% were held by the investors in the Private
Placement, and approximately 6.5% were held by investors in
shares of our registered common stock. The foregoing percentages
exclude warrants to purchase 3,520,000 shares of common
stock issued to investors and the Placement Agents in connection
with the Private Placement, and 4,542,000 shares of common
stock reserved for issuance under our 2009 Equity Incentive Plan.
Neither we nor Genesis Fluid Solutions had any outstanding
options or warrants to purchase shares of capital stock
immediately prior to the closing of the Merger. However, prior
to the Merger, we adopted the 2009 Equity
4
Incentive Plan and reserved 4,542,000 shares of common
stock for issuance as awards to officers, directors, employees,
consultants and others. Upon the closing of the Merger, the
Company issued options under the 2009 Equity Incentive Plan to
purchase an aggregate of 3,222,000 shares of our common
stock to a total of ten individuals. Each of the options expires
10 years from the award date and has an exercise price of
either $0.90, $0.99 or $1.00 per share. The recipients of the
options received awards in recognition of services
and/or
cancellation of shares of stock of Genesis Fluid Solutions they
owned, and included: (i) Michael Hodges, who received
options to purchase 600,000 shares, (ii) Larry
Campbell, who received options to purchase 600,000 shares,
and (iii) Carol Shobrook, who received options to purchase
400,000 shares, each of whom was an executive officer of
Genesis Fluid Solutions prior to the Merger and of the Company
following the Merger.
The shares of our common stock issued to former holders of
Genesis Fluid Solutions stock in connection with the
Merger, and the shares of our common stock and warrants issued
in the Private Placement, were not registered under the
Securities Act of 1933, as amended (the Securities
Act), in reliance upon an exemption from registration
provided by Section 4(2) under the Securities Act and
Regulation D thereof. These securities may not be
transferred or sold without registration under or an applicable
exemption from the Securities Act.
At the closing of the Merger, an aggregate of
9,481,000 shares of our common stock were issued to the
holders of Genesis Fluid Solutions common stock. Of the
9,481,000 shares issued in the Merger,
1,300,000 shares issuable to Michael Hodges have been
agreed to be registered in the name of the escrow agent, set
aside in escrow and held for three years in order to provide for
certain claims, indebtedness and liabilities, including
potential tax liabilities, of Genesis Fluid Solutions. Upon
receipt of written instructions from the chief financial officer
of the Company, the escrow agent is permitted to sell shares to
cover any of these liabilities. The escrow agent has complete
and absolute discretion as to the method and timing of any
related sale of shares of common stock.
Pursuant to the terms of the Escrow Agreement, (i) Michael
Hodges may at any time exchange cash for escrowed shares at a
rate of $1.00 per share, (ii) the Escrow Agent will provide
a voting proxy to Michael Hodges to vote the escrowed shares,
and (iii) the Company has agreed to file a registration
statement covering the escrowed shares as soon as practicable
following the closing of the Merger.
5
THE
OFFERING
|
|
|
Common stock offered by selling stockholders |
|
This prospectus relates to the sale by certain selling
stockholders of 11,847,500 shares of our common stock
consisting of: |
|
|
|
(i) 7,027,500 shares of our common stock
issued to investors in the Private Placement;
|
|
|
|
(ii) 3,412,500 shares of our common stock
issuable upon the exercise of warrants issued to investors in
the Private Placement;
|
|
|
|
(iii) 1,300,000 shares of our common stock
issued in connection with the Merger that are currently being
held in escrow for three years in order to cover certain claims,
indebtedness and liabilities, including potential tax
liabilities of Genesis Fluid Solutions; and
|
|
|
|
(iv) 107,500 shares of our common stock
issuable upon the exercise of warrants issued to the Placement
Agents in the Private Placement.
|
|
Offering price |
|
Market price or privately negotiated prices. |
|
Common stock outstanding before the offering |
|
17,751,500 shares(1) |
|
Common stock to be outstanding after the offering |
|
21,271,500 shares(2) |
|
Use of proceeds |
|
We will not receive any proceeds from the sale of the common
stock by the selling stockholders. However, we will receive the
exercise price, if the cashless exercise feature is not used,
upon exercise of the warrants by the selling stockholders. We
expect to use the proceeds received from the exercise of the
warrants, if any, for general working capital purposes. |
|
OTB Bulletin Board Symbol |
|
GSFL.OB |
|
Risk Factors |
|
You should carefully consider the information set forth in this
prospectus and, in particular, the specific factors set forth in
the Risk Factors section beginning on page 9 of
this prospectus before deciding whether or not to invest in our
common stock. |
|
|
|
(1) |
|
Represents the number of shares of our common stock outstanding
as of April 15, 2010. Excludes
(i) 4,542,000 shares of our common stock issuable upon
exercise of options granted or reserved under the 2009 Equity
Incentive Plan; and (ii) 3,520,000 shares of our
common stock issuable upon exercise of outstanding warrants. |
|
(2) |
|
Includes 3,520,000 shares of our common stock issuable upon
exercise of outstanding warrants, which shares are offered for
sale in this prospectus. Excludes 4,542,000 shares of our
common stock issuable upon exercise of options granted or
reserved under the 2009 Equity Incentive Plan. |
6
SPECIAL
NOTE REGARDING FORWARD LOOKING STATEMENTS
This prospectus contains forward-looking statements within the
meaning of Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act of 1934, as
amended (the Exchange Act). Such statements include
statements regarding our expectations, hopes, beliefs or
intentions regarding the future, including but not limited to
statements regarding our market, strategy, competition,
development plans (including acquisitions and expansion),
financing, revenues, operations, and compliance with applicable
laws. Forward-looking statements involve certain risks and
uncertainties, and actual results may differ materially from
those discussed in any such statement. Factors that could cause
actual results to differ materially from such forward-looking
statements include the risks described in greater detail in the
following paragraphs. All forward-looking statements in this
document are made as of the date hereof, based on information
available to us as of the date hereof, and we assume no
obligation to update any forward- looking statement. Market data
used throughout this prospectus is based on published third
party reports or the good faith estimates of management, which
estimates are based upon their review of internal surveys,
independent industry publications and other publicly available
information. Although we believe that such sources are reliable,
we do not guarantee the accuracy or completeness of this
information, and we have not independently verified such
information.
7
RISK
FACTORS
Investing in our common stock involves a high degree of risk.
Prospective investors should carefully consider the risks
described below, together with all of the other information
included or referred to in this prospectus, before purchasing
shares of our common stock. There are numerous and varied risks
that may prevent us from achieving our goals. If any of these
risks actually occurs, our business, financial condition or
results of operations may be materially adversely affected. In
such case, the trading price of our common stock could decline
and investors in our common stock could lose all or part of
their investment.
Risks
Relating to Our Business
We may
not be able to adequately protect our proprietary rights, which
would have an adverse effect on our ability to competitively
conduct our business.
We rely on our patented technology, both domestically and
internationally, to deliver our equipment and services. To
protect our proprietary rights, we rely on a combination of
patent and trade secret laws, confidentiality agreements, and
protective contractual provisions. Despite these efforts, our
patents and intellectual property relating to our business may
not provide us with any competitive advantages. Additionally,
another party may obtain a blocking patent and we would need to
either obtain a license or design around the patent in order to
continue to offer the contested item in our products and
services. Further, effective protection of intellectual property
rights may be unavailable or limited in some foreign countries.
Our inability to adequately protect our proprietary rights would
have an adverse impact on our ability to competitively
manufacture, distribute and use our products on a worldwide
basis.
We
could become involved in intellectual property disputes that
create a drain on our resources and could ultimately impair our
assets.
We do not knowingly infringe on patents, copyrights or other
intellectual property rights owned by other parties; however, in
the event of an infringement claim, we may be required to spend
a significant amount of money to defend a claim, develop a
non-infringing alternative or to obtain licenses. We may not be
successful in developing an alternative or obtaining licenses on
reasonable terms, if at all. Any litigation, even if without
merit, could result in substantial costs and diversion of our
resources and could materially and adversely affect our
business, financial condition and results of operations.
Since
we have a somewhat limited operating history, it is difficult
for potential investors to evaluate our business.
We began research and development operations in the mid-1990s
and have completed 12 projects to date. Our somewhat limited
operating history makes it difficult for potential investors to
evaluate our business or prospective operations. Since our
formation, we have generated only limited and sporadic revenues.
As an early stage company, we are subject to all the risks
inherent in the initial organization, financing, expenditures,
complications and delays inherent in a new business.
Accordingly, our business and success faces risks from
uncertainties faced by developing companies in a competitive
environment. There can be no assurance that our efforts will be
successful or that we will ultimately be able to attain
profitability.
We are
dependent upon key personnel whose loss may adversely impact our
business.
We rely heavily on the expertise, experience and continued
services of Michael Hodges, our Chairman and Interim Chief
Executive Officer. The loss of Mr. Hodges and the inability
to attract or retain other key individuals, could materially
adversely affect us. We seek to compensate and motivate our
executives, as well as other personnel, through competitive
salaries and bonus and equity incentive plans, but there can be
no assurance that these programs will allow us to attract or
retain personnel. If Mr. Hodges were to leave, we could
face substantial difficulty in hiring a qualified successor and
could experience a loss in productivity while any successor
obtains the necessary training and experience. We have not
entered into an employment agreement with Mr. Hodges.
8
We
face risks associated with our anticipated international
business.
We expect to establish, and to expand over time, international
commercial or licensing operations and activities in various
countries. These international business operations will be
subject to a variety of risks associated with conducting
business internationally. We do not know the impact that these
regulatory, geopolitical and other factors may have on our
international business in the future, including the following:
|
|
|
|
|
changes in or interpretations of foreign regulations that may
adversely affect our ability to perform services or repatriate
profits to the United States;
|
|
|
|
the imposition of tariffs;
|
|
|
|
economic or political instability in foreign countries;
|
|
|
|
imposition of limitations on or increase of withholding and
other taxes on remittances and other payments by foreign
subsidiaries or joint ventures or customers;
|
|
|
|
conducting business in places where business practices and
customs are unfamiliar and unknown;
|
|
|
|
the imposition of restrictive trade policies;
|
|
|
|
the existence of inconsistent laws or regulations;
|
|
|
|
the imposition or increase of investment requirements and other
restrictions or requirements by foreign governments;
|
|
|
|
uncertainties relating to foreign laws and legal proceedings;
|
|
|
|
fluctuations in foreign currency and exchange rates; and
|
|
|
|
compliance with a variety of U.S. laws, including the
Foreign Corrupt Practices Act.
|
We may
need additional financing to execute our business plan and fund
operations, which additional financing may not be available on
reasonable terms or at all.
We have limited funds. Even with the aggregate proceeds of
$6,150,000 from the recent private placement (the Private
Placement), we may not be able to execute our current
business plan and fund business operations long enough to
achieve profitability. Our ultimate success may depend upon our
ability to raise additional capital. There can be no assurance
that additional funds will be available when needed from any
source or, if available, will be available on terms that are
acceptable to us. We may be required to pursue sources of
additional capital through various means, including joint
venture projects and debt or equity financing. Future financing
through equity investments is likely to be dilutive to existing
stockholders. Also, the terms of securities we may issue in
future capital transactions may be more favorable to new
investors than our current investors. Newly issued securities
may include preferences, superior voting rights, the issuance of
warrants or other derivative securities, and the issuance of
incentive awards under employee equity incentive plans, which
may have additional dilutive effects. Further, we may incur
substantial costs in pursuing future capital
and/or
financing, including investment banking fees, legal fees,
accounting fees, printing and distribution expenses and other
costs. We may also be required to recognize non-cash expenses in
connection with certain securities we may issue, such as
convertible notes and warrants, which will adversely impact our
financial condition and results of operations. Our ability to
obtain needed financing may be impaired by factors, including
the condition of the economy and capital markets, both generally
and specifically in our industry, and the fact that we are not
profitable, which could impact the availability or cost of
future financing. If the amount of capital we are able to raise
from financing activities, together with our revenues from
operations, is not sufficient to satisfy our capital needs, even
to the extent that we reduce our operations accordingly, we may
be required to cease operations.
We may
be subject to fines for the non-payment of payroll taxes in
prior quarters and, if we are unable to repay the amounts owed,
some of our assets could be taken away.
We may be subject to both federal and state fines for the
non-payment of payroll taxes, penalties and interest for certain
quarters in 2007 through 2009. We have agreed with Michael
Hodges to set aside in escrow
9
1,300,000 shares of our common stock, that were to be
delivered to him as consideration in the Merger, to cover these
and other potential liabilities, but this may not be sufficient
to cover, and we may not otherwise have sufficient funds or be
able to obtain sufficient funds to repay, these liabilities. If
we are unable to repay the amounts owed, the Internal Revenue
Service and various state taxing agencies may levy liens against
our assets and acquire ownership of our assets. The enforcement
of a lien could have a material adverse affect on our business.
In addition, the Internal Revenue Service can seek reimbursement
from our officers and directors that have or have had a direct
relationship over our cash resources
and/or
signature authority on checks.
Our
independent auditors have expressed doubt about our ability to
continue as a going concern.
In their report dated April 14, 2010, our current
independent registered public accounting firm stated that our
consolidated financial statements for the year ended
December 31, 2009 were prepared assuming that we would
continue as a going concern, and that they have doubt about our
ability to continue as a going concern. In their report dated
November 11, 2009, our former independent registered public
accounting firm stated that our consolidated financial
statements for the year ended December 31, 2008 were
prepared assuming that we would continue as a going concern, and
that they have doubt about our ability to continue as a going
concern. Our auditors doubts are based on our recurring
losses, accumulated deficits and negative cash flows from
operations. We continue to experience net operating losses and
negative cash flows from operating activities. Our ability to
continue as a going concern is subject to our ability to
generate profits
and/or
obtain necessary funding from outside sources, including by the
sale of our securities, or obtaining loans from lenders, where
possible. Our continued net operating losses and our
auditors doubts increase the difficulty of our meeting
these goals, and our efforts to continue as a going concern may
not prove successful.
We
depend on our ability to continue to obtain government dredging
contracts, and are therefore greatly impacted by the amount of
government funding for dredging projects. A reduction in this
funding could materially limit future revenues and
profits.
We expect that a material portion of our revenues will be
derived from government dredging contracts. Therefore, if there
is a reduction in government funding for dredging contracts, it
could limit future revenues and profits.
Our
business is subject to significant operating risks and hazards
that could result in damage or destruction to persons or
property, which could result in losses or liabilities to
us.
The dredging business is generally subject to a number of risks
and hazards, including environmental hazards, industrial
accidents, encountering unusual or unexpected geological
formations, cave-ins below water levels, collisions, disruption
of transportation services and flooding. These risks could
result in damage to, or destruction of, dredges, transportation
vessels and other maritime structures and buildings, and could
also result in personal injury, environmental damage,
performance delays, monetary losses or legal liability to third
parties. Although we have general liability and equipment
insurance, if our insurance policies do not cover all of the
potential different risks
and/or
liability amounts, the resulting liabilities could be costly to
us.
Adverse
weather may cause us to incur additional costs and decreased
profit margins.
Our ability to perform a contract may depend on weather
conditions. Inclement weather can delay the completion of a
project, thereby causing us to incur additional costs. As part
of bidding on fixed-price contracts, we make allowances,
consistent with historic weather data, for project downtime due
to adverse weather conditions. In the event that we experience
adverse weather beyond these allowances, we may incur additional
costs and decreased profit margins on these projects.
Seasonality
makes it harder for us to manage our business and for investors
to evaluate our performance.
Our operations may be affected by seasonal fluctuations due to
weather and budgetary cycles influencing the timing of
customers spending for remediation activities. Typically,
during the first quarter of each calendar year there is less
demand for our services due to weather related reasons,
particularly in the northern and mid-western
10
United States and Canada, and an increased possibility of
unplanned weather related stoppages. This seasonality in our
business makes it harder for us to manage our business and for
investors to evaluate our performance.
Environmental
regulations could force us to incur significant capital and
operational costs.
Our operations are subject to various environmental laws and
regulations relating to, among other things, dredging
operations; the disposal of dredged material; protection of
wetlands; storm water and waste water discharges; and,
transportation and disposal of hazardous substances and
materials. We are also subject to laws designed to protect
certain marine species and habitats. Compliance with these
statutes and regulations can delay performance of particular
projects and increase related project costs. These delays and
increased costs could have a material adverse effect on our
results of operations and cash flows.
Our projects may involve transportation and disposal of
hazardous substances and materials. Various laws strictly
regulate the removal and transportation of hazardous substances
and materials, and impose liability for human health effects and
environmental contamination caused by these materials. Services
rendered in connection with hazardous substance and material
removal may involve professional judgments by licensed experts
about the nature of soil conditions and other physical
conditions, including the extent to which hazardous substances
and materials are present, and about the probable effect of
procedures to mitigate or otherwise affect those conditions. If
these judgments and the recommendations based upon these
judgments are incorrect, we may be liable for resulting damages
that we or our customers incur, which may be material. The
failure of certain contractual protections, including any
indemnification from our customers or subcontractors, to protect
us from incurring this liability could have a material adverse
effect on our business, financial condition, results of
operations and cash flows.
Difficult
conditions in the global capital markets and the economy
generally may materially adversely affect our business and
results of operations, and we do not expect these conditions to
improve in the near future.
Our results of operations are materially affected by conditions
in the global capital markets and the economy generally, both in
the U.S. and elsewhere around the world. The stress
experienced by global capital markets that began in the second
half of 2007 continued and substantially increased during the
third and fourth quarter of 2008 and is continuing. Recently,
concerns over inflation, energy costs, geopolitical issues, the
availability and cost of credit, the U.S. mortgage market,
and a declining real estate market in the U.S. have
contributed to increased volatility and diminished expectations
for the economy and the markets going forward. These factors,
combined with volatile oil prices, declining business and
consumer confidence and increased unemployment, have
precipitated an economic slowdown and a global recession.
Domestic and international equity markets have been experiencing
heightened volatility and turmoil. These events and the
continuing market upheavals may have an adverse effect on our
business. In the event of extreme prolonged market events, such
as the global credit crisis, we could incur significant losses.
Risks
Relating to Our Organization and Our Common Stock
We may
be unable to register for resale all of the shares of common
stock and shares of common stock underlying the warrants
included within the units sold in the Private Placement, in
which case purchasers in the Private Placement will need to rely
on an exemption from registration requirements in order to sell
their shares.
In connection with the Private Placement, we entered into a
registration rights agreement, pursuant to which we are
obligated to file a resale registration statement
with the Securities and Exchange Commission (the
SEC) that covers all of the common stock and shares
of common stock underlying the warrants included within the
units sold in the Private Placement (the Warrant
Shares) and to have the resale registration
statement declared effective by the SEC no later than
180 days after the final closing of the Private Placement.
Nevertheless, it is possible that the SEC may not permit us to
register all of the shares of common stock for resale. In
certain circumstances, the SEC may take the view that the
Private Placement requires us to register the resale of the
securities as a primary offering. It is possible that, if
registration is barred by current or future rules and
regulations, rescission of the Private Placement could be sought
by investors or an offer of rescission may be mandated by the
11
SEC, which would result in a material adverse effect on us. In
addition, our shares of public float are limited and are held by
persons who acquired those shares under an effective
registration filed prior to the Merger. Investors should be
aware of the existence of risks that interpretive positions
taken with respect to Rule 415, or similar rules or
regulations including those that may be adopted subsequent to
the date of this prospectus, could impede the manner in which
the common stock and Warrant Shares may be registered or our
ability to register the common stock or Warrant Shares for
resale at all, or the trading in our securities. If we are
unable to register some or all of the common stock or Warrant
Shares, or if shares previously registered are not deemed to be
freely tradeable, these shares would only be able to be sold
pursuant to an exemption from registration under the Securities
Act, such as Rule 144, that currently permits the resale of
securities by holders who are not affiliated with the issuer
following twelve months from November 16, 2009.
As a
result of the Merger, Genesis Fluid Solutions became a
subsidiary of ours and, we are subject to the reporting
requirements of federal securities laws. Such reporting
requirements can be expensive and may divert resources from
other projects, thus impairing our ability to
grow.
As a result of the Merger, Genesis Fluid Solutions became a
subsidiary of ours and, accordingly, is subject to the
information and reporting requirements of the Exchange Act, and
other federal securities laws, including compliance with the
Sarbanes-Oxley Act of 2002. The costs of preparing and filing
annual and quarterly reports, proxy statements and other
information with the SEC (including reporting of the Merger) and
furnishing audited reports to stockholders will cause our
expenses to be higher than they would have been if Genesis Fluid
Solutions had remained privately held and did not consummate the
Merger. In addition, we will incur substantial expenses in
connection with the preparation of the registration statement
and related documents required under the terms of the Private
Placement that require us to register the shares of common stock
included in the units and the Warrant Shares. It may be time
consuming, difficult and costly for us to develop and implement
the internal controls and reporting procedures required by the
Sarbanes-Oxley Act of 2002. We will need to hire additional
financial reporting, internal controls and other finance
personnel in order to develop and implement appropriate internal
controls and reporting procedures. If we are unable to comply
with the internal controls requirements of the Sarbanes-Oxley
Act of 2002, then we may not be able to obtain the independent
accountant certifications required by that act, which may
preclude us from keeping our filings with the SEC current, and
interfere with the ability of investors to trade our securities
and our shares to continue to be quoted on the OTC
Bulletin Board or our ability to list our shares on any
national securities exchange.
If we
fail to establish and maintain an effective system of internal
controls, we may not be able to report our financial results
accurately or prevent fraud. Any inability to report and file
our financial results accurately and timely could harm our
reputation and adversely impact the trading price of our common
stock.
Effective internal controls are necessary for us to provide
reliable financial reports and prevent fraud. If we cannot
provide reliable financial reports or prevent fraud, we may not
be able to manage our business as effectively as we would if an
effective control environment existed, and our business and
reputation with investors may be harmed. As a result, our small
size and any current internal control deficiencies may adversely
affect our financial condition, results of operations and access
to capital. We have not performed an in-depth analysis to
determine if historical undiscovered failures of internal
controls exist, and may in the future discover areas of our
internal controls that need improvement.
Public
company compliance may make it more difficult to attract and
retain officers and directors.
The Sarbanes-Oxley Act of 2002 and rules implemented by the SEC
have required changes in corporate governance practices of
public companies. As a public company, we expect these rules and
regulations to increase our compliance costs in 2010 and beyond
and to make certain activities more time consuming and costly.
As a public company, we also expect that these rules and
regulations may make it more difficult and expensive for us to
obtain director and officer liability insurance and we may be
required to accept reduced policy limits and coverage or incur
substantially higher costs to obtain the same or similar
coverage. As a result, it may be more difficult for us
12
to attract and retain qualified persons to serve on our board of
directors or as executive officers, and to maintain insurance at
reasonable rates, or at all.
Because
we became public by means of a reverse merger, we may not be
able to attract the attention of major brokerage
firms.
There may be risks associated with us becoming public through a
reverse merger. Securities analysts of major
brokerage firms may not provide coverage of us since there is no
incentive to brokerage firms to recommend the purchase of our
common stock. No assurance can be given that brokerage firms
will, in the future, want to conduct any offerings on behalf of
our post-Merger company.
Our
stock price may be volatile.
The market price of our common stock is likely to be highly
volatile and could fluctuate widely in price in response to
various factors, many of which are beyond our control, including
the following:
|
|
|
|
|
changes in our industry;
|
|
|
|
competitive pricing pressures;
|
|
|
|
our ability to obtain working capital financing;
|
|
|
|
additions or departures of key personnel;
|
|
|
|
limited public float following the Merger, in the
hands of a small number of persons whose sales or lack of sales
could result in positive or negative pricing pressure on the
market price for our common stock;
|
|
|
|
sales of our common stock (particularly following effectiveness
of the resale registration statement required to be filed in
connection with the Private Placement);
|
|
|
|
our ability to execute our business plan;
|
|
|
|
operating results that fall below expectations;
|
|
|
|
loss of any strategic relationship;
|
|
|
|
regulatory developments;
|
|
|
|
economic and other external factors;
|
|
|
|
period-to-period fluctuations in our financial results; and
|
|
|
|
our inability to develop or acquire new or needed technology.
|
In addition, the securities markets have from time to time
experienced significant price and volume fluctuations that are
unrelated to the operating performance of particular companies.
These market fluctuations may also materially and adversely
affect the market price of our common stock.
We
have not paid dividends in the past and do not expect to pay
dividends in the future. Any return on investment may be limited
to the value of our common stock.
We have never paid cash dividends on our common stock and do not
anticipate doing so in the foreseeable future. The payment of
dividends on our common stock will depend on earnings, financial
condition and other business and economic factors affecting us
at the time as our board of directors may consider relevant. If
we do not pay dividends, our common stock may be less valuable
because a return on your investment will only occur if our stock
price increases.
13
Our
shares of common stock are very thinly traded, the price may not
reflect our value, and there can be no assurance that there will
be an active market for our shares of common stock either now or
in the future.
Our shares of common stock are very thinly traded, only a small
percentage of our common stock is available to be traded and is
held by a small number of holders, and the price, if traded, may
not reflect our actual or perceived value. There can be no
assurance that there will be an active market for our shares of
common stock either now or in the future. The market liquidity
will be dependent on the perception of our operating business,
among other things. We will take certain steps including
utilizing investor awareness campaigns, press releases, road
shows and conferences to increase awareness of our business, and
any steps that we might take to bring us to the awareness of
investors may require we compensate consultants with cash
and/or
stock. There can be no assurance that there will be any
awareness generated or the results of any efforts will result in
any impact on our trading volume. Consequently, investors may
not be able to liquidate their investment or liquidate it at a
price that reflects the value of the business, and trading may
be at an inflated price relative to the performance of the
Company due to, among other things, availability of sellers of
our shares. If a market should develop, the price may be highly
volatile. Because there may be a low price for our shares of
common stock, many brokerage firms or clearing firms may not be
willing to effect transactions in the securities or accept our
shares for deposit in an account. Even if an investor finds a
broker willing to effect a transaction in the shares of our
common stock, the combination of brokerage commissions, transfer
fees, taxes, if any, and any other selling costs may exceed the
selling price. Further, many lending institutions will not
permit the use of low priced shares of common stock as
collateral for any loans. A significant number of shares have
been issued to our counsel and others as payment for services.
In the aggregate, 1,160,000 shares of freely trading stock
were available for trading immediately following closing of the
Merger. Our counsel serves as escrow agent under the Escrow
Agreement, under which 1,300,000 shares may be registered
for resale. Those shares, in addition to other shares issued to
our counsel, may from time to time be sold in open market
transactions, or in privately negotiated transactions. In the
event we are required to pay any liability or claim under the
Escrow Agreement, the escrow agent will have discretion in
determining the timing and manner of those sales, as well as the
timing and manner of sale of other shares issued to our counsel
for services.
There
is currently a very limited trading market for our common stock
and we cannot ensure that one will ever develop or be
sustained.
To date there has been a very limited trading market for our
common stock. We cannot predict how liquid the market for our
common stock might become. We anticipate having our common stock
continue to be quoted for trading on the OTC
Bulletin Board, however, we cannot be sure that these
quotations will continue. As soon as is practicable, we
anticipate applying for listing of our common stock on the NYSE
Amex, The NASDAQ Capital Market or another national securities
exchange, assuming that we can satisfy the initial listing
standards of the exchange. We currently do not satisfy the
initial listing standards, and cannot ensure that we will be
able to satisfy the listing standards or that our common stock
will be accepted for listing on any exchange. Should we fail to
satisfy the initial listing standards of an exchange, or our
common stock is otherwise rejected for listing and remains
listed on the OTC Bulletin Board or suspended from the OTC
Bulletin Board, the trading price of our common stock could
suffer and the trading market for our common stock may be less
liquid and our common stock price may be subject to increased
volatility. Furthermore, for companies whose securities are
traded in the OTC Bulletin Board, it is more difficult
(1) to obtain accurate quotations, (2) to obtain
coverage for significant news events because major wire services
generally do not publish press releases about these companies,
and (3) to obtain needed capital. We are not required to
register for sale the warrants, and do not intend to register
the warrants for resale by the holders. As a result, the only
value in the warrants will be in the spread between
the trading price of our common stock and the exercise price of
the warrants.
Our
common stock may be deemed a penny stock, which
would make it more difficult for our investors to sell their
shares.
Our common stock may be subject to the penny stock
rules adopted under Section 15(g) of the Exchange Act. The
penny stock rules generally apply to companies whose common
stock is not listed on The NASDAQ Stock Market or another
national securities exchange and trades at less than $4.00 per
share, other than companies that
14
have had average revenues of at least $6,000,000 for the last
three years or that have tangible net worth of at least
$5,000,000 ($2,000,000 if the company has been operating for
three or more years). These rules require, among other things,
that brokers who trade penny stock to persons other than
established customers complete certain
documentation, make suitability inquiries of investors and
provide investors with certain information concerning trading in
the security, including a risk disclosure document and quote
information under certain circumstances. Many brokers have
decided not to trade penny stocks because of the requirements of
the penny stock rules and, as a result, the number of
broker-dealers willing to act as market makers in these
securities is limited. If we remain subject to the penny stock
rules for any significant period, it could have an adverse
effect on the market, if any, for our securities. If our
securities are subject to the penny stock rules, investors will
find it more difficult to dispose of our securities.
Offers
or availability for sale of a substantial number of shares of
our common stock may cause the price of our common stock to
decline.
If our stockholders sell substantial amounts of our common stock
in the public market, including shares issued in the Private
Placement upon the effectiveness of the registration statement
required to be filed, upon the expiration of any statutory
holding period under Rule 144, upon expiration of
lock-up
periods applicable to outstanding shares, or shares issued upon
the exercise of outstanding options or warrants, it could create
a circumstance commonly referred to as an overhang
and, in anticipation of which, the market price of our common
stock could fall. The existence of an overhang, whether or not
sales have occurred or are occurring, also could make more
difficult our ability to raise additional financing through the
sale of equity or equity-related securities in the future at a
time and price that we deem reasonable or appropriate. The
shares of common stock issued in the Merger to the current and
former officers and directors of Genesis Fluid Solutions are
subject to a
lock-up
agreement prohibiting sales of these shares for a period of
12 months following the Merger. Following that date, all of
those shares will become freely tradable, subject to securities
laws and SEC regulations regarding sales by insiders. In
addition, the shares of common stock sold in the Private
Placement and the Warrant Shares will be freely tradable upon
the earlier of (i) effectiveness of a registration
statement covering these shares; and, (ii) the date on
which these shares may be sold without registration pursuant to
Rule 144 (or other applicable exemption) under the
Securities Act.
We may
apply the proceeds of the Private Placement to uses that
ultimately do not improve our operating results or increase the
value of your investment.
We intend to use a portion of the net proceeds from the Private
Placement, including proceeds received upon the exercise of the
warrants, for general working capital purposes. Therefore, our
management will have broad discretion in how we use these
proceeds. These proceeds could be applied in ways that do not
ultimately improve our operating results or otherwise increase
the value of the investment in our common stock or warrants.
Because
our directors and executive officers are among our largest
stockholders, they can exert significant control over our
business and affairs and have actual or potential interests that
may depart from those of our other stockholders.
Our directors and executive officers own or control a
significant percentage of the common stock following the Merger
and completion of the Private Placement. Additionally, the
holdings of our directors and executive officers may increase in
the future upon vesting or other maturation of exercise rights
under any of the options or warrants they may hold or in the
future be granted or if they otherwise acquire additional shares
of our common stock. Following the Merger, our executive
officers and directors, in the aggregate, beneficially own
5,729,920 shares of our common stock, which represents
approximately 32.6% of the voting power of all of our
outstanding shares of stock. Our President, Michael Hodges,
beneficially owns 2,833,800 shares of our common stock
(including the right to vote 1.3 million shares held in
escrow pursuant to the escrow agreement, which he has the right
to re-acquire), and will be able to vote an additional
1,231,120 shares under voting agreements with the
beneficial owners of the shares, until the beneficial owners no
longer own such shares, or a total of approximately 28.3% of the
voting power of all our outstanding shares of stock. Our Senior
Vice President-Field Operations, Larry Campbell, beneficially
owns 600,000 shares of our common stock (consisting of
600,000 shares of our common stock issuable upon exercise
of currently exercisable options). Mary Losty, a director of
ours, beneficially owns 1,030,000 shares of our common
15
stock (including 20,000 shares of our common stock
purchased in the Private Placement and 10,000 shares of our
common stock underlying warrants issued in the Private
Placement. John Freshman, a director of ours, beneficially owns
35,000 shares of our common stock. As a result, in addition
to their board seats and offices, such persons will have
significant influence over and control all corporate actions
requiring stockholder approval, irrespective of how the
Companys other stockholders, including purchasers in the
Private Placement, may vote, including the following actions:
|
|
|
|
|
to elect or defeat the election of our directors;
|
|
|
|
to amend or prevent amendment of our Certificate of
Incorporation or By-laws;
|
|
|
|
to effect or prevent a merger, sale of assets or other corporate
transaction; and
|
|
|
|
to control the outcome of any other matter submitted to our
stockholders for vote.
|
In addition, these persons stock ownership may discourage
a potential acquirer from making a tender offer or otherwise
attempting to obtain control of the Company, which in turn could
reduce our stock price or prevent our stockholders from
realizing a premium over our stock price.
Exercise
of options and warrants may have a dilutive effect on our common
stock.
If the price per share of our common stock at the time of
exercise of any warrants, options, or any other convertible
securities is in excess of the various exercise or conversion
prices of these convertible securities, exercise or conversion
of these convertible securities would have a dilutive effect on
our common stock. As of April 15, 2010, we had
(i) outstanding warrants to purchase 3,412,500 shares
of our common stock at an exercise price of $2.00 per share,
(ii) outstanding Placement Agent warrants to purchase
107,500 shares of our common stock at an exercise price of
$1.25 per share, (iii) outstanding options to purchase
770,000 shares of our common stock at an exercise price of
$0.99 per share, (iv) outstanding options to purchase
1,852,000 shares of our common stock at an exercise price
of $0.90 per share, and (v) outstanding options to purchase
600,000 shares of our common stock at an exercise price of
$1.00 per share. Further, any additional financing that we
secure may require the granting of rights, preferences or
privileges senior to those of our common stock and which result
in additional dilution of the existing ownership interests of
our common stockholders.
Our
certificate of incorporation allows for our board of directors
to create new series of preferred stock without further approval
by our stockholders, which could adversely affect the rights of
the holders of our common stock.
Our board of directors has the authority to fix and determine
the relative rights and preferences of preferred stock. Our
board of directors also has the authority to issue preferred
stock without further stockholder approval. As a result, our
board of directors could authorize the issuance of series of
preferred stock that would grant to holders the preferred right
to our assets upon liquidation, the right to receive dividend
payments before dividends are distributed to the holders of
common stock and the right to the redemption of the shares,
together with a premium, prior to the redemption of our common
stock. In addition, our board of directors could authorize the
issuance of series of preferred stock that have greater voting
power than our common stock or that are convertible into our
common stock, which could decrease the relative voting power of
our common stock or result in dilution to our existing
stockholders.
16
USE OF
PROCEEDS
The selling stockholders will receive all of the proceeds from
the sale of the shares offered by them under this prospectus. We
will not receive any proceeds from the sale of the shares by the
selling stockholders covered by this prospectus. We will,
however, receive proceeds from the exercise of the warrants if
the warrants are exercised for cash. Proceeds received by us, if
any, will be used for working capital and general corporate
purposes.
MARKET
FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS
Our common stock has been quoted on the OTC Bulletin Board
under the symbol GSFL.OB since November 23, 2009. Prior to
November 23, 2009, there was no active market for our
common stock. Trading of our common stock commenced on
November 23, 2009. As of April 12, 2010, there were
approximately 214 holders of record of our common stock.
The following table sets forth the high and low bid prices for
our common stock for the periods indicated, as reported by the
OTC Bulletin Board. The quotations reflect inter-dealer
prices, without retail
mark-up,
mark-down or commission, and may not represent actual
transactions.
|
|
|
|
|
|
|
|
|
Period
|
|
High
|
|
Low
|
|
November 23, 2009 through December 31, 2009
|
|
$
|
6.00
|
|
|
$
|
1.60
|
|
January 1, 2010 through March 31, 2010
|
|
$
|
5.85
|
|
|
$
|
2.60
|
|
The last reported sales price of our common stock on the OTC
Bulletin Board on April 12, 2010 was $3.40 per share.
DIVIDEND
POLICY
We have not declared nor paid any cash dividend on our common
stock, and we currently intend to retain future earnings, if
any, to finance the expansion of our business, and we do not
expect to pay any cash dividends in the foreseeable future. The
decision whether to pay cash dividends on our common stock will
be made by our board of directors, in their discretion, and will
depend on our financial condition, results of operations,
capital requirements and other factors that our board of
directors considers significant.
17
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following discussion and analysis should be read in
conjunction with our consolidated financial statements and
related notes appearing elsewhere in this prospectus. In
addition to historical information, this discussion and analysis
contains forward-looking statements that involve risks,
uncertainties, and assumptions. Our actual results may differ
materially from those anticipated in these forward-looking
statements as a result of certain factors, including but not
limited to those set forth under Risk Factors.
Company
Overview
Genesis Fluid Solutions began operations in 1994 as a sole
proprietorship owned by our founder, Michael Hodges and was
incorporated in Colorado in 2005. We are engaged in the design
and development of waterway restoration, mining, and paper mill
(water) remediation technologies. Our patented Rapid Dewatering
System (RDS) removes different types of debris, sediments, and
contaminates from waterways and industrial sites, which assists
in the recovery of lakes, canals, reservoirs and harbors. The
RDS system separates water from the solid materials that are
dredged, a process that is known as dewatering. Because of the
scalability of the equipment, the small footprint required, and
our own real-time rapid dewatering capabilities, RDS can remove
thousands of cubic yards of sediment per day, and return clear
water to waterways at rates of thousands of gallons per minute.
We believe we accomplish this at significantly lower costs than
our competitors.
Domestically, we have secured two contracts under which we will
perform the work directly. These waterway dredging projects are
due to begin in 2010. Our performance under such contracts is
presently not anticipated to commence until June 2010 and
September 2010, respectively, as the projects are currently
completing permitting requirements.
Results
of Operations
Our revenues are derived from professional services contracts to
dewater dredged material, including fine-grained sediment, for
lake and waterway restoration.
Year
Ended December 31, 2009 Compared with Year Ended
December 31, 2008
Revenues
The Company recognized no revenue for the year ended
December 31, 2009 as compared to $35,097 of revenue for the
year ended December 31, 2008. The decrease is primarily due
to the effects of accounting for revenues under the completed
contract method whereby the company defers revenue until
completion of the project. In addition, the two projects we
currently have contracts for were delayed. The development of
our business was further hindered by a general lack of private
and public financing for the dewatering projects to which we
market and sell our services.
All of our sales for the year ended December 31, 2008, were
to customers in the United States.
Operating
Expenses
Selling,
General and Administrative Expenses
Selling, general and administrative expenses were $1,941,484 for
the year ended December 31, 2009 as compared to $713,424
for the year ended December 31, 2008, an increase of 172%.
Utilizing the proceeds received from financing activities (see
below), we began implementing our business plan and thus, our
selling, general and administrative expenses increased
accordingly. Our selling, general and administrative expenses
consist of expenses paid for payroll and related costs,
consultant and professional fees, stock-based compensation,
insurance, impairments on long-lived assets, equipment
maintenance, depreciation expense, and other general operating
costs.
We expect our costs for personnel, consultants and other
operating costs to increase as we implement our business plan.
Thus, our selling, general and administrative expenses are
likely to increase significantly in future reporting periods.
18
Other
Income (Expense)
Other income (expense) for the year ended December 31, 2009
was $306,283 compared to $496,241 for the year ended
December 31, 2008, a decrease of 38.3%. The decrease was
primarily attributable to the fact that the prior year included
a loss on disposal of property and equipment of $174,125.
Interest expense (which includes $101,250 of stock-based
interest) also decreased by $44,537 primarily due to the
decrease in interest-bearing liabilities (most notably
convertible notes payable decreased by $713,190). The decrease
in interest expense is significantly offset by an increase in
inducement expense on debt conversion of $40,759.
Net
Loss
Net loss for the year ended December 31, 2009 was
$2,247,767 compared to a net loss of $1,568,251 for the year
ended December 31, 2008. The change was attributable to an
increase in operating expenses of $1,228,060, offset by a
decrease in other expenses of $189,958.
Liquidity
and Capital Resources
Net cash used in operations during the year ended
December 31, 2009 totaled $1,737,841 and resulted primarily
from a net loss of $2,247,767, an increase in prepaid expenses
and other current assets of $124,805 and a gain on settlement of
accounts payable of $118,910, partially offset by stock-based
compensation of $284,714, an increase in accounts payable of
$215,592, impairment of patents pending of $119,896,
depreciation of property and equipment of $112,345, and
stock-based interest expense of $101,250.
Net cash used in investing activities during the year ended
December 31, 2009 totaled $69,721 and resulted from $47,922
of purchases of property and equipment and $21,799 of patent
costs.
Net cash provided by financing activities during the year ended
December 31, 2009 totaled $6,661,531 and resulted primarily
from proceeds of $5,909,750 from sales common stock and warrants
(net of offering costs), proceeds of $773,500 from issuances of
convertible notes payable, and capital contributions of
$491,374, partially offset by principal payments of $202,034 on
capital leases, principal payments of $158,179 on convertible
notes payable, and principal payments of $116,662 on a secured
note payable.
At December 31, 2009, we had working capital of $3,232,419,
including $4,873,912 in cash and cash equivalents. We had
minimal revenue generating activities in 2009 and are
transitioning to a new business model. We anticipate that
revenues will resume in June 2010 as we begin to provide
services under waterway dredging contracts. Our cash used in
operating activities during the year ended December 31,
2009 totaled $1,737,841. Our auditors have expressed a going
concern in our consolidated financial statements. Nonetheless,
the Company expects that it has sufficient cash and borrowing
capacity to meet its working capital needs for at least the next
12 months.
Historically, we have financed our working capital and capital
expenditure requirements primarily from notes payable and the
sales of our equity securities. We may seek additional equity
and/or debt
financing in order to implement our business plan. We completed
a Private Placement, commencing October 30, 2009 through
December 29, 2009, whereby we received net proceeds of
$5,909,750, which we believe will fund our operations at least
through December 2010. We do not have any lines of credit or
borrowing facilities to meet our cash needs. As a result, we may
not be able to continue as a going concern, without further
financing, following December 2010. It is reasonably possible
that we will not be able to obtain sufficient financing to
continue operations. Furthermore, any additional equity or
convertible debt financing will be dilutive to existing
shareholders and may involve preferential rights over common
shareholders. Debt financing, with or without equity conversion
features, may involve restrictive covenants.
Related
Party Transactions
No related party transactions had a material impact on our
operating results. See Notes 14 and 19 to our consolidated
financial statements.
19
New
Accounting Pronouncements
See Note 2 to our consolidated financial statements for a
discussion of recent accounting pronouncements.
Critical
Accounting Estimates
Managements discussion and analysis of financial condition
and results of operations is based upon our consolidated
financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United
States of America. The preparation of these consolidated
financial statements requires us to make estimates and
assumptions that affect the reported amounts of assets,
liabilities, revenues, and expenses, and related disclosure of
contingent assets and liabilities. On an ongoing basis, we
evaluate our estimates and assumptions, including, but not
limited to, those related to the estimates of depreciable lives
and valuation of property and equipment, valuation and
amortization periods of intangible assets, valuation of
derivatives, valuation of payroll tax contingencies, valuation
of share-based payments, and the valuation allowance on deferred
tax assets.
20
BUSINESS
The
Company
We are engaged in the design and development of waterway and
water remediation technologies for the environmental, mining and
paper industries. Our patented Rapid Dewatering System (RDS)
removes different types of debris, sediments, and contaminates
from waterways and industrial sites, which assists in the
recovery of lakes, canals, reservoirs and harbors. The RDS
system separates water from the solid materials that are
dredged, a process that is known as dewatering. Because of the
scalability of the equipment, the small footprint required, and
our own real time rapid dewatering capabilities, our RDS can
remove thousands of cubic yards of sediment per day, and return
clear water to waterways at rates of thousands of gallons per
minute. We believe we accomplish this at significantly lower
costs than our competitors.
After demonstrating proof of concept on a port restoration
project in California, we were acknowledged by the Water Board
of the State of California, the United States Environmental
Protection Agency and the United States Army Corps of Engineers
as having an innovative technology acceptable for the
restoration of both contaminated and non-contaminated waterways.
We believe our technologies have a variety of benefits for both
industry and the environment.
Water
Recovery Industry
Many waterways worldwide suffer from eutrophication or
deterioration, leading to the formation of wetlands. This
typically results from agricultural run-off and other man-made
causes. Some waterways are so polluted and stagnant that their
animal and plant life die off and, in the case of rivers and
streams, the current ceases to flow. Having continued access to
healthy, clean lakes, rivers, marinas, shipping ports and other
waterways is vital to maintaining affordable water supplies,
vibrant economies and entire ecosystems. Additionally, mining
operations and paper mills can greatly limit their water usage
by recycling their carriage water in their industrial circuit,
instead of discharging it into natural waterways or disposal
sites.
Cleaning a waterway often requires dredging. Dredging empties
the water body of large quantities of
built-up
debris along the bottom, ranging from coarse material, such as
shells, organic vegetation and garbage, to sand and fine grained
sediment, such as clays, silts and organics.
The methodologies currently employed in the industry to dewater
dredged sentiment from waterways primarily fall into three
categories: (1) upland disposal sites, (2) belt
presses and thickeners, and (3) geo-synthetic tubes. These
techniques have prohibitive costs and, since they are
land-intensive, they are environmentally destructive and slow.
Therefore, increasingly, many communities and governments either
cannot afford to restore their waterways or are unwilling to
accept a process that involves the destruction of one ecosystem
to save another.
Upland Disposal Sites. Unlike coarse material
and sand, fine-grained sediment requires a long settling period
to release even minimal water content. Historically, dredged
sediment has been dewatered in upland disposal sites. These
sites are created by clearing vast areas of land and building
dykes or levees around the sites, resulting in large sludge
lagoons to hold the sediment discharged from hydraulic dredges.
Contained disposal facilities require purchasing land, if
available, which is often expensive, and leveling it, so that it
is completely flat. This construction process completely
destroys all ecosystems in the area, including forests. The
process rate for sun drying in containment areas is
discouragingly slow, requiring an average drying time of seven
or more years. Also, in many coastal areas around the world,
ocean dumping of sediment is now prohibited.
Belt Presses and Thickeners. Dredges can pump
sludge to dewatering plants, which will slowly process it. By
building large or numerous tank farms, the material can be
flocculated, which is a process that facilitates the separation
of water from solids. This process is slow. Typical ratios in
this industry are 3:1 to 5:1. That is, three hours to five hours
to dewater 1 hour of dredge pumping. This approach pulls
the settled flocculated material from the tank bottoms,
generally flocculates the material a second time, then utilizes
a belt press to squeeze the flocculated solids, wringing water
from the solids. Belt press operations are slow and expensive
and require additional operators.
Geo-Synthetic Tubes. Geo-tubes are long and
wide synthetic sausage tubes. Flocculated material
from the dredge is poured into these tubes. Water slowly drains
from numerous and small porous openings in the synthetic
21
material. Eventually the material becomes dry enough to be
removed from the Geo-tube, which is accomplished by cutting the
tubes open. The tubes are expensive, slow to dewater and can
only be used once.
Rapid
Dewatering System (RDS)
We have inverted the concept of settling sediment through a
water column and instead drain water instantly away from the
sediment through our patented system. This eliminates the need
for vast amounts of time
and/or land
to dewater, and does not have the negative environmental effects
found with the other techniques. Our process encompasses several
stages of sediment/asset recovery prior to reaching our RDS unit.
This three-stage process of removing sand and coarse material
yields a slurry of liquid and fine grained particulates that is
suitable for polymer dosing, flocculation and instant
dewatering. By removing heavier solids prior to polymer
introduction, polymer is reserved for only the finest grain
solids, resulting in significant cost savings.
Fine grain sediment removal represents the most challenging
aspect of waterway restoration. We believe that no other
technology can approach the real-time capacity for high-speed
dewatering of ultra-fine solids that we have achieved. The
patented RDS recovers and classifies solid material down to
ultra-fine clays, silts, and organics (7-14 angstroms in size)
and simultaneously returns clear water (30 parts per million
(ppm) of total suspended solids) to the waterway.
|
|
|
|
|
Stage 1 utilizes a coarse screening system to
facilitate removal of coarse debris that may include a variety
of obstructive materials, such as shells, beverage cans, tree
stumps, shoes, lumber, fiberglass or fibrous plant life.
|
|
|
|
Stage 2 utilizes a screening unit designed to
remove, classify and stockpile gravel. The unit we use is
capable of classifying retrieved gravel according to client
specifications and washing the material, which is an important
factor in asset resale.
|
|
|
|
Stage 3 continues the process by salvaging the sand.
The sand recovery system that provides the greatest flexibility
utilizes the dual technologies of sand screws and hydro-cyclones
working in tandem. This process also allows for the
classification, washing and stockpiling of sand for reuse or
sale.
|
Once coarse debris, gravel, and sand have been removed from the
dredge flow, polymer is introduced into the mix. We have
developed a precise, agile technology that continually monitors
the slurry and provides instant response to varying flow rates
and densities. Our state of the art technology measures the
density of the remaining solids to be processed. This data,
coupled with the flow rate, is fed to a programmable logic
control system, which in turn controls a variable speed pump
that injects polymer into the slurry at very close tolerances.
The slurry and polymer are gently blended, initiating a
flash-flocculation process that provides for polymer extension,
contact time, and particle capture. The flocculated substrate is
then distributed over a micro-screen system that enables water
to drain away from the accumulated flocs, instantaneously
separating the clear water from the accumulating cake. The
accumulated cake, which at this point has a consistency of
cottage cheese, is gravity fed into our dewatering boxes for
final dewatering, if desired. The recovered cake is stackable
dirt and ready for disposal or reuse. The turbidity of the clear
water phase is continually monitored, as clear water is returned
to the waterway. The speed and agility of the RDS enables the
dewatering unit to operate in steady state balance with a
hydraulic dredge. Thus, production and recovery occur in a
synchronized, operational rhythm.
Competition
and Competitive Strengths
Our business is highly competitive. We expect to depend on
government contracts for a significant portion of our business.
Competition for government contracts depends upon our ability to
satisfy bidding requirements as well as subcontracting
requirements in the event that we are a subcontractor to a prime
contractor. Many larger more well capitalized companies may be
able to satisfy the financial, size, equipment, employment,
bonding,
22
certification, track record, and other government regulatory
requirements more readily than we are able to. Our typical
competitors are represented by the following companies:
|
|
|
|
|
Deme Environmental Contractors DEC NV (Zwijndrecht,
Belgium) employs belt presses and plate and frame presses and
clarifier (tank) settling systems in Europe. This company is
associated with several large European dredging groups and
performs dewatering operations for ports and waterways.
|
|
|
|
Dredge America, Inc. (Kansas City, Missouri) works with
Geo-Textile tubes. These Geo-Tubes are filled with
flocculated dredge slurry. The tubes, shaped like large
sausages, slowly bleed out capillary moisture from the contained
sludge until the material is relatively dry, and are then cut
open to extricate the dewatered solids.
|
|
|
|
PHOENIX Process Equipment Co. (Louisville, Kentucky) uses belt
presses, screw presses and thickeners, and processes dredge flow
through a flocculation process. This company also provides
consulting services for mining operations and has in-house
fabrication capability.
|
We believe that our RDS gives us an advantage over our
competitors for the following reasons:
|
|
|
|
|
quicker process can dewater a dredge flow in real
time, rather than dry the sediment under the sun over the course
of months
and/or
years, so projects can be completed much quicker;
|
|
|
|
returns clear water can simultaneously return clear,
aerated water to the waterway, thereby providing natural,
oxygenated water to the habitat;
|
|
|
|
works on fine-grained solids can separate water from
even fine-grained solids at high speeds;
|
|
|
|
lower cost is much more cost efficient since
(i) our system is able to sustain a better ratio (dredge
time to dewatering time) than many alternatives so that projects
may be able to be completed sooner than other dewatering
processes, and (ii) we do not need to utilize large amounts
of land to spread out and dewater the dredged sediment;
|
|
|
|
environmentally friendlier is less destructive on
the environment by immediately returning natural, clear water to
the habitat;
|
|
|
|
greater mobility has a small footprint, is mobile
and scalable, which allows for quick set up and restoration of
sites, and access to waterways that other companies
equipment is unable to reach;
|
|
|
|
easier to remove solids can dewater the solids to
less than 50% moisture content, which is the equivalent of dry
dirt, so that they can be stacked for removal, trucking, or
reuse options such as topsoil or landfill;
|
|
|
|
quieter uses sound attenuated equipment, so the only
noise heard resembles a gentle waterfall;
|
|
|
|
odorless has no odor associated with the process,
due to the speed the sediment is dewatered; and,
|
|
|
|
cleaner designed to contain spillage, which is
automatically reprocessed through the system, so that the entire
staging area remains clean.
|
Marketing
Strategies
Our strategy includes directly marketing services to government
and other users, and licensing our technology to others. We
intend to initially focus our efforts on the United States,
Europe and the Pacific Rim.
We may provide the equipment and training necessary to launch
projects while retaining ownership of equipment and intellectual
property. By seeking to cultivate strategic relationships with
large, established companies in various regions of the world, we
believe we can grow more quickly than establishing offices
throughout the world.
Government
and Environmental Regulation
Our operations are subject to various environmental laws and
regulations related to, among other things: dredging operations;
the disposal of dredged material; protection of wetlands; storm
water and waste water
23
discharges; and, transportation and disposal of hazardous
substances and materials. We are also subject to laws designed
to protect certain marine species and habitats. Compliance with
these statutes and regulations can delay appropriation
and/or
performance of particular projects and increase related
expenses. Our projects may involve transportation and disposal
of hazardous waste and other hazardous substances and materials.
Various laws strictly regulate the removal, treatment and
transportation of hazardous substances and materials and impose
liability for human health effects and environmental
contamination caused by these materials. We cannot predict what
environmental legislation or regulations will be enacted in the
future, how existing or future laws or regulations will be
enforced, administered or interpreted, or the amount of future
expenditures that may be required to comply with these
environmental or health and safety laws or regulations, or to
respond to future cleanup matters or other environmental claims.
Intellectual
Property
We have invested significantly in the development of proprietary
technology and also to establish and maintain an extensive
knowledge of the leading technologies, and incorporate these
technologies into the RDS and the services that we offer and
provide to our customers. We hold a patent, which expires in
2021, that covers the European Union, China, South Africa,
Eurasia and New Zealand; a patent pending in the United States,
which is expected in the next 12 months; and, a number of
other patent applications. We believe that we hold adequate
rights to all intellectual property used in our business and
that we do not infringe upon any intellectual property rights
held by other parties.
Properties
We lease our Colorado Springs headquarters, consisting of
approximately 300 square feet of office space, at $1,152.15
per month. The lease is on a month-to-month basis and may be
terminated by either us our landlord with 30 days notice.
Employees
As of April 15, 2010, we had four persons engaged in
management, marketing, sales, project development, and finance
activities for us.
Legal
Proceedings
From time to time, the Company may become involved in litigation
relating to claims arising out of its operations in the normal
course of business. Except as described below, no legal
proceedings, government actions, administrative actions,
investigations or claims are currently pending against us or
involve the Company which, in the opinion of the management of
the Company, could reasonably be expected to have a material
adverse effect on its business or financial condition.
There are no proceedings in which any of the directors, officers
or affiliates of the Company, or any registered or beneficial
stockholder, is an adverse party or has a material interest
adverse to that of the Company.
On May 27, 2008, Eagle North America, Inc.
(Eagle), which provided certain equipment and
consulting services to the Company, filed suit against Genesis
Fluid Solutions and its chief executive officer and director
Michael Hodges for monies owed pursuant to an equipment lease
agreement between Eagle and the Company. Eagle claimed damages
of $152,103.28. The Company made counter claims against Eagle
for a breach of representations and warranties and alleged
damages related to the performance and operation of certain
leased equipment and losses incurred as a result of its
inadequate operation and maintenance of approximately $280,000.
The two parties entered mediation in November 2008.
24
On June 26, 2009, the parties entered into a settlement
agreement under which Eagle dismissed its claims against the
Company, and the Company dismissed its claims against Eagle. The
settlement agreement provided that the Company was to pay Eagle
the sum of $152,000 payable as follows:
|
|
|
|
|
$25,000.00 within thirty days of the settlement, and
|
|
|
|
thereafter 15 equal installments of $8,466.67 beginning on
August 26, 2009.
|
As of April 15, 2010, the Company has on a timely basis
made all payments to date required by the settlement agreement.
On or about March 31, 2010, the Companys agent for
service of process in Delaware notified the Company of its
receipt of service of a partial Summons and Complaint to the
Company. The action was commenced before the Supreme Court, New
York County. We understand the service agent was served with an
incomplete Summons and Complaint, missing pages. We requested a
copy of the Court file. Plaintiff Big Fuel Communications, LLC
seeks $41,250 in damages under various theories of recovery:
breach of contract, quantum meruit and unjust enrichment, for
services allegedly rendered to Genesis Fluid Solutions. The
Company disputes the complaints allegations.
We have a potential dispute concerning a letter with a potential
joint venture partner in the Netherlands, which is more fully
described in Note 15 to our audited consolidated financial
statements for the year ended December 31, 2009. The
parties have alleged certain damages and defenses and are
working together to resolve the issue.
25
MANAGEMENT
Set forth below is certain information regarding our executive
officers and directors. Each of the directors listed below was
elected to our board of directors to serve until our next annual
meeting of stockholders or until his successor is elected and
qualified. All directors hold office for one-year terms until
the election and qualification of their successors. The
following table sets forth information regarding the members of
our board of directors and our executive officers:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position with the Company
|
|
Michael Hodges
|
|
|
59
|
|
|
Chairman and Interim Chief Executive Officer
|
Larry Campbell
|
|
|
61
|
|
|
Senior Vice President-Field Operations
|
Mary Losty
|
|
|
50
|
|
|
Director
|
John Freshman
|
|
|
63
|
|
|
Director
|
Robert Stempel
|
|
|
77
|
|
|
Director
|
Michael Hodges, Chairman and Interim Chief
Executive Officer. Mr. Hodges has been
chairman of the board of directors of the Company since October
2009 and Interim Chief Executive Officer since March 2010. From
October 2005 to October 2009, he was president, chief executive
officer and director of Genesis Fluid Solutions, and founded the
predecessor business to Genesis Fluid Solutions in 1994. He has
30 years of experience in liquid technology, which
culminated with the Genesis Fluid Solutions Rapid Dewatering
System. His experience includes management of lake, marina and
other waterway restoration projects. Prior to founding Genesis
Fluid Solutions, he worked for Black & Veatch. He was
also director and project manager for several, large refinery
and environmental projects. As an early developer of excess
polymer mud systems, he has expertise in working with carbon
dioxide, hydrogen sulfide, anhydrite, and numerous other liquid
contaminants. His extensive operations experience includes
centrifuge, belt press, linear motion shakers, hydrocyclones,
separators, pumping systems, polymer
make-up
units, programmable logic control systems, polymer injection,
flocculation chemistry, coagulation and contaminated sediments.
Mr. Hodges collaborates with colleagues worldwide on a
variety of liquid and water projects and is a speaker at
national and international forums. He has been published in
industry journals, including Engineering News Record, Dredging
and Port Construction, and International Dredging Review. He has
invented a number of dewatering systems and filed several
national and international patents. He holds qualifications in
attapulgite, bentonitic, and montmorillonite mud systems and is
certified in enhanced centrifuge technology. Mr. Hodges
created Mud School, the only certification process
in rapid dewatering technology.
Larry Campbell, Senior Vice President-Field
Operations. Mr. Campbell has been senior
vice president-field operations of Genesis Fluid Solutions since
January 2010. From October 2005 to January 2010, he was senior
vice president and director of field operations of Genesis Fluid
Solutions, and held a similar position with the predecessor
business to Genesis Fluid Solutions since 1994.
Mr. Campbell is responsible for Genesis Fluid Solutions
dewatering operations, and works closely with Mr. Hodges in
research and development. In this capacity, he has brought
solutions to the field of water and waterway restoration
projects that have resulted in Genesis Fluid Solutions being
awarded patents on a variety of innovations, and is the
fabricator of the Genesis Fluid Solutions Rapid Dewatering
System and related clarifier applications and energy dampening
equipment. He has 33 years of experience in commercial
construction management, all phases of related field activity,
and on-site
client relations. He has also designed coarse debris and
manifold systems, as well as inline filters, distributive
systems, and sand recovery units. Earlier in his career,
Mr. Campbell designed and constructed high pressure
snubbing tools for Kuwaiti oilfield recovery, and production
plants for agricultural applications. He is certified as a Lead
Operations Superintendent for contaminated sediments (including
Haz-Mat training), closed loop mud systems, and enhanced belt
press procedures. With expertise in all phases of centrifugal,
positive displacement and gear pump operations,
Mr. Campbell is also a Master Fabricator and Welder.
Mary Losty, Director. Since 1998,
Ms. Losty has been a general partner and portfolio manager
of Cornwall Asset Management, LLC. Prior to that, she worked as
a portfolio manager at Duggan & Associates, as an
equity research analyst and assistant portfolio manager at M.
Kimelman & Co., and at Morgan Stanley &
Company. Since May 2007, she has served on the board of
directors of Procera Networks (AMEX:PKT), a Silicon Valley
bandwidth management company. She is also the commissioner of
the Cambridge, Maryland Planning and Zoning
26
Commission, as well as a member of the Am Board of Directors of
the United Nations University for Peace. Ms. Losty has a
law degree from Georgetown University.
John Freshman, Director. Mr. Freshman has
served as a principal of Troutman Sanders Strategies, a
full-service government relations and issue management firm
since 2006. Prior to joining Troutman Sanders Strategies,
Mr. Freshman served as president of Freshman Kast, Inc., a
multi-purposed government relations and lobbying firm
specializing in environment and natural resources, from 1981
through 2006. Mr. Freshman helped write the original 1972
Clean Water Act, Clean Air Act, and Endangered Species Act. He
has contributed to wetlands protection programs and other
federal legislative proposals and regulations. As a result, he
has been involved in many appropriations legislation for water
including navigation, water supply, dams, and flood control. He
has also served in senior positions in the Senate Environment
and Public Works Committee, the White House, and the
Environmental Protection Agency. His first government position
was as a staff assistant to Senator Richard Schweiker in 1969.
He holds a Political Science degree from Middlebury College.
Robert Stempel,
Director. Mr. Stempel began his career at
General Motors in 1958, was promoted to President and Chief
Operating Officer in 1987, and finally elevated to CEO and
Chairman in 1990. From 1995 through 2007, he served as Chief
Executive Officer and Chairman of Energy Conversion Devices,
where he accomplished exceptional growth in advanced nickel
metal hydride batteries and thin film solar panel technology. In
addition, he was the Chairman of Great Lakes Industries, where
he coordinated industry engagement in key great lakes water
quality, environmental, and policy issues. Mr. Stempel
earned an engineering degree from the Worcester Polytechnic
Institute and an MBA from Michigan State University. He is a
member of the National Academy of Engineering, a Fellow of The
Society of Automotive Engineers and the Engineering Society of
Detroit, and a Life Fellow of the American Society of Mechanical
Engineers.
There are no family relationships among any of our directors and
executive officers.
Independent
Directors
We believe Mary Losty, John D. Freshman, and Robert Stempel are
independent directors, as that term is defined by
listing standards of the national exchanges and SEC rules,
including the rules relating to the independence standards of an
audit committee and the non-employee director definition of
Rule 16b-3
of the Exchange Act.
Committees
of the Board of Directors
We intend to appoint persons to the board of directors and
committees of the board of directors as required to meet the
corporate governance requirements of a national securities
exchange, although we are not required to comply with these
requirements until we elect to seek listing on a national
securities exchange. We intend to appoint directors in the
future so that a majority of our directors will be independent
directors, of which at least one director will qualify as an
audit committee financial expert, within the meaning
of Item 407(d)(5) of
Regulation S-K
of the SEC.
On October 30, 2009, the board of directors appointed an
executive committee, audit committee, compensation committee,
nominating committee and executive committee, and adopted
charters relative to its audit committee, compensation committee
and nominating committee.
Audit
Committee
Mary Losty is currently the sole member of the audit committee.
The audit committees duties are to recommend to our board
of directors the engagement of independent auditors to audit our
financial statements and to review our accounting and auditing
principles. The audit committee reviews the scope, timing and
fees for the annual audit and the results of audit examinations
performed by independent public accountants, including their
recommendations to improve the system of accounting and internal
controls. The audit committee oversees the independent auditors,
including their independence and objectivity. However, the
committee members are not acting as professional accountants or
auditors, and their functions are not intended to duplicate or
substitute for the activities of management and the independent
auditors. The audit committee is empowered to retain independent
27
legal counsel and other advisors as it deems necessary or
appropriate to assist the audit committee in fulfilling its
responsibilities, and to approve the fees and other retention
terms of the advisors. Our audit committee member possesses an
understanding of financial statements and generally accepted
accounting principles. The Company does not currently have an
audit committee financial expert. The Company and its board of
directors have yet to identify a suitable candidate to serve as
the audit committee financial expert due to the small size of
the Company and its limited reporting history, however, the
Company intends to appoint an audit committee financial expert
as soon as it is practical.
Compensation
Committee
Mary Losty is currently the sole member of the compensation
committee. The compensation committee has certain duties and
powers as described in its charter, including but not limited to
periodically reviewing and approving our salary and benefits
policies, compensation of our executive officers, administering
our stock option plans, and recommending and approving grants of
stock options under those plans.
Nominating
Committee
Mary Losty is currently the sole member of the nominating
committee. The nominating committee considers and makes
recommendations on matters related to the practices, policies
and procedures of the board of directors and takes a leadership
role in shaping our corporate governance. As part of its duties,
the nominating committee assesses the size, structure and
composition of the board of directors and its committees,
coordinates evaluation of board performance and reviews board
compensation. The nominating committee also acts as a screening
and nominating committee for candidates considered for election
to the board of directors.
Executive
Committee
Mary Losty is currently the sole member of the executive
committee. The executive committee has certain duties and
powers, including but not limited to assisting the board of
directors in fulfilling its obligations relating to its
operational oversight of the Company. The executive committee
also acts as a screening and nominating committee for candidates
considered for appointment as officers of the Company.
Compensation
Committee Interlocks and Insider Participation
Mary Losty is currently the sole member of the compensation
committee.
None of our directors or executive officers serves as a member
of the board of directors or compensation committee of any other
entity that has one or more of its executive officers serving as
a member of our board of directors.
Director
Compensation
We have not had compensation arrangements in place for members
of our board of directors and have not finalized any plan to
compensate directors in the future for their services as
directors. We may develop a compensation plan for our
independent directors in order to attract qualified persons and
to retain them. We expect that the compensation arrangements may
be comprised of a combination of cash
and/or
equity awards.
28
EXECUTIVE
COMPENSATION
Summary
Compensation Table
The table below sets forth, for the last two fiscal years, the
compensation earned by (i) each individual who served as
our principal executive officer or principal financial officer
during the last fiscal year and (ii) our most highly
compensated executive officer, other than those listed in
clause (i) above, who was serving as executive officers at
the end of the last fiscal year (together, the Named
Executive Officers). No other executive officer had annual
compensation in excess of $100,000 during the last fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Compensation
|
|
Total
|
Name and Principal Position
|
|
Year
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Michael Hodges,
|
|
|
2009
|
|
|
$
|
30,000
|
|
|
|
|
|
|
$
|
279,365
|
|
|
$
|
71,615
|
(1)
|
|
$
|
380,980
|
|
Chairman of the Board of Directors
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
66,998
|
(2)
|
|
$
|
66,998
|
|
of the Company and Interim Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Martin Hedley,
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,313
|
|
|
$
|
15,313
|
|
Former Chief Executive Officer(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selby Little,
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,916
|
|
|
$
|
4,916
|
|
Former Chief Financial Officer(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carol Shobrook
|
|
|
2009
|
|
|
$
|
29,840
|
|
|
|
|
|
|
$
|
154,906
|
|
|
$
|
79,601
|
(6)
|
|
$
|
264,347
|
|
Former Chief Operating Officer(5)
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
36,564
|
|
|
$
|
36,564
|
|
|
|
|
(1) |
|
Consists of (i) $70,500 that was paid to Mr. Hodges
for consulting services performed for Genesis Fluid Solutions
and (ii) $1,115 in life insurance policy premiums that were
paid by the Company on behalf of Mr. Hodges. |
|
(2) |
|
Consists of (i) $44,500 that was paid to Mr. Hodges
for consulting services performed for Genesis Fluid Solutions
and (ii) $22,498 miscellaneous expense reimbursement. |
|
(3) |
|
Mr. Hedley was appointed as the Companys Chief
Executive Officer effective December 14, 2009. Effective
March 9, 2010, Mr. Hedley is no longer serving as the
Companys Chief Executive Officer and is no longer
affiliated with the Company. |
|
(4) |
|
Mr. Little was appointed as the Companys Chief
Financial Officer effective December 15, 2009. Effective
February 14, 2010, Mr. Little is no longer serving as
the Companys Chief Financial Officer and is no longer
affiliated with the Company. |
|
(5) |
|
Ms. Shobrook was appointed as the Companys Chief
Operating Officer effective November 15, 2009. Effective
February 5, 2010, Ms. Shobrook is no longer serving as
our Chief Operating Officer and is no longer affiliated with the
Company. |
|
(6) |
|
Consists of (i) $50,000 that was paid to Ms. Shobrook
for consulting services performed for Genesis Fluid Solutions
and (ii) $29,601 in life insurance policies. |
29
Outstanding
Equity Awards at Fiscal Year-End
Other than as set forth below, there were no outstanding
unexercised options, unvested stock,
and/or
equity incentive plan awards issued to our named executive
officers as of December 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Award
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Market
|
|
|
Option Award
|
|
|
|
|
|
Number
|
|
or Payout
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
Market
|
|
of
|
|
Value of
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
Number
|
|
Value
|
|
Unearned
|
|
Unearned
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
of
|
|
of
|
|
Shares,
|
|
Shares,
|
|
|
Number of
|
|
Number of
|
|
Awards:
|
|
|
|
|
|
Shares
|
|
Shares
|
|
Units or
|
|
Units or
|
|
|
Securities
|
|
Securities
|
|
Number of
|
|
|
|
|
|
or Units
|
|
or Units
|
|
Other
|
|
Other
|
|
|
Underlying
|
|
Underlying
|
|
Securities
|
|
|
|
|
|
of Stock
|
|
of Stock
|
|
Rights
|
|
Rights
|
|
|
Unexercised
|
|
Unexercised
|
|
Underlying
|
|
Option
|
|
|
|
That
|
|
That
|
|
That
|
|
That
|
|
|
Options
|
|
Options
|
|
Unexercised
|
|
Exercise
|
|
Option
|
|
Have
|
|
Have Not
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Unearned
|
|
Price
|
|
Expiration
|
|
Not
|
|
Vested
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
Options
|
|
($)
|
|
Date
|
|
Vested
|
|
($)
|
|
(#)
|
|
($)
|
|
Michael Hodges
|
|
|
|
|
|
|
|
|
|
|
600,000
|
(1)
|
|
$
|
1.00
|
|
|
|
October 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carol Shobrook
|
|
|
|
|
|
|
|
|
|
|
400,000
|
|
|
$
|
0.90
|
|
|
|
October 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Upon closing of the Merger, Michael Hodges was granted
10-year
options to purchase 600,000 shares of our common stock at
$1.00 per share, which options vest upon our reaching the
following milestones: |
|
|
|
Number of Option Shares
|
|
Milestone
|
|
200,000
|
|
Company having pre-tax income of $5 million during the
first year following the closing of the Merger
|
Additional 200,000
|
|
Company having pre-tax income of an additional $12 million
during the second year following the closing of the Merger
|
Additional 200,000
|
|
Company having pre-tax income of an additional $25 million
during the third year following the closing of the Merger
|
Such amounts and bonuses should be calculated on a cumulative
basis. For example, if the Company has $0 pre-tax income in year
1 and $17 million in year 2, then options to purchase
400,000 shares would vest at the end of the second year.
All options described are subject to and have been issued under
our 2009 Equity Incentive Plan.
Employment
Agreements
The Company has not entered into employment agreements with any
of its personnel. Michael Hodges, our Chairman of the Board of
Directors and Interim Chief Executive Officer, earns a salary of
$11,000 per month. Mr. Hodges is entitled to receive such
additional consideration, including higher salaries, bonuses
and/or
option grants, as determined by our Board of Directors.
Equity
Compensation Plan Information
Equity
Incentive Plan
On October 30, 2009, our board of directors and
stockholders adopted the 2009 Equity Incentive Plan. The purpose
of the 2009 Equity Incentive Plan is to provide an incentive to
attract and retain directors, officers, consultants, advisors
and employees whose services are considered valuable, to
encourage a sense of proprietorship, and to stimulate an active
interest of these persons in our development and financial
success. Under the 2009 Equity Incentive Plan, we are authorized
to issue incentive stock options intended to qualify under
Section 422 of the Internal Revenue Code of 1986, as
amended, non-qualified stock options, stock appreciation rights,
performance shares, restricted stock and long term incentive
awards. The 2009 Equity Incentive Plan will be administered by
our board of directors until authority has been delegated to a
committee of the board of directors. On the closing
30
date of the Merger, certain of our executive officers, directors
and other persons were granted options to purchase common stock
exercisable at prices ranging from $0.90 to $1.00 per share as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Shares
|
|
Vesting Schedule
|
|
Exercise Price
|
|
Expiration
|
|
Colleen Stiles
|
|
|
770,000
|
|
|
Six months
|
|
$
|
0.99
|
|
|
|
10/30/19
|
|
Michael Hodges
|
|
|
600,000
|
|
|
Based on milestones
|
|
$
|
1.00
|
|
|
|
10/30/19
|
|
Larry Campbell
|
|
|
600,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Paul Vette
|
|
|
500,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Carol Shobrook
|
|
|
400,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Dan Lohrmeyer
|
|
|
200,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Amanda Sorenson
|
|
|
100,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Michael Whaley
|
|
|
30,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Brittany Jorgenson
|
|
|
20,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
Tim Holt
|
|
|
2,000
|
|
|
Immediate
|
|
$
|
0.90
|
|
|
|
10/30/19
|
|
31
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Except as set forth below, during the past three years, there
have been no transactions, whether directly or indirectly,
between the Company and any of its officers, directors or their
family members.
Loans
On November 28, 2008, the Company entered into a loan
agreement with Maria Hodges, the wife of the Companys
Chief Executive Officer, Michael Hodges for $9,800. The note
bears an annual 4.29 percent interest rate and is due on
November 28, 2018. The note does not have any conversion
feature and is unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, no
principal or interest had been paid on the note. During 2009,
principal and accrued interest on this note was paid in full.
On September 29, 2008, the Company entered into a loan
agreement with Maria Hodges, wife of the Companys Chief
Executive Officer Michael Hodges for $9,000. The note bears an
annual 4.29 percent interest rate and is due on
September 29, 2019. The note does not have conversion
feature and is unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, no
principal interest had been paid on the note. During 2009,
principal and accrued interest on this note was paid in full.
On June 17, 2008, the Company entered into a loan agreement
with Jack Speer, who was then a member of the Genesis Ltd. board
of directors, for $5,000. The note bears an annual
4.29 percent interest rate and is due on June 17,
2018. The note does not have conversion feature and is
unsecured. Accrued and unpaid interest is due at the termination
of the loan. In September 2008, the Company paid Mr. Speer
$2,925 which was recorded as a reduction of the outstanding
principal balance.
On May 28, 2008, the Company entered into a loan agreement
with Jack Speer, who was then a member of the Genesis Ltd. board
of directors, for $1,075. The note had no stated interest rate
or maturity date. The note does not have any conversion feature
and is unsecured. In September 2008, the Company paid
Mr. Speer $1,075 and cancelled the note.
On February 4, 2008, the Company entered into a loan
agreement with Greg Rankin, who has provided legal services to
the Company, for $5,000. The note had no stated interest rate or
maturity date. The note does not have conversion feature and was
unsecured. On July 23, 2008, the principal balance plus
$600 of accrued and unpaid interest was converted into
1,120 shares of common stock.
On August 9, 2007, the Company entered into a loan
agreement with Michael Whaley, the former Chief Financial
Officer of the Company, for $50,000. The note originally bore an
annual interest rate of 20 percent, which was later amended
to 80 percent, and subsequently, in combination with his
separation, was revised to a 15 percent interest rate and
was due on November 5, 2007. The note does not have a
conversion feature and is unsecured. Accrued and unpaid interest
is due at maturity date of the loan. At December 31, 2008,
$37,500, respectively, had been repaid under the note. At
December 31, 2009, $12,500 of principal plus accrued
interest was due on the note. On September 17, 2009,
Michael Whaley, the former chief financial officer of the
Company, resigned. As part of his separation agreement and in
exchange for mutual releases, the Company is required to deliver
the following to Mr. Whaley after completion of the Merger:
(i) $40,000 in cash,
(ii) $30,000 shares of common stock of the
Company, and
(iii) payment of all amounts due under his loan agreement.
As of December 31, 2009, all of the amounts due under the
separation agreement were outstanding as the separation
agreement is in dispute.
On August 9, 2007, the Company entered into a loan
agreement with Larry McCurry, who was then a member of the
Genesis Ltd. board of directors, for $25,000. The note bears an
annual 40 percent interest rate and was due on
November 10, 2007. The note does not have conversion
feature and was unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, the
Company had made payments of $22,500 of which
32
approximately $13,000 had been applied against principal and the
remaining amount recognized as interest. During 2009, principal
and accrued interest on this note was paid in full.
On January 5, 2009, the Company entered into a loan
agreement with Larry McCurry, who was then a member of the
Genesis Ltd. board of directors, for $50,000. The note was
unsecured, bore 40% interest and was due on February 3,
2009. During 2009, principal and accrued interest on this note
was paid in full.
Intellectual
Property Assignment
On August 16, 2009, Michael Hodges and Larry Campbell
executed an assignment agreement, pursuant to which they
assigned to Genesis Fluid Solutions all of the their rights,
title and interest in an invention entitled Apparatus and Method
for De-Watering of Slurries, as described
and/or
claimed in US Application No. 11/676,699 and PCT
Application No. PCT/GB2007/000544, and all rights of
priority in the invention as described
and/or
claimed in any applications for patents based on the invention.
On September 30, 2009, Michael Hodges and Larry Campbell
executed another assignment agreement, pursuant to which they
assigned to Genesis Fluid Solutions all of the their rights,
title and interest in all patents, whether in the United States
or internationally, that they may have in their respective
names, that they may have applied for, or that they will apply
for, directly or indirectly relating to the business currently
conducted
and/or to be
conducted by the Company.
Release
of Cherry Tankers Debt
Pursuant to the terms of a release dated October 30, 2009,
a third party lender forgave loans made to us in the aggregate
amount of $42,727 and released us from any claims he may have
against us. These loans were made to cover certain expenses
incurred by us before the Merger.
Bridge
Notes
Mary Losty, a director of the Company, purchased $100,000 in
principal amount of 10% secured promissory notes as part of our
bridge note financing conducted from May 2009 through
October 13, 2009. Pursuant to the terms of the bridge note
financing, Ms. Losty converted the aggregate principal
amount of her note into units sold in the Private Placement
which closed immediately following the Merger at a rate of
1.3 shares of common stock and warrants to purchase
0.5 shares of common stock for each $1.00 of bridge note
converted.
33
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information as of
April 15, 2010 regarding the beneficial ownership of our
common stock, taking into account the consummation of the
Merger, the Private Placement and the Split-Off, by
(i) each person or entity who, to our knowledge, owns more
than 5% of our common stock; (ii) our executive officers
named in the Summary Compensation Table above; (iii) each
director; and, (iv) all of our executive officers and
directors as a group. Unless otherwise indicated in the
footnotes to the following table, each person named in the table
has sole voting and investment power and that persons
address is
c/o Genesis
Fluid Solutions Holdings, Inc., 830 Tender Foot Hill
Road #301 Colorado Springs, CO 80906 Shares of common
stock subject to options, warrants, or other rights currently
exercisable or exercisable within 60 days of April 14,
2010, are deemed to be beneficially owned and outstanding for
computing the share ownership and percentage of the stockholder
holding the options, warrants or other rights, but are not
deemed outstanding for computing the percentage of any other
stockholder.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Percentage
|
Name of Beneficial Owner
|
|
Beneficially Owned
|
|
Beneficially Owned(1)
|
|
5% Owners :
|
|
|
|
|
|
|
|
|
John Liviakis
|
|
|
1,000,000
|
(2)
|
|
|
5.6
|
%
|
Executive Officers and Directors :
|
|
|
|
|
|
|
|
|
Michael Hodges
|
|
|
4,064,920
|
(3)
|
|
|
22.9
|
%
|
Larry Campbell
|
|
|
600,000
|
(4)
|
|
|
3.3
|
%
|
Mary Losty
|
|
|
1,080,000
|
(5)
|
|
|
6.1
|
%
|
John Freshman
|
|
|
35,000
|
|
|
|
|
*
|
Robert Stempel
|
|
|
0
|
|
|
|
0
|
|
All executive officers and directors as a group
(five persons)
|
|
|
5,779,920
|
(3)(4)(5)
|
|
|
32.6
|
%
|
|
|
|
* |
|
Represents less than one percent. |
|
(1) |
|
Based on 17,751,500 shares of our common stock outstanding
on April 15, 2010. |
|
(2) |
|
Does not include 234,000 shares issued to certain designees
of Liviakis Financial Communications, Inc., a company hired by
us to provide investor relations and public relations services
through May 10, 2011. |
|
(3) |
|
Includes (i) 1,231,120 shares of our common stock that
Mr. Hodges has the power to vote pursuant to certain voting
agreements with existing stockholders, and
(ii) 1,300,000 shares of our common stock that he owns
and that are being held in escrow pursuant to the terms of the
Merger. Does not include 600,000 shares of our common stock
issuable upon exercise of outstanding stock options that are not
exercisable within the next 60 days. |
|
(4) |
|
Consists of 600,000 shares of our common stock issuable
upon exercise of currently exercisable stock options. |
|
(5) |
|
Includes (i) 30,000 shares of our common stock
purchased in the Private Placement upon conversion of certain
outstanding promissory notes and (ii) 50,000 shares of
our common stock underlying warrants issued in the Private
Placement. |
34
SELLING
STOCKHOLDERS
Up to 11,847,500 shares of common stock are being offered
by this prospectus, all of which are being registered for sale
for the accounts of the selling security holders and include the
following:
|
|
|
|
|
7,027,500 shares of common stock issued in the Private
Placement;
|
|
|
|
3,412,500 shares of common stock issuable upon the exercise
of warrants issued to investors in the Private Placement;
|
|
|
|
1,300,000 shares issued in connection with the Merger,
which are being held in escrow for three years in order to cover
certain potential claims, indebtedness and liabilities,
including potential tax liabilities, of Genesis Fluid Solutions;
and
|
|
|
|
107,500 shares of common stock issuable upon the exercise
of warrants issued to the placement agent in connection with the
Private Placements.
|
Each of the transactions by which the selling stockholders
acquired their securities from us was exempt under the
registration provisions of the Securities Act.
The shares of common stock referred to above are being
registered to permit public sales of the shares, and the selling
stockholders may offer the shares for resale from time to time
pursuant to this prospectus. The selling stockholders may also
sell, transfer or otherwise dispose of all or a portion of their
shares in transactions exempt from the registration requirements
of the Securities Act or pursuant to another effective
registration statement covering those shares. We may from time
to time include additional selling stockholders in supplements
or amendments to this prospectus.
The table below sets forth certain information regarding the
selling stockholders and the shares of our common stock offered
by them in this prospectus. None of the selling stockholders
have had a material relationship with us within the past three
years other than as described in the footnotes to the table
below or as a result of their acquisition of our shares or other
securities. To our knowledge, subject to community property laws
where applicable, each person named in the table has sole voting
and investment power with respect to the shares of common stock
set forth opposite such persons name.
Beneficial ownership is determined in accordance with the rules
of the SEC. Each selling stockholders percentage of
ownership of our outstanding shares in the table below is based
upon 17,751,500 shares of common stock outstanding as of
April 15, 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ownership Before Offering
|
|
After Offering(1)
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
Shares of
|
|
|
|
Shares of
|
|
Percentage of
|
|
|
Common Stock
|
|
Number of
|
|
Common Stock
|
|
Common Stock
|
|
|
Beneficially
|
|
Shares
|
|
Beneficially
|
|
Beneficially
|
Selling Stockholder
|
|
Owned
|
|
Offered
|
|
Owned
|
|
Owned
|
|
Stephen J. and Lauren Reynolds Anderson
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Robert A. Ayerle
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Timothy J. Barkocy
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Michael E. and Mary P. Baroody
|
|
|
22,500
|
(4)
|
|
|
22,500
|
(4)
|
|
|
0
|
|
|
|
0
|
|
Michael E. Baroody (IRA) fbo Michael E. Baroody(5)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
James C., Jr. and Nancy F. Barragan
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
George M. Bradvica, Trustee, Bradvica Living Trust, 7/1989(7)
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Cagan Capital LLC(8)
|
|
|
750,000
|
(9)
|
|
|
750,000
|
(9)
|
|
|
0
|
|
|
|
0
|
|
UBS Financial Services FBO Michael T. Collins (IRA Rollover)(10)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Linden Growth Partners Master Fund LP(11)
|
|
|
600,000
|
(43)
|
|
|
600,000
|
(43)
|
|
|
0
|
|
|
|
0
|
|
Seth Ian Fishman
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ownership Before Offering
|
|
After Offering(1)
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
Shares of
|
|
|
|
Shares of
|
|
Percentage of
|
|
|
Common Stock
|
|
Number of
|
|
Common Stock
|
|
Common Stock
|
|
|
Beneficially
|
|
Shares
|
|
Beneficially
|
|
Beneficially
|
Selling Stockholder
|
|
Owned
|
|
Offered
|
|
Owned
|
|
Owned
|
|
Bruce A. Gates
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Kevin Geraghty
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Black Stocking Ventures, LLC(13)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Timothy P. Hecht
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
William H. Hecht
|
|
|
112,500
|
(14)
|
|
|
112,500
|
(14)
|
|
|
0
|
|
|
|
0
|
|
Washington Strategies 401(K) Profit Sharing Plan, fbo William
Jarrell(15)
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Washington Strategies 401K Plan fbo Jennifer Jarrell(16)
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
J Robert Jesmer
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Frank R. Koons, III
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Edward Kowlowitz
|
|
|
450,000
|
(18)
|
|
|
450,000
|
(18)
|
|
|
0
|
|
|
|
0
|
|
Colorado Springs Orthopedic Group Profit Sharing Plan FBO
Kenneth B. Kurica, MD(19)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
John E. Kyees
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Don and Marie Lamberson
|
|
|
52,500
|
(20)
|
|
|
52,500
|
(20)
|
|
|
0
|
|
|
|
0
|
|
Ross Lamberson
|
|
|
105,000
|
(21)
|
|
|
105,000
|
(21)
|
|
|
0
|
|
|
|
0
|
|
Daryl Marcus Lechner
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Sandor Capital Master Fund, L.P.(22)
|
|
|
750,000
|
(9)
|
|
|
750,000
|
(9)
|
|
|
0
|
|
|
|
0
|
|
JSL Kids Partners(23)
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Glengar International Invs Ltd(24)
|
|
|
825,000
|
(25)
|
|
|
825,000
|
(25)
|
|
|
0
|
|
|
|
0
|
|
Daniel J. Mattoon, Sr.
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Rachel McKernan
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Patrick D. McSwain
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Micha Mottale
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
David O. Palmer, M.D.
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
The Barbara L. Kolar Family Trust- 1988(26)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
NTC & CO
26-1356253
FBO Daniel Rivers(27)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Scott Robinson
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Neil Arthur Tallo
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Gordon Clements
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Maria E. Henderson
|
|
|
18,750
|
(28)
|
|
|
18,750
|
(28)
|
|
|
0
|
|
|
|
0
|
|
James A. Lewandowski
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Staffan Lofgren
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
London Family Trust(29)
|
|
|
510,000
|
(30)
|
|
|
510,000
|
(30)
|
|
|
0
|
|
|
|
0
|
|
Harriet Loshin
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Terry and Marci Nelson
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Oman International Holdings(31)
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Christopher Paasch
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
W. Thomas Rhoads
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ownership Before Offering
|
|
After Offering(1)
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
Shares of
|
|
|
|
Shares of
|
|
Percentage of
|
|
|
Common Stock
|
|
Number of
|
|
Common Stock
|
|
Common Stock
|
|
|
Beneficially
|
|
Shares
|
|
Beneficially
|
|
Beneficially
|
Selling Stockholder
|
|
Owned
|
|
Offered
|
|
Owned
|
|
Owned
|
|
Ben Sparango
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Michael C. Brown Trust dated 6/30/2000(32)
|
|
|
225,000
|
(33)
|
|
|
225,000
|
(33)
|
|
|
0
|
|
|
|
0
|
|
James Burzotta
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Kiana Cagan
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Kyla Cagan
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
William S. Daugherty
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Keith W. Davidson
|
|
|
40,000
|
(37)
|
|
|
40,000
|
(37)
|
|
|
0
|
|
|
|
0
|
|
William E. and Frances H. Davidson
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Carl J. Domino
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Jason T. and Dannette E. Evans
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Robert and Amy Frei
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Dean Gardner
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Thomas Glenndahl
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Mikael Johannesson
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Linda U. Kuhlman Trust dated 7/12/94(35)
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Barry Thomas Lechner
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
David J. Lies
|
|
|
330,000
|
(36)
|
|
|
330,000
|
(36)
|
|
|
0
|
|
|
|
0
|
|
John Liviakis Custodian FBO Audrey Liviakis(38)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
John Liviakis Custodian FBO Caroline Liviakis(39)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Janice M. Loshin
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Susan E. Loshin
|
|
|
7,500
|
(40)
|
|
|
7,500
|
(40)
|
|
|
0
|
|
|
|
0
|
|
Andrew S. Losty
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Edward J. Losty and Gretchen N. Losty JT WROS
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Lawrence J. Losty and Esther A. Losty JT WROS
|
|
|
45,000
|
(34)
|
|
|
45,000
|
(34)
|
|
|
0
|
|
|
|
0
|
|
Margaret M. Losty
|
|
|
60,000
|
(41)
|
|
|
60,000
|
(41)
|
|
|
0
|
|
|
|
0
|
|
Mario V. Mele
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
The James Molesky Family Trust(42)
|
|
|
18,750
|
(28)
|
|
|
18,750
|
(43)
|
|
|
0
|
|
|
|
0
|
|
Mark L. Moskowitz
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Paul Francis Pelosi, Jr.
|
|
|
30,000
|
(37)
|
|
|
30,000
|
(37)
|
|
|
0
|
|
|
|
0
|
|
Jan Pettersen
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Robert H. Richardson
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Bradley Rotter
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
J. Rune Sandell
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Sherman Capital Group(45)
|
|
|
150,000
|
(3)
|
|
|
150,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Sustainable Tech Fund(46)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Tarn M. Sublett
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ownership Before Offering
|
|
After Offering(1)
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
Shares of
|
|
|
|
Shares of
|
|
Percentage of
|
|
|
Common Stock
|
|
Number of
|
|
Common Stock
|
|
Common Stock
|
|
|
Beneficially
|
|
Shares
|
|
Beneficially
|
|
Beneficially
|
Selling Stockholder
|
|
Owned
|
|
Offered
|
|
Owned
|
|
Owned
|
|
Charles N. Travers Trustee WDT Dated Oct 24, 1988 FBO Charles N.
and Elizabeth Hall Travers(47)
|
|
|
450,000
|
(18)
|
|
|
450,000
|
(18)
|
|
|
0
|
|
|
|
0
|
|
Joseph J. and Margaret C. Trefaller
|
|
|
75,000
|
(6)
|
|
|
75,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
K. Douglas Whittington Jr. and Carol A. Whittington
|
|
|
15,000
|
(17)
|
|
|
15,000
|
(17)
|
|
|
0
|
|
|
|
0
|
|
Frederick W. Vogel
|
|
|
300,000
|
(48)
|
|
|
300,000
|
(48)
|
|
|
0
|
|
|
|
0
|
|
Roberta T. and Victor Yori
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Todd A. Zuckerbrod IRA(49)
|
|
|
37,500
|
(2)
|
|
|
37,500
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Judy R Block
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Richard Fellin
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Alice Ferdinand
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Margaret Stone Higgins
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Timothy P. Hughes
|
|
|
180,000
|
(3)
|
|
|
180,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Mary M. Losty
|
|
|
80,000
|
(3)
|
|
|
80,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Fourth Street Fund LP(50)
|
|
|
45,000
|
(2)
|
|
|
45,000
|
(2)
|
|
|
0
|
|
|
|
0
|
|
Andrew J. Jr. and Linda L. Pasden
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Robert B. Prag
|
|
|
90,000
|
(6)
|
|
|
90,000
|
(6)
|
|
|
0
|
|
|
|
0
|
|
Donald Rauch
|
|
|
180,000
|
(3)
|
|
|
180,000
|
(3)
|
|
|
0
|
|
|
|
0
|
|
Richard Schmitt
|
|
|
20,000
|
(37)
|
|
|
20,000
|
(37)
|
|
|
0
|
|
|
|
0
|
|
Mary Jo Sherrock
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Patricia M.B. Sinnott and Robert J. Sinnott
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Susan D. Stavish
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
0
|
|
|
|
0
|
|
Colorado Financial Services Corporation(51)
|
|
|
2,700
|
(52)
|
|
|
2,700
|
(52)
|
|
|
0
|
|
|
|
0
|
|
John Lemak
|
|
|
14,000
|
(54)
|
|
|
14,000
|
(54)
|
|
|
0
|
|
|
|
0
|
|
Legend Merchant(55)
|
|
|
8,000
|
(56)
|
|
|
8,000
|
(56)
|
|
|
0
|
|
|
|
0
|
|
Jesup and Lamont(57)
|
|
|
350
|
(58)
|
|
|
350
|
(58)
|
|
|
0
|
|
|
|
0
|
|
Gar Wood Securities(59)
|
|
|
50,000
|
(60)
|
|
|
50,000
|
(60)
|
|
|
0
|
|
|
|
0
|
|
Dave Evanson
|
|
|
2,000
|
(61)
|
|
|
2,000
|
(61)
|
|
|
0
|
|
|
|
0
|
|
Scott Furman
|
|
|
150
|
(62)
|
|
|
150
|
(62)
|
|
|
0
|
|
|
|
0
|
|
Mark Moskowitz
|
|
|
10,200
|
(63)
|
|
|
10,200
|
(63)
|
|
|
0
|
|
|
|
0
|
|
Laird Cagan
|
|
|
11,625
|
(64)
|
|
|
11,625
|
(64)
|
|
|
0
|
|
|
|
0
|
|
Daniel Murphy
|
|
|
825
|
(65)
|
|
|
825
|
(65)
|
|
|
0
|
|
|
|
0
|
|
Brad Ellis
|
|
|
3,400
|
(66)
|
|
|
3,400
|
(66)
|
|
|
0
|
|
|
|
0
|
|
Ramin J. Azar
|
|
|
4,250
|
(44)
|
|
|
4,250
|
(44)
|
|
|
0
|
|
|
|
0
|
|
Sichenzia Ross Friedman Ference LLP
|
|
|
1,300,000
|
(53)
|
|
|
1,300,000
|
(53)
|
|
|
0
|
|
|
|
0
|
|
|
|
|
(1) |
|
Represents the amount of shares that will be held by the selling
stockholders after completion of this offering based on the
assumptions that (a) all shares registered for sale by the
registration statement of which this prospectus is part will be
sold and (b) no other shares of our common stock are
acquired or sold by the selling stockholders prior to completion
of this offering. However, the selling stockholders may sell
all, some or none of the shares offered pursuant to this
prospectus and may sell other shares of our common stock that
they may own pursuant to another registration statement under
the Securities Act or sell some or all of their shares |
38
|
|
|
|
|
pursuant to an exemption from the registration provisions of the
Securities Act, including under Rule 144. To our knowledge
there are currently no agreements, arrangements or understanding
with respect to the sale of any of the shares that may be held
by the selling stockholders after completion of this offering or
otherwise. |
|
(2) |
|
Includes currently exercisable warrants to purchase
12,500 shares of our common stock at an exercise price of
$2.00 per share. |
|
(3) |
|
Includes currently exercisable warrants to purchase
50,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(4) |
|
Includes currently exercisable warrants to purchase
7,500 shares of our common stock at an exercise price of
$2.00 per share. |
|
(5) |
|
Michael E. Baroody, as Beneficial Owner, has voting and
dispositive power over these securities. |
|
(6) |
|
Includes currently exercisable warrants to purchase
25,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(7) |
|
George M. Bradvica, as Trustee, has voting and dispositive power
over these securities. |
|
(8) |
|
Laird Cagan, as Managing Member, has voting and dispositive
power over these securities. |
|
(9) |
|
Includes currently exercisable warrants to purchase
250,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(10) |
|
Michael T. Collins, as beneficial owner, has voting and
dispositive power over these securities. |
|
(11) |
|
Lara Coviello, as Analyst, has voting and dispositive power over
these securities. |
|
(12) |
|
Includes currently exercisable warrants to purchase
100,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(13) |
|
Garrett Gross, as Member, has voting and dispositive power over
these securities. |
|
(14) |
|
Includes currently exercisable warrants to purchase
37,500 shares of our common stock at an exercise price of
$2.00 per share. |
|
(15) |
|
William Jarrell, as Beneficial Owner, has voting and dispositive
power over these securities. |
|
(16) |
|
Jennifer Jarrell, as Beneficial Owner, has voting and
dispositive power over these securities. |
|
(17) |
|
Includes currently exercisable warrants to purchase
5,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(18) |
|
Includes currently exercisable warrants to purchase
150,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(19) |
|
Kenneth B. Kurica and Ashley. Wiechmann, as Trustees, have
voting and dispositive power over these securities. |
|
(20) |
|
Includes currently exercisable warrants to purchase
17,500 shares of our common stock at an exercise price of
$2.00 per share. |
|
(21) |
|
Includes currently exercisable warrants to purchase
35,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(22) |
|
John Lemak, as Manager, has voting and dispositive power over
these securities. |
|
(23) |
|
John S. Lemak, Lacey E. Lemak, Eleanor J. Lemak, and Bailey A.
Lemak, as Partners, have voting and dispositive power over these
securities. |
|
(24) |
|
Ian Crosby, James Colclough, Cora Binchy, Robert Douglas, Mervyn
Ellis, Guy Gibson, Karen Oliver, Paul Roper, Philip Dean,
Phillippe De Salis, Simon Harvey, Nigel Mifsud, Pauline Quach,
Daniel Recordon, Aris Tatos, Christelle Theurillat, Olivier
Perroud, Magali Garcia, Nicola Roberts, Nicholas Bernard, Samuel
Caporossi, Raji Karattuparambil, Corinne Jaggy, and Phillipe
Rauber, as Authorized Signatures, have voting and dispositive
power over these securities. |
|
(25) |
|
Includes currently exercisable warrants to purchase
275,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(26) |
|
Daniel Rivers, as Trustee has voting and dispositive power over
these securities. |
39
|
|
|
(27) |
|
Daniel River, as Beneficial Owner, has voting and dispositive
power over these securities. |
|
(28) |
|
Includes currently exercisable warrants to purchase
6,250 shares of our common stock at an exercise price of
$2.00 per share. |
|
(29) |
|
Robert S. London, as Trustee, has voting and dispositive power
over these securities. |
|
(30) |
|
Includes currently exercisable warrants to purchase
150,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(31) |
|
Ian Crosby, James Colclough, Cora Binchy, Robert Douglas, Mervyn
Ellis, Guy Gilson, Karen Oliver, Paul Roper, Philip Dean,
Phillippe De Salis, Simon Harvey, Nigel Mifsud, Pauline Quach,
Daniel Recordon, Aris Tatos, Christelle Theurillat, Olivier
Perroud, Magali Garcia, Nicola Roberts, Nicholas Bernard, Samuel
Caporossi, Raji Karattuparambil, Corinne Jaggy, and Phillipe
Rauber, as Authorized Signatures, have voting and dispositive
power over these securities. |
|
(32) |
|
Michael C. Brown, as Trustee, has voting and dispositive power
over these securities. |
|
(33) |
|
Includes currently exercisable warrants to purchase
75,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(34) |
|
Includes currently exercisable warrants to purchase
15,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(35) |
|
Linda U. Kuhlman, as Trustee, has voting and dispositive power
over these securities. |
|
(36) |
|
Includes currently exercisable warrants to purchase
100,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(37) |
|
Includes currently exercisable warrants to purchase
10,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(38) |
|
John Liviakis, as Custodian, has voting and dispositive power
over these securities. |
|
(39) |
|
John Liviakis, as Custodian, has voting and dispositive power
over these securities. |
|
(40) |
|
Includes currently exercisable warrants to purchase
2,500 shares of our common stock at an exercise price of
$2.00 per share. |
|
(41) |
|
Includes currently exercisable warrants to purchase
20,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(42) |
|
James Molesky, as Trustee, has voting and dispositive power over
these securities. |
|
(43) |
|
Includes currently exercisable warrants to purchase
200,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(44) |
|
Includes currently exercisable warrants to purchase
4,250 shares of our common stock at an exercise price of
$1.25 per share |
|
(45) |
|
Samuel Sherman, as Manager, has voting and dispositive power
over these securities. |
|
(46) |
|
Paul Ferreri, as CIO and Founder, has voting and dispositive
power over these securities. |
|
(47) |
|
Charles N. Travers, as Trustee, has voting and dispositive power
over these securities. |
|
(48) |
|
Includes currently exercisable warrants to purchase
100,000 shares of our common stock at an exercise price of
$2.00 per share. |
|
(49) |
|
Todd A. Zuckerbrod, as Beneficial Owner, has voting and
dispositive power over these securities. |
|
(50) |
|
Paul Mannion, as Managing Member, has voting and dispositive
power over these securities. |
|
(51) |
|
Laird Cagan, as Managing Member, has voting and dispositive
power over these securities. |
|
(52) |
|
Includes currently exercisable warrants to purchase
33,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(53) |
|
Includes 1,300,000 shares issued in connection with the
Merger to Michael Hodges, our Chairman and Interim Chief
Executive Officer, which are being held in escrow by Sichenzia
Ross Friedman Ference LLP (SRFF) as escrow agent for
three years pursuant to the terms of an escrow agreement in
order to cover certain potential claims, indebtedness and
liabilities, including potential tax liabilities, of Genesis
Fluid Solutions. Pursuant to |
40
|
|
|
|
|
the escrow agreement, Mr. Hodges has voting power over the
shares and Harvey Kesner, a member of SRFF has dispositive power
over the shares. Does not include shares received by SRFF as
compensation for services provided to us. |
|
(54) |
|
Includes currently exercisable warrants to purchase
14,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(55) |
|
David W. Unsworth Jr., as Member, has voting and dispositive
power over these securities. |
|
(56) |
|
Includes currently exercisable warrants to purchase
8,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(57) |
|
William Holub, as Chief Financial Officer, has voting and
dispositive power over these securities. |
|
(58) |
|
Includes currently exercisable warrants to purchase
20,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(59) |
|
Dennis Gerecke, as EVP and COO, has voting and dispositive power
over these securities. |
|
(60) |
|
Includes currently exercisable warrants to purchase
50,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(61) |
|
Includes currently exercisable warrants to purchase
2,000 shares of our common stock at an exercise price of
$1.25 per share. |
|
(62) |
|
Includes currently exercisable warrants to purchase
150 shares of our common stock at an exercise price of
$1.25 per share. |
|
(63) |
|
Includes currently exercisable warrants to purchase
10,200 shares of our common stock at an exercise price of
$1.25 per share. |
|
(64) |
|
Includes currently exercisable warrants to purchase
11,625 shares of our common stock at an exercise price of
$1.25 per share. |
|
(65) |
|
Includes currently exercisable warrants to purchase
825 shares of our common stock at an exercise price of
$1.25 per share. |
|
(66) |
|
Includes currently exercisable warrants to purchase
3,400 shares of our common stock at an exercise price of
$1.25 per share. |
41
DESCRIPTION
OF SECURITIES
Authorized
and Outstanding Capital Stock
We have authorized 125,000,000 shares of capital stock, par
value $0.001 per share, of which 100,000,000 are shares of
common stock and 25,000,000 are shares of
blank-check preferred stock.
As of April 15, 2010, we had the following issued and
outstanding securities on a fully diluted basis:
|
|
|
|
|
17,751,500 shares of common stock;
|
|
|
|
No shares of preferred stock;
|
|
|
|
Warrants to purchase 3,520,000 shares of common stock, of
which (i) three-year callable warrants to purchase
3,412,500 shares of common stock at an exercise price of
$2.00 per share were issued to investors in the Private
Placement and (ii) two-year warrants to purchase
107,500 shares of common stock at an exercise price of
$1.25 per share were issued to the Placement Agents in
connection with the Private Placement; and,
|
|
|
|
Options to purchase 1,852,000 shares of common stock at an
exercise price of $0.90 per share, options to purchase
770,000 shares of common stock at an exercise price of
$0.99 per share, and options to purchase 600,000 shares of
common stock at an exercise price of $1.00 per share.
|
Common
Stock
The holders of our common stock are entitled to one vote per
share. In addition, the holders of our common stock will be
entitled to receive ratably dividends, if any, declared by our
board of directors out of legally available funds; however, the
current policy of our board of directors is to retain earnings,
if any, for operations and growth. Upon liquidation, dissolution
or
winding-up,
the holders of our common stock will be entitled to share
ratably in all assets that are legally available for
distribution. The holders of our common stock will have no
preemptive, subscription, redemption or conversion rights. The
rights, preferences and privileges of holders of our common
stock will be subject to, and may be adversely affected by, the
rights of the holders of any series of preferred stock, which
may be designated solely by action of our board of directors and
issued in the future.
Preferred
Stock
Our board of directors will be authorized, subject to any
limitations prescribed by law, without further vote or action by
our stockholders, to issue from time to time shares of preferred
stock in one or more series. Each series of preferred stock will
have the number of shares, designations, preferences, voting
powers, qualifications and special or relative rights or
privileges as shall be determined by our board of directors,
which may include, among others, dividend rights, voting rights,
liquidation preferences, conversion rights and preemptive rights.
Warrants
We issued three-year warrants to purchase 3,412,500 shares
of our common stock, at an exercise price of $2.00 per share to
investors in the Private Placement. We also issued two-year
warrants to the Placement Agents to purchase an aggregate of
107,500 shares of our common stock, at an initial cash
exercise price of $1.25 per share, in connection with their
efforts as placement agents in connection with the Private
Placement. We are prohibited from effecting the exercise of the
warrants to the extent that as a result of the exercise the
holder of the exercised warrants beneficially owns more than
4.99% (or, if this limitation is waived by the holder upon no
less than 61 days prior notice to us, 9.99%) in the
aggregate of the issued and outstanding shares of our common
stock calculated immediately after giving effect to the issuance
of shares of common stock upon the exercise of the warrants.
Prior to exercise, the warrants do not confer upon holders any
voting or any other rights as a stockholder. In the event that
we are not in material compliance with our registration
obligations set forth in the registration rights agreement
entered into with the investors in the Private Placement, then
the investors have a cashless exercise option upon exercising
their warrants. In addition, so long as the underlying shares of
common stock are registered in an effective registration
statement, if and when shares of the common stock are trading at
or above $3.50 per share for
42
20 consecutive trading days, we will have the option to
redeem the three-year warrants from the investors for a purchase
price of $0.001 per share. A holder of three-year warrants will
have 10 days following notice to convert their warrants or
we may retire the warrants upon the payment of $0.001 per share
underlying each warrant. The warrants contain provisions that
protect the holders against dilution by adjustment of the
purchase price in certain events such as stock dividends, stock
splits and other similar events. In addition, the warrants have
anti-dilution protection in the event we issue securities at a
value less than $1.00 per share (see Future Stock
Issuances below). No fractional shares will be issued upon
exercise of the warrants. If, upon exercise of the warrants, a
holder would be entitled to receive a fractional interest in a
share, we may, in our discretion, upon exercise, round up to the
nearest whole number the number of shares of our common stock to
be issued to the warrant holder or otherwise equitably adjust
the exercise amount and exercise price per share.
Options
As of April 15, 2010, we have granted options to purchase
an aggregate of 3,222,000 shares of our common stock,
pursuant to our 2009 Equity Incentive Plan. See Equity
Compensation Plan Information Equity Incentive
Plan.
Right to
Purchase
On July 30, 2008, Genesis Fluid Solutions entered into a
loan agreement providing for a secured loan in the amount of
$200,000. The loan was secured by substantially all Genesis
Fluid Solutions intellectual property, including its patents,
and guaranteed by its chief executive officer, Michael Hodges.
On August 31, 2009, the loan was repaid in full, and the
collateral released from all liens. Under the loan agreement,
Genesis Fluid Solutions granted to the lender a right to
purchase up to the amount of principal and interest plus $40,000
worth of its common stock at $1 per share for up to one year
from the date of the loans repayment. Following the
repayment of the loan, this right to purchase allows the lender
to purchase 280,000 shares of our common stock at $1.00 per
share until August 31, 2010.
Registration
Rights
We have agreed to file a resale registration
statement with the SEC covering all shares of our common stock
included within the Units sold in the Offering and underlying
any warrants as well as the shares underlying the Placement
Agent warrants, on or before the date which is 90 days
after the final closing date of the Private Placement or the
termination date, whichever occurs later (the Filing
Deadline). We will maintain the effectiveness of the
resale registration statement from the effective
date through and until twelve (12) months after the final
closing date, unless all securities registered under the
registration statement have been sold or are otherwise able to
be sold pursuant to Rule 144. We have agreed to use
commercially reasonable efforts to have the resale
registration statement declared effective by the SEC as soon as
possible and, in any event, within 180 days after the final
closing date of the Private Placement or the termination date,
whichever occurs later (the Effectiveness Deadline).
In addition, if the registration statement is not effective,
then the investors in the Offering are permitted to
piggy-back onto other registration statements that
are filed by the Company, with certain exceptions. One of these
exceptions is in connection with a registration statement filed
to register the sale of certain shares held in escrow in
connection with the Merger. We are obligated to pay to investors
in the Offering a fee of 1% per month of the investors
investment, payable in cash, up to a maximum of 10%, for each
month: (i) in excess of the Filing Deadline that the
registration statement has not been filed; and, (ii) in
excess of the Effectiveness Deadline that the registration
statement has not been declared effective; provided, however,
that the Company shall not be obligated to pay any liquidated
damages if the Company is unable to fulfill its registration
obligations as a result of rules, regulations, positions or
releases issued or actions taken by the SEC pursuant to its
authority with respect to Rule 415, provided
the Company registers at that time the maximum number of shares
of common stock permissible upon consultation with the staff of
the SEC.
Lock-up
Agreements
All our shares of common stock issued in the Merger to the
officers and directors of Genesis Fluid Solutions, as well as to
certain stockholders of Genesis Fluid Solutions, in exchange for
their shares of common stock of Genesis Fluid Solutions, in the
following amounts, are subject to
lock-up
agreements: (i) Michael Hodges
1,533,800 shares and 600,000 shares underlying
options, (ii) Mary Losty 1,000,000 shares,
(iii) Larry Campbell
43
600,000 shares underlying options, and
(iv) Carol Shobrook 400,000 shares
underlying options. These
lock-up
agreements provide that these persons may not sell or transfer
any of their shares for a period of 12 months following the
Merger, with the exception of contributions made to non-profit
organizations qualified as charitable organizations under
Section 501(c)(3) of the Internal Revenue Code of 1986, as
amended, or in privately negotiated sales to persons who agree,
in writing, to be bound to the terms of the
lock-up
agreements.
Transfer
Agent
Our transfer agent is Island Stock Transfer, 100 Second Avenue
South, Suite 104N, St. Petersburg, Florida 33701.
Future
Stock Issuances
Until the earlier of (i) the 12 month anniversary of
the initial closing date of the Private Placement or
(ii) the date that the SEC declared a registration
statement effective that registers the resale of the common
stock issued in the Private Placement and the Warrant Shares
issued in the Private Placement, should we issue or sell any
shares of common stock or any warrants or other convertible
security convertible into our common stock pursuant to which
shares of our common stock may be acquired at a price less than
$1.00 per share (except for issuances under a stock option plan,
upon conversion or exercise of outstanding securities, or in
connection with acquisitions or strategic transactions with a
synergistic business), we shall promptly issue additional shares
to each investor in the Private Placement in an amount
sufficient that the subscription price paid in the Private
Placement, when divided by the total number of shares issued
will result in an actual price per share paid by each investor
equal to the lower price (this is intended to be a full
ratchet adjustment). For example, if an investor purchases
one Unit in the Offering (25,000 shares of common stock)
for a purchase price of $25,000 (equals $1.00 per share) and
then the Company issues additional shares of common stock at
$0.50 per share during the Adjustment Period, the Company will
issue an additional 25,000 shares of common stock to the
investor ($25,000/50,000 shares = $0.50 per share). In
addition, in the event of the issuance of securities at a price
less than $1.00 per share, the exercise price of the warrants
issued in the Private Placement shall be reduced to four times
the lower price, if the resulting exercise price is less than
$2.00 per share.
Changes
in and Disagreements with Accountants
Effective as of January 8, 2010, we dismissed Davis
Accounting Group, P.C. (Davis) as our
independent registered public accounting firm. Davis had
previously been engaged as the principal accountant to audit our
financial statements.
The report of Davis on our financial statements for all periods
prior to January 8, 2010 did not contain an adverse opinion
or disclaimer of opinion, nor was it qualified or modified as to
uncertainty, audit scope or accounting principles, except that
the report was qualified as to our ability to continue as a
going concern.
From our inception through January 8, 2010, there were no
disagreements with Davis on any matter of accounting principles
or practices, financial statement disclosure, or auditing scope
or procedure which, if not resolved to the satisfaction of
Davis, would have caused it to make reference to the matter in
connection with its reports.
As of January 8, 2010, Salberg & Company, P.A.
(Salberg) was engaged as our new independent
registered public accounting firm. Salberg is located at 2295 NW
Corporate Blvd. Suite 240 Boca Raton, FL
33431-7328.
The appointment of Salberg was approved by our board of
directors. During our two most recent fiscal years and the
subsequent interim periods through January 8, 2010 (the
date of engagement of Salberg), we did not consult Salberg
regarding either: (i) the application of accounting
principles to a specific completed or contemplated transaction,
or the type of audit opinion that might be rendered on our
financial statements; or (ii) any matter that was the
subject of a disagreement as described in
Item 304(a)(1)(iv) of
Regulation S-K.
Indemnification
of Directors and Officers
Section 145 of the Delaware General Corporation Law (the
DGCL) provides, in general, that a corporation
incorporated under the laws of the State of Delaware, as we are,
may indemnify any person who was or is a party or
44
is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding (other than a derivative
action by or in the right of the corporation) by reason of the
fact that such person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of
another enterprise, against expenses (including attorneys
fees), judgments, fines and amounts paid in settlement actually
and reasonably incurred by such person in connection with such
action, suit or proceeding if such person acted in good faith
and in a manner such person reasonably believed to be in or not
opposed to the best interests of the corporation and, with
respect to any criminal action or proceeding, had no reasonable
cause to believe such persons conduct was unlawful. In the
case of a derivative action, a Delaware corporation may
indemnify any such person against expenses (including
attorneys fees) actually and reasonably incurred by such
person in connection with the defense or settlement of such
action or suit if such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed
to the best interests of the corporation, except that no
indemnification will be made in respect of any claim, issue or
matter as to which such person will have been adjudged to be
liable to the corporation unless and only to the extent that the
Court of Chancery of the State of Delaware or any other court in
which such action was brought determines such person is fairly
and reasonably entitled to indemnity for such expenses.
Our Certificate of Incorporation and Bylaws provide that we will
indemnify our directors, officers, employees and agents to the
extent and in the manner permitted by the provisions of the
DGCL, as amended from time to time, subject to any permissible
expansion or limitation of such indemnification, as may be set
forth in any stockholders or directors resolution or
by contract. In addition, our director and officer
indemnification agreements with each of our directors and
officers provide, among other things, for the indemnification to
the fullest extent permitted or required by Delaware law,
provided that no indemnitee will be entitled to indemnification
in connection with any claim initiated by the indemnitee against
us or our directors or officers unless we join or consent to the
initiation of the claim, or the purchase and sale of securities
by the indemnitee in violation of Section 16(b) of the
Exchange Act.
Any repeal or modification of these provisions approved by our
stockholders will be prospective only and will not adversely
affect any limitation on the liability of any of our directors
or officers existing as of the time of such repeal or
modification.
We are also permitted to apply for insurance on behalf of any
director, officer, employee or other agent for liability arising
out of his actions, whether or not the DGCL would permit
indemnification.
Limitation
of Liability of Directors
Our certificate of incorporation provides that, to the fullest
extent permitted by the DGCL, no director of the Company will be
personally liable to the Company or its stockholders for
monetary damages for breach of fiduciary duty as a director.
Anti-Takeover
Effect of Delaware Law, Certain By-Law Provisions
Certain provisions of our Bylaws are intended to strengthen the
board of directors position in the event of a hostile
takeover attempt. These provisions have the following effects:
We are subject to the provisions of Section 203 of the
DGCL, an anti-takeover law. In general, Section 203
prohibits a publicly held Delaware corporation from engaging in
a business combination with an interested
stockholder for a period of three years after the date of
the transaction in which the person became an interested
stockholder, unless the business combination is approved in a
prescribed manner. For purposes of Section 203, a
business combination includes a merger, asset sale
or other transaction resulting in a financial benefit to the
interested stockholder, and an interested
stockholder is a person who, together with affiliates and
associates, owns, or within three years prior, did own, 15% or
more of the corporations voting stock.
Disclosure
of Commission Position on Indemnification for Securities Act
Liabilities
Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to our directors, officers, and
persons controlling us, we have been advised that it is the
SECs opinion that such indemnification is against public
policy as expressed in the Securities Act and is, therefore,
unenforceable.
45
PLAN OF
DISTRIBUTION
Each selling stockholder and any of their pledgees, assignees
and
successors-in-interest
may, from time to time, sell any or all of their shares of
common stock on the over-the-counter market or any other stock
exchange, market or trading facility on which the shares are
traded, or in private transactions. These sales may be at fixed
or negotiated prices. A selling stockholder may use any one or
more of the following methods when selling shares:
|
|
|
|
|
ordinary brokerage transactions and transactions in which the
broker-dealer solicits purchasers;
|
|
|
|
block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the
block as principal to facilitate the transaction;
|
|
|
|
purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;
|
|
|
|
conducting business in places where business practices and
customs are unfamiliar and unknown;
|
|
|
|
an exchange distribution in accordance with the rules of the
applicable exchange;
|
|
|
|
privately negotiated transactions;
|
|
|
|
settlement of short sales entered into after the date of this
prospectus;
|
|
|
|
broker-dealers may agree with the selling stockholders to sell a
specified number of the shares at a stipulated price per share;
|
|
|
|
a combination of any of these methods of sale;
|
|
|
|
through the writing or settlement of options or other hedging
transactions, whether through an options exchange or
otherwise; or
|
|
|
|
any other method permitted pursuant to applicable law.
|
The selling stockholders may also sell shares under
Rule 144 under the Securities Act, if available, rather
than under this prospectus.
Broker-dealers engaged by the selling stockholders may arrange
for other brokers-dealers to participate in sales.
Broker-dealers may receive commissions or discounts from the
selling stockholders (or, if any broker-dealer acts as agent for
the purchaser of shares, from the purchaser) in amounts to be
negotiated. Each selling stockholder does not expect these
commissions and discounts relating to its sales of shares to
exceed what is customary in the types of transactions involved.
GarWood Securities LLC, Colorado Financial Service Corporation,
WFG Investments, Inc., Legend Merchant Group, and
Jesup & Lamont Securities Corp. are registered
broker-dealers and FINRA member firms and listed as selling
stockholders in this prospectus. Colorado Financial Service
Corporation, WFG Investments, Inc., Legend Merchant Group and
Jessup & Lamont Securities Group served as placement
agents in our recently completed Private Placement offering, and
received, in addition to cash commissions, warrants to purchase
an aggregate of 50,000, 33,000, 14,000, 8,000 and
2,500 shares of our common stock, respectively, with an
exercise price of $1.25 per share. In addition, GarWood
Securities LLC received warrants to purchase an aggregate of
50,000 shares of common stock effective on
November 10, 2009, which expire on November 11, 2011.
The registration statement of which this prospectus forms a part
includes the shares of common stock underlying the warrants held
by these firms and certain associated persons. The SEC has
indicated that it is their position that any broker-dealer firm
which is a selling stockholder is deemed an underwriter and
therefore these firms may be deemed an underwriter with respect
to the securities being sold by them.
Of the total of 33,000 warrants held by Colorado Financial
Service Corporation (or its associated persons as listed in the
Selling Stockholders table above), 13,000 were
received in connection with the Private Placement closing on
October 30, 2009 and the remainder were received in
connection with the final closing of the Private Placement on
December 29, 2009, and expire on October 30, 2011 and
December 29, 2011, respectively. The 14,000 warrants held
by WFG Investments, Inc. (or its associated persons as listed in
the Selling Stockholders table above) were received
in connection with the Private Placement closing on
October 30, 2009, and expire on October 30, 2011. Of
the total of 8,000 warrants held by Legend Merchant Group (or
its associated persons as listed
46
in the Selling Stockholders table above), 2,000 were
received in connection with the Private Placement closing on
November 19, 2009 and the remainder were received in
connection with the final closing of the Private Placement on
December 29, 2009, and expire on November 19, 2011 and
December 29, 2011, respectively. The 2,500 warrants held by
Jesup & Lamont Securities Corp (or its associated
persons as listed in the Selling Stockholders table
above) were received in connection with the final closing of the
Private Placement on December 29, 2009, and expire on
December 29, 2011. The 107,500 shares of common stock
issued or issuable upon conversion of Placement Agent warrants
received by these firms (or their assignees as indicated in the
Selling Stockholders table above) are restricted
from sale, transfer, assignment, pledge or hypothecation or
being the subject of any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic
disposition of the securities by any person for a period of
180 days immediately following the effective date of the
registration statement, of which this prospectus forms a part,
except transfers of the warrants to officers or partners within
these firms as allowed under FINRA Rule 2710 (g)(1) and (2).
Each of these firms has indicated to us its willingness to act
as selling agent on behalf of certain of the selling
stockholders named in this prospectus under Selling
Stockholders that purchased our privately placed
securities. All shares sold, if any, on behalf of selling
stockholders by these firms would be in transactions executed by
these firms on an agency basis and commissions charged to its
customers in connection with each transaction shall not exceed a
maximum of 4.5% of the gross proceeds. These firms do not have
an underwriting agreement with us
and/or the
selling stockholders and no selling stockholders are required to
execute transactions through these firms. Further, other than
their existing brokerage relationship as customers with these
firms, no selling stockholders have any pre-arranged agreement,
written or otherwise, with these firms to sell their securities
through these firms.
FINRA Rule 2710 requires FINRA member firms (unless an
exemption applies) to satisfy the filing requirements of
Rule 2710 in connection with the resale, on behalf of
selling stockholders, of the securities on a principal or agency
basis. FINRA Notice to Members
88-101 states
that in the event a selling stockholder intends to sell any of
the shares registered for resale in this Prospectus through a
member of FINRA participating in a distribution of our
securities, the member is responsible for ensuring that a timely
filing, if required, is first made with the Corporate Finance
Department of FINRA and disclosing to FINRA the following:
|
|
|
|
|
it intends to take possession of the registered securities or to
facilitate the transfer of the certificates;
|
|
|
|
the complete details of how the selling shareholders shares are
and will be held, including location of the particular accounts;
|
|
|
|
whether the member firm or any direct or indirect affiliates
thereof have entered into, will facilitate or otherwise
participate in any type of payment transaction with the selling
shareholders, including details regarding these
transactions; and
|
|
|
|
in the event any of the securities offered by the selling
shareholders are sold, transferred, assigned or hypothecated by
any selling shareholder in a transaction that directly or
indirectly involves a member firm of FINRA or any affiliates
thereof, that prior to or at the time of said transaction the
member firm will timely file for review with the Corporate
Finance Department of FINRA all relevant documents with respect
to these transactions.
|
FINRA has recently proposed rule changes to FINRA Rule 2710
which may, if approved, modify the requirements of its members
to make filings under FINRA Rule 2710. Further, no FINRA
member firm may receive compensation in excess of that allowable
under FINRA rules, including Rule 2710, in connection with
the resale of the securities by the selling shareholders, which
total compensation may not exceed 8%.
We have advised the selling stockholders that the
anti-manipulation rules of Regulation M under the Exchange
Act may apply to sales of shares in the market and to the
activities of the selling stockholders and their affiliates. In
addition, we will make copies of this Prospectus available to
the selling stockholders for the purpose of satisfying the
Prospectus delivery requirements of the Securities Act.
In connection with the sale of our common stock or interests
therein, the selling stockholders may enter into hedging
transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the
common stock in the course of hedging the positions they assume.
The selling stockholders may also sell shares
47
of our common stock short and deliver these securities to close
out their short positions, or loan or pledge the common stock to
broker-dealers that in turn may sell these securities. The
selling stockholders may also enter into option or other
transactions with broker-dealers or other financial institutions
or the creation of one or more derivative securities which
require the delivery to these broker-dealers or other financial
institutions of shares offered by this prospectus, which shares
these broker-dealers or other financial institutions may resell
pursuant to this prospectus (as supplemented or amended to
reflect these transactions).
The selling stockholders and any broker-dealers or agents that
are involved in selling the shares may be deemed to be
underwriters within the meaning of the Securities
Act in connection with these sales. In this event, any
commissions received by these broker-dealers or agents and any
profit on the resale of the shares purchased by them may be
deemed to be underwriting commissions or discounts under the
Securities Act. Each selling stockholder has informed us that it
does not have any agreement or understanding, directly or
indirectly, with any person to distribute the common stock. In
no event shall any broker-dealer receive fees, commissions and
markups which, in the aggregate, would exceed eight percent (8%).
We are required to pay certain fees and expenses incurred by us
incident to the registration of the shares. We have agreed to
indemnify the selling stockholders against certain losses,
claims, damages and liabilities, including liabilities under the
Securities Act.
The selling stockholders may agree to indemnify any agent,
dealer or broker-dealer that participates in transactions
involving sales of the shares against certain liabilities,
including liabilities arising under the Securities Act.
Because selling stockholders may be deemed to be
underwriters within the meaning of the Securities
Act, they will be subject to the prospectus delivery
requirements of the Securities Act. In addition, any securities
covered by this prospectus which qualify for sale pursuant to
Rule 144 under the Securities Act may be sold under
Rule 144 rather than under this prospectus. There is no
underwriter or coordinating broker acting in connection with the
proposed sale of the shares by the selling stockholders.
Under applicable rules and regulations under the Exchange Act,
any person engaged in the distribution of the shares may not
simultaneously engage in market making activities with respect
to our common stock for a period of two business days prior to
the commencement of the distribution. In addition, the selling
stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including
Regulation M, which may limit the timing of purchases and
sales of shares of our common stock by the selling stockholders
or any other person. We will make copies of this prospectus
available to the selling stockholders and have informed them of
the need to deliver a copy of this prospectus to each purchaser
at or prior to the time of the sale.
LEGAL
MATTERS
Sichenzia Ross Friedman and Ference LLP (SRFF), New
York, New York, will pass upon the validity of the shares of our
common stock to be sold in this offering. SRFF, as escrow agent,
and Harvey Kesner, a member of SRFF, beneficially owns shares of
our common stock.
EXPERTS
The consolidated financial statements as of and for the year
ended December 31, 2009 included in this prospectus have
been audited by Salberg & Company, P.A., an
independent registered public accounting firm as set forth in
their report, and are included in reliance upon such report
given on the authority of such firm as experts in accounting and
auditing. The financial statements as of and for the year ended
December 31, 2008 included in this prospectus have been
audited by Davis Accounting Group P.C., an independent
registered public accounting firm as set forth in their report,
and are included in reliance upon such report given on the
authority of such firm as experts in accounting and auditing.
48
WHERE YOU
CAN FIND ADDITIONAL INFORMATION
We have filed with the SEC a registration statement on
Form S-1,
together with any amendments and related exhibits, under the
Securities Act with respect to our shares of common stock
offered by this prospectus. The registration statement contains
additional information about us and our shares of common stock
that we are offering in this prospectus.
We file annual, quarterly and current reports and other
information with the SEC under the Exchange Act. Our SEC filings
are available to the public over the Internet at the SECs
website at
http://www.sec.gov.
You may also read and copy any document we file at the
SECs public reference room located at
100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at
1-800-SEC-0330
for further information on the public reference rooms and their
copy charges. You may also request a copy of those filings,
excluding exhibits, from us at no cost. These requests should be
addressed to us at: Michael Hodges, Interim Chief Executive
Officer, Genesis Fluid Solutions Holdings, Inc., 830 Tender Foot
Hill Road #301 Colorado Springs, CO 80906.
49
Report of
Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of:
Genesis Fluid Solutions Holdings, Inc.
We have audited the accompanying consolidated balance sheet of
Genesis Fluid Solutions Holdings, Inc. and Subsidiary as of
December 31, 2009 and the related consolidated statements
of operations, changes in stockholders equity
(deficiency), and cash flows for the year then ended. These
consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial
statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating
the overall consolidated financial statement presentation. We
believe that our audit provides a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the
consolidated financial position of Genesis Fluid Solutions
Holdings, Inc. and Subsidiary as of December 31, 2009 and
the consolidated results of its operations and its cash flows
for the year then ended in conformity with accounting principles
generally accepted in the United States of America.
The accompanying consolidated financial statements have been
prepared assuming the Company will continue as a going concern.
As discussed in Note 3 to the consolidated financial
statements, the Company reported a net loss and used cash in
operations of $2,247,767 and $1,737,841, respectively, in 2009.
As of December 31, 2009, the Company had an accumulated
deficit of $6,217,899. In addition, the Company has minimal
revenue generating activities in 2009 and is transitioning to a
new business model. These matters raise substantial doubt about
the Companys ability to continue as a going concern.
Managements plans as to these matters are also described
in Note 3. The consolidated financial statements do not
include any adjustments that might result from the outcome of
this uncertainty.
/s/ Salberg
& Company, P.A.
SALBERG &
COMPANY, P.A.
Boca Raton, Florida
April 14, 2010
F-2
REPORT OF
REGISTERED INDEPENDENT AUDITORS
To the Board of Directors and Stockholders of
Genesis Fluid Solutions, Ltd.:
We have audited the accompanying balance sheet of Genesis Fluid
Solutions, Ltd. (a Colorado corporation) as of December 31,
2008, and the related statements of operations and comprehensive
(loss), stockholders (deficit), and cash flows for the
year then ended. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States of
America). Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of
its internal control over financial reporting. Our audit
included consideration of internal control over financial
reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Companys
internal control over financial reporting. Accordingly, we
express no such opinion. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audit provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the financial position
of Genesis Fluid Solutions, Ltd. as of December 31, 2008,
and the results of its operations and its cash flows for the
year ended December 31, 2008, in conformity with accounting
principles generally accepted in the United States of America.
The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As
discussed in Note 2 to the financial statements, the
Company has experienced operating losses, and has negative
working capital. These and other factors raise substantial doubt
about the Companys ability to continue as a going concern.
Managements plans regarding these matters are also
described in Note 2 to the financial statements. The
financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
Respectfully submitted,
/s/ Davis Accounting Group P.C.
Cedar City, Utah,
November 11, 2009
F-3
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
4,873,912
|
|
|
$
|
9,076
|
|
Costs in excess of billings on uncompleted contracts
|
|
|
59,506
|
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
185,273
|
|
|
|
60,468
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
5,118,691
|
|
|
|
69,544
|
|
Property and equipment, net
|
|
|
719,469
|
|
|
|
844,999
|
|
Patents, net
|
|
|
|
|
|
|
54,492
|
|
Patents pending
|
|
|
|
|
|
|
98,097
|
|
Other assets
|
|
|
|
|
|
|
2,334
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
5,838,160
|
|
|
$
|
1,069,466
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIENCY)
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
82,206
|
|
|
$
|
110,524
|
|
Accrued expenses
|
|
|
476,800
|
|
|
|
771,540
|
|
Warrant derivative liability
|
|
|
804,718
|
|
|
|
|
|
Billings in excess of costs on uncompleted contracts
|
|
|
201,219
|
|
|
|
215,000
|
|
Equipment payable
|
|
|
84,795
|
|
|
|
84,795
|
|
Settlement due to vendor, current portion
|
|
|
84,667
|
|
|
|
67,334
|
|
Loan payable
|
|
|
68,076
|
|
|
|
68,076
|
|
Obligations under capital leases, current portion
|
|
|
59,216
|
|
|
|
143,428
|
|
Convertible notes payable
|
|
|
10,000
|
|
|
|
723,190
|
|
Secured note payable
|
|
|
|
|
|
|
116,662
|
|
Notes payable related parties
|
|
|
14,575
|
|
|
|
50,819
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
1,886,272
|
|
|
|
2,351,368
|
|
Obligations under capital leases, net of current portion
|
|
|
|
|
|
|
117,822
|
|
Settlement due to vendor, net of current portion
|
|
|
|
|
|
|
84,666
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
1,886,272
|
|
|
|
2,553,856
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies See Note 15
|
|
|
|
|
|
|
|
|
Stockholders equity (deficiency):
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value; 25,000,000 shares
authorized, zero shares issued and outstanding
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value; 100,000,000 shares
authorized, 17,668,500 and 10,000,000 issued and outstanding,
respectively
|
|
|
17,669
|
|
|
|
10,000
|
|
Additional paid-in capital
|
|
|
10,152,118
|
|
|
|
2,486,609
|
|
Accumulated other comprehensive loss
|
|
|
|
|
|
|
(10,867
|
)
|
Accumulated deficit
|
|
|
(6,217,899
|
)
|
|
|
(3,970,132
|
)
|
|
|
|
|
|
|
|
|
|
Total stockholders equity (deficiency)
|
|
|
3,951,888
|
|
|
|
(1,484,390
|
)
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity (deficiency)
|
|
$
|
5,838,160
|
|
|
$
|
1,069,466
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-4
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
35,097
|
|
Cost of revenues
|
|
|
|
|
|
|
393,683
|
|
|
|
|
|
|
|
|
|
|
Gross loss
|
|
|
|
|
|
|
(358,586
|
)
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
1,941,484
|
|
|
|
713,424
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
1,941,484
|
|
|
|
713,424
|
|
|
|
|
|
|
|
|
|
|
Operating loss from continuing operations
|
|
|
(1,941,484
|
)
|
|
|
(1,072,010
|
)
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
Change in warrant derivative liability
|
|
|
21,960
|
|
|
|
|
|
Interest income
|
|
|
198
|
|
|
|
10,103
|
|
Interest expense
|
|
|
(287,682
|
)
|
|
|
(332,219
|
)
|
Inducement expense on debt conversion
|
|
|
(40,759
|
)
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
|
|
|
|
(174,125
|
)
|
|
|
|
|
|
|
|
|
|
Total other income (expense), net
|
|
|
(306,283
|
)
|
|
|
(496,241
|
)
|
|
|
|
|
|
|
|
|
|
Loss from continuing operations before income taxes
|
|
|
(2,247,767
|
)
|
|
|
(1,568,251
|
)
|
Income tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(2,247,767
|
)
|
|
|
(1,568,251
|
)
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
Gain (loss) on foreign currency translation, net of income tax
of $0
|
|
|
10,867
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss), net of income taxes
|
|
|
10,867
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
$
|
(2,236,900
|
)
|
|
$
|
(1,568,696
|
)
|
|
|
|
|
|
|
|
|
|
Net loss per share basic and diluted
|
|
$
|
(0.19
|
)
|
|
$
|
(0.16
|
)
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares basic and
diluted
|
|
|
12,050,759
|
|
|
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-5
For the Years Ended December 31, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
Stockholders
|
|
|
|
Common Stock
|
|
|
Paid-In
|
|
|
Comprehensive
|
|
|
Accumulated
|
|
|
Equity
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Loss
|
|
|
Deficit
|
|
|
(Deficiency)
|
|
|
Balance, December 31, 2007
|
|
|
10,000,000
|
|
|
$
|
10,000
|
|
|
$
|
2,230,309
|
|
|
$
|
(10,422
|
)
|
|
$
|
(2,401,881
|
)
|
|
$
|
(171,994
|
)
|
Principal stockholder contribution of cash derived from sale of
common shares of Company stock
|
|
|
|
|
|
|
|
|
|
|
68,360
|
|
|
|
|
|
|
|
|
|
|
|
68,360
|
|
Principal stockholder issuance of shares on behalf of company
for conversion of convertible notes payable and accrued interest
|
|
|
|
|
|
|
|
|
|
|
187,940
|
|
|
|
|
|
|
|
|
|
|
|
187,940
|
|
Foreign currency translation loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
(445
|
)
|
Net loss, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,568,251
|
)
|
|
|
(1,568,251
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
10,000,000
|
|
|
|
10,000
|
|
|
|
2,486,609
|
|
|
|
(10,867
|
)
|
|
|
(3,970,132
|
)
|
|
|
(1,484,390
|
)
|
Principal stockholder contribution of cash derived from sale of
common shares of Company stock
|
|
|
|
|
|
|
|
|
|
|
491,374
|
|
|
|
|
|
|
|
|
|
|
|
491,374
|
|
Principal stockholder issuance of common shares on behalf of
company to settle debt and accrued interest
|
|
|
|
|
|
|
|
|
|
|
770,063
|
|
|
|
|
|
|
|
|
|
|
|
770,063
|
|
Principal stockholder issuance of common shares on behalf of
company for loan origination fees
|
|
|
|
|
|
|
|
|
|
|
265
|
|
|
|
|
|
|
|
|
|
|
|
265
|
|
Common shares returned to treasury and canceled
|
|
|
(1,232,730
|
)
|
|
|
(1,233
|
)
|
|
|
1,233
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares returned in exchange for stock options issued
|
|
|
(1,972,000
|
)
|
|
|
(1,972
|
)
|
|
|
1,972
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issued to settle debt and accrued interest
|
|
|
101,730
|
|
|
|
102
|
|
|
|
142,312
|
|
|
|
|
|
|
|
|
|
|
|
142,414
|
|
Common shares issued for nominal cash and services
|
|
|
2,584,000
|
|
|
|
2,584
|
|
|
|
23,256
|
|
|
|
|
|
|
|
|
|
|
|
25,840
|
|
Consideration paid by stockholders, on behalf of company, to
service providers
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
Consideration paid by stockholders, on behalf of company, to
settle accounts payable
|
|
|
|
|
|
|
|
|
|
|
125,000
|
|
|
|
|
|
|
|
|
|
|
|
125,000
|
|
Common shares issued pursuant to recapitalization
|
|
|
1,160,000
|
|
|
|
1,160
|
|
|
|
(1,160
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares and warrants issued under private placement, net
of offering costs
|
|
|
6,150,000
|
|
|
|
6,150
|
|
|
|
5,903,600
|
|
|
|
|
|
|
|
|
|
|
|
5,909,750
|
|
Common shares and warrants issued for conversions of bridge
notes payable
|
|
|
877,500
|
|
|
|
878
|
|
|
|
775,372
|
|
|
|
|
|
|
|
|
|
|
|
776,250
|
|
Stock option expense
|
|
|
|
|
|
|
|
|
|
|
233,900
|
|
|
|
|
|
|
|
|
|
|
|
233,900
|
|
Reclassifications of warrants from equity to a liability
|
|
|
|
|
|
|
|
|
|
|
(826,678
|
)
|
|
|
|
|
|
|
|
|
|
|
(826,678
|
)
|
Foreign currency translation gain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,867
|
|
|
|
|
|
|
|
10,867
|
|
Net loss, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,247,767
|
)
|
|
|
(2,247,767
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2009
|
|
|
17,668,500
|
|
|
$
|
17,669
|
|
|
$
|
10,152,118
|
|
|
$
|
|
|
|
$
|
(6,217,899
|
)
|
|
$
|
3,951,888
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-6
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(2,247,767
|
)
|
|
$
|
(1,568,251
|
)
|
Adjustments to reconcile net loss from continuing operations to
net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
284,714
|
|
|
|
|
|
Impairment of patents pending
|
|
|
119,896
|
|
|
|
|
|
Depreciation of property and equipment
|
|
|
112,345
|
|
|
|
252,609
|
|
Stock-based interest expense
|
|
|
101,250
|
|
|
|
|
|
Impairment of property and equipment
|
|
|
61,107
|
|
|
|
124,630
|
|
Impairment of patents
|
|
|
50,077
|
|
|
|
|
|
Convertible debt inducement expense
|
|
|
40,759
|
|
|
|
|
|
Amortization of patents
|
|
|
4,415
|
|
|
|
4,415
|
|
Stock-based loan fees
|
|
|
265
|
|
|
|
|
|
Gain on settlement of accounts payable
|
|
|
(118,910
|
)
|
|
|
|
|
Change in warrant derivative liability
|
|
|
(21,960
|
)
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
|
|
|
|
174,125
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Decrease in accounts receivable
|
|
|
|
|
|
|
72,728
|
|
Decrease in inventories
|
|
|
|
|
|
|
2,116
|
|
Increase in costs in excess of billings on uncompleted contracts
|
|
|
(59,506
|
)
|
|
|
|
|
Increase in prepaid expenses and other current assets
|
|
|
(124,805
|
)
|
|
|
|
|
Decrease in other assets
|
|
|
2,334
|
|
|
|
30,000
|
|
Increase (decrease) in accounts payable
|
|
|
215,592
|
|
|
|
(144,518
|
)
|
(Decrease) increase in accrued expenses
|
|
|
(76,533
|
)
|
|
|
320,687
|
|
(Decrease) increase in billings in excess of costs on
uncompleted contracts
|
|
|
(13,781
|
)
|
|
|
215,000
|
|
Decrease in settlement due to vendor
|
|
|
(67,333
|
)
|
|
|
(58,984
|
)
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(1,737,841
|
)
|
|
|
(575,443
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(47,922
|
)
|
|
|
(10,712
|
)
|
Patent costs
|
|
|
(21,799
|
)
|
|
|
(64,290
|
)
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(69,721
|
)
|
|
|
(75,002
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from common stock and warrants issued for cash, net of
offering costs
|
|
|
5,909,750
|
|
|
|
|
|
Capital contributions received
|
|
|
491,374
|
|
|
|
68,360
|
|
Proceeds from issuance of convertible notes payable
|
|
|
773,500
|
|
|
|
595,330
|
|
Principal payments on convertible notes payable
|
|
|
(158,179
|
)
|
|
|
(94,007
|
)
|
Proceeds from issuance of notes payable
|
|
|
|
|
|
|
607,987
|
|
Principal payments on secured note payable
|
|
|
(116,662
|
)
|
|
|
(297,529
|
)
|
Proceeds from notes payable related parties
|
|
|
|
|
|
|
71,975
|
|
Principal payments on notes payable related parties
|
|
|
(36,244
|
)
|
|
|
(85,500
|
)
|
Debt issuance costs
|
|
|
|
|
|
|
(4,000
|
)
|
Principal payments on capital leases
|
|
|
(202,034
|
)
|
|
|
(252,018
|
)
|
Nominal cash received for common shares issued for services
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
6,661,531
|
|
|
|
610,598
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
10,867
|
|
|
|
(445
|
)
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
4,864,836
|
|
|
|
(40,292
|
)
|
Cash and cash equivalents at beginning of year
|
|
|
9,076
|
|
|
|
49,368
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
4,873,912
|
|
|
$
|
9,076
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-7
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH
FLOWS (Continued)
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
111,847
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
Issuance of common stock to settle accounts payable
|
|
$
|
125,000
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of accrued interest payable to convertible notes
payable
|
|
$
|
129,298
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of accrued interest payable to common stock
|
|
$
|
88,909
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible notes payable to common stock
|
|
$
|
1,457,809
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification of warrant derivative liability from additional
paid-in capital
|
|
$
|
826,678
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-8
DECEMBER 31, 2009 AND 2008
|
|
Note 1.
|
Nature of
Operations and Recapitalization
|
Overview
Genesis Fluid Solutions Holdings, Inc. (Holdings or
the Company) is an environmental company that
supplies a Rapid Dewatering System (RDS) technology
for dredged material, including fine-grained sediment, for lake
and waterway restoration. The Companys subsidiary, Genesis
Fluid Solutions, Ltd (Genesis Ltd), was incorporated
on October 26, 2005 under the laws of the State of Colorado.
On October 30, 2009, Genesis Ltd. entered into and
consummated an Agreement of Merger and Plan of Reorganization
(the Merger Agreement) with Holdings, an inactive
publicly-held company, and Genesis Fluid Solutions Acquisition
Corp. (Acquisition Sub), which was Holdings
newly formed, wholly-owned Delaware subsidiary. Upon closing of
the transaction contemplated under the Merger Agreement (the
Merger), Acquisition Sub merged with and into
Genesis Ltd., and Genesis Ltd., as the surviving corporation,
became a wholly-owned subsidiary of Holdings. On
October 30, 2009, the Company changed its name to Genesis
Fluid Solutions Holdings, Inc.
At the closing of the Merger, each share of Genesis Ltd. common
stock that was issued and outstanding immediately prior to the
closing of the Merger was exchanged for ten shares of
Holdings common stock. This transaction was treated as a
recapitalization of Genesis Ltd. with 1,160,000 common shares
deemed issued to the pre-merger stockholders of Holdings.
Subsequent to the merger, but prior to the same day closing of
the first traunche of a private placement of common stock and
warrants, the stockholders of Genesis Ltd. had approximately 89%
voting control of the Company. The accounting effects of the
recapitalization are reflected retroactively for all periods
presented in the accompanying consolidated financial statements
and footnotes (See Note 16).
|
|
Note 2.
|
Significant
Accounting Policies
|
Use of
Estimates
Our consolidated financial statements are prepared in accordance
with accounting principles generally accepted in the United
States (GAAP). These accounting principles require
us to make certain estimates, judgments and assumptions. We
believe that the estimates, judgments and assumptions upon which
we rely are reasonable based upon information available to us at
the time that these estimates, judgments and assumptions are
made. These estimates, judgments and assumptions can affect the
reported amounts of assets and liabilities as of the date of our
consolidated financial statements as well as the reported
amounts of revenues and expenses during the periods presented.
Our consolidated financial statements would be affected to the
extent there are material differences between these estimates
and actual results. In many cases, the accounting treatment of a
particular transaction is specifically dictated by GAAP and does
not require managements judgment in its application. There
are also areas in which managements judgment in selecting
any available alternative would not produce a materially
different result. Significant estimates include the estimates of
depreciable lives and valuation of property and equipment,
valuation and amortization periods of intangible assets,
valuation of derivatives, valuation of payroll tax
contingencies, valuation of share-based payments, and the
valuation allowance on deferred tax assets.
Principles
of Consolidation
The consolidated financial statements include the accounts of
Holdings and its wholly-owned subsidiary Genesis Ltd. All
significant inter-company balances and transactions have been
eliminated in consolidation.
Cash and
Cash Equivalents
The Company considers all short-term highly liquid investments
with an original maturity at the date of purchase of three
months or less to be cash equivalents. There were no cash
equivalents at December 31, 2009.
F-9
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
Accounts
Receivable
The Company records accounts receivable related to its
construction contracts based on billings or on amounts due under
the contractual terms. Accounts receivable throughout the year
may decrease based on payments received, credits for change
orders, or back charges incurred.
Management reviews accounts receivable periodically to determine
if any receivables will potentially be uncollectible.
Managements evaluation includes several factors including
the aging of the accounts receivable balances, a review of
significant past due accounts, economic conditions, and our
historical write-off experience, net of recoveries. The Company
includes any accounts receivable balances that are determined to
be uncollectible, along with a general reserve, in its allowance
for doubtful accounts. After all attempts to collect a
receivable have failed, the receivable is written off against
the allowance.
Property
and Equipment
Property and equipment are stated at cost less accumulated
depreciation. Depreciation is provided for on a straight-line
basis over the estimated useful lives of the assets per the
following table. Expenditures for additions and improvements are
capitalized while repairs and maintenance are expensed as
incurred.
|
|
|
Category
|
|
Depreciation Term
|
|
Computer and office equipment
|
|
3-5 years
|
Equipment and tools
|
|
5-10 years
|
Intangible
Assets
The Company records the purchase of intangible assets not
purchased in a business combination in accordance with the
Financial Accounting Standards Board (FASB)
Accounting Standards Codification (ASC or
Codification) Topic 350 Intangibles - Goodwill
and Other and records intangible assets acquired in a
business combination in accordance with ASC Topic 805
Business Combinations.
The Company capitalizes the costs associated with the
application for and issuance of international patents related to
its technology. Such costs are classified as patents pending in
the accompanying consolidated balance sheet until such time as
the patents are issued. Upon issuance, such costs are
reclassified to patents and subsequently amortized over the
useful life of the related patents.
Long-Lived
Assets
Management evaluates the recoverability of the Companys
identifiable intangible assets and other long-lived assets in
accordance with ASC Topic 360, Property Plant and
Equipment, which generally requires the assessment of
these assets for recoverability when events or circumstances
indicate a potential impairment exists. Events and circumstances
considered by the Company in determining whether the carrying
value of identifiable intangible assets and other long-lived
assets may not be recoverable include, but are not limited to:
significant changes in performance relative to expected
operating results, significant changes in the use of the assets,
significant negative industry or economic trends, a significant
decline in the Companys stock price for a sustained period
of time, and changes in the Companys business strategy. In
determining if impairment exists, the Company estimates the
undiscounted cash flows to be generated from the use and
ultimate disposition of these assets. If impairment is indicated
based on a comparison of the assets carrying values and
the undiscounted cash flows, the impairment loss is measured as
the amount by which the carrying amount of the assets exceeds
the fair market value of the assets.
F-10
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
Fair
Value Measurements
On January 1, 2008, the Company adopted the provisions of
ASC Topic 820 Fair Value Measurements and
Disclosures. ASC Topic 820 defines fair value as used in
numerous accounting pronouncements, establishes a framework for
measuring fair value and expands disclosure of fair value
measurements. Excluded from the scope of ASC Topic 820 are
certain leasing transactions accounted for under ASC Topic 840,
Leases. The exclusion does not apply to fair value
measurements of assets and liabilities recorded as a result of a
lease transaction but measured pursuant to other pronouncements
within the scope of ASC Topic 820.
Revenue
Recognition
The Company generates revenues from professional services
contracts. Customers are billed, according to individual
agreements, typically based upon the amount of cubic yards of
material processed. Revenues from professional services are
recognized on a completed-contract basis, in accordance with ASC
Topic
605-35,
Construction-Type and Production-Type Contracts.
Under the completed-contract basis, contract costs are recorded
to a deferred asset account and billings
and/or cash
received are recorded to a deferred revenue liability account
during the periods of construction. Costs include direct
material, direct labor and subcontract labor. All revenues,
costs, and profits are recognized in operations upon completion
of the contract. A contract is considered complete when all
costs except insignificant items have been incurred and final
acceptance has been received from the customer. Corporate
general and administrative expenses are charged to the periods
as incurred. However, in the event a loss on a contract is
foreseen, the Company will recognize the loss as it is incurred.
For uncompleted contracts, the deferred asset (accumulated
contract costs) in excess of the deferred liability (billings
and/or cash
received) is classified under current assets as Costs in excess
of billings on uncompleted contracts. The deferred liability
(billings
and/or cash
received) in excess of the deferred asset (accumulated contract
costs) is classified under current liabilities as Billings in
excess of costs on uncompleted contracts. Contract retentions
are included in accounts receivable.
The Company is transitioning to a licensing model, under which
it will not be directly performing dredging services. Under such
a contractual arrangement, license fees would typically be paid
to the Company at a negotiated, flat monthly rate, which would
not be tied to the volume of material processed.
Advertising
The Company conducts advertising for the promotion of its
services. In accordance with ASC Topic 720.35.25, advertising
costs are charged to operations when incurred. Advertising costs
aggregated $3,216 and $8,024 for the years ended
December 31, 2009 and 2008, respectively.
Income
Taxes
The Company uses the asset and liability method of accounting
for income taxes in accordance with ASC Topic 740, Income
Taxes. Under this method, income tax expense is recognized
for the amount of: (i) taxes payable or refundable for the
current year, and (ii) deferred tax consequences of
temporary differences resulting from matters that have been
recognized in an entitys financial statements or tax
returns. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be
recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in the
results of operations in the period that includes the enactment
date. A valuation allowance is provided to reduce the deferred
tax assets reported if, based on the weight of the available
positive and negative evidence, it is more likely than not some
portion or all of the deferred tax assets will not be realized.
A liability (including interest if applicable) is established in
the consolidated financial statements to the extent a current
benefit has been recognized on a tax return for matters that are
considered contingent upon the
F-11
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
outcome of an uncertain tax position. Applicable interest is
included as a component of income tax expense and income taxes
payable.
ASC Topic 740.10.30 clarifies the accounting for uncertainty in
income taxes recognized in an enterprises financial
statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition
and measurement of a tax position taken or expected to be taken
in a tax return. ASC Topic 740.10.40 provides guidance on
derecognition, classification, interest and penalties,
accounting in interim periods, disclosure, and transition. The
Company believes its tax positions are all highly certain of
being upheld upon examination. As such, the Company has not
recorded a liability for unrecognized tax benefits. As of
December 31, 2009, the tax years 2006 through 2008 remain
open for IRS audit. The Company has received no notice of audit
from the Internal Revenue Service for any of the open tax years.
The Company adopted the provisions of ASC Topic 740.10.25.09,
which provides guidance on how an entity should determine
whether a tax position is effectively settled for the purpose of
recognizing previously unrecognized tax benefits. The term
effectively settled replaces the term
ultimately settled when used to describe
recognition, and the terms settlement or
settled replace the terms ultimate
settlement or ultimately settled when used to
describe measurement of a tax position under ASC Topic 740.
Topic 740.10.25.09 clarifies that a tax position can be
effectively settled upon the completion of an examination by a
taxing authority without being legally extinguished. For tax
positions considered effectively settled, an entity would
recognize the full amount of tax benefit, even if the tax
position is not considered more likely than not to be sustained
based solely on the basis of its technical merits and the
statute of limitations remains open.
Stock-Based
Compensation
The Company recognizes compensation expense for stock-based
compensation in accordance with ASC Topic No. 718. For
employee stock-based awards, the Company calculates the fair
value of the award on the date of grant using the Black-Scholes
method for stock options; the expense is recognized over the
service period for awards expected to vest. For non-employee
stock-based awards, the Company calculates the fair value of the
award on the date of grant in the same manner as employee
awards, however, the awards are revalued at the end of each
reporting period and the prorata compensation expense is
adjusted accordingly until such time the nonemployee award is
fully vested, at which time the total compensation recognized to
date shall equal the fair value of the stock-based award as
calculated on the measurement date, which is the date at which
the award recipients performance is complete. The
estimation of stock-based awards that will ultimately vest
requires judgment, and to the extent actual results or updated
estimates differ from original estimates, such amounts are
recorded as a cumulative adjustment in the period estimates are
revised. The Company considers many factors when estimating
expected forfeitures, including types of awards, employee class,
and historical experience.
Net Loss
Per Share
Basic net loss per share is computed by dividing the net loss by
the weighted average number of shares of common stock
outstanding during the periods presented. Diluted net loss per
common share is computed using the weighted average number of
common shares outstanding for the period, and, if dilutive,
potential common shares outstanding during the period. Potential
common shares consist of the incremental common shares issuable
upon the exercise of stock options, stock warrants, convertible
debt instruments or other common stock equivalents.
Options to purchase 3,222,000 common shares and warrants to
purchase 3,520,000 common shares were outstanding at
December 31, 2009, but were not included in the computation
of diluted loss per share because the effects would have been
anti-dilutive. These options and warrants may dilute future
earnings per share.
F-12
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
Reclassifications
Certain amounts in the accompanying 2008 consolidated financial
statements have been reclassified to conform to the 2009
presentation.
Comprehensive
Loss
Comprehensive loss includes net loss as currently reported by
the Company adjusted for other comprehensive items. Other
comprehensive items for the Company consist of foreign currency
translations gains and losses.
Foreign
Currency Translation
The Company accounts for foreign currency translation according
to ASC Topic 830, Foreign Currency Matters. The
Companys functional currency is the United States Dollar,
but it had a capital lease obligation that is denominated in
Euros. The capital lease obligation denominated in Euros is
translated into United States Dollars using the current exchange
rate at the end of each fiscal period. Such debt translation
adjustments are included in accumulated other comprehensive
income (loss) for the period. Expenses are translated using the
average exchange rates prevailing throughout the respective
periods. Translation gains or losses related to operating and
interest expenses are recognized for each reporting period in
the related statement of operations and comprehensive loss.
Accounting
for Derivatives
The Company evaluates its options, warrants or other contracts
to determine if those contracts or embedded components of those
contracts qualify as derivatives to be separately accounted for
under ASC Topic 815, Derivatives and Hedging. The
result of this accounting treatment is that the fair value of
the derivative is
marked-to-market
each balance sheet date and recorded as a liability. In the
event that the fair value is recorded as a liability, the change
in fair value is recorded in the statement of operations as
other income (expense). Upon conversion or exercise of a
derivative instrument, the instrument is marked to fair value at
the conversion date and then that fair value is reclassified to
equity. Equity instruments that are initially classified as
equity that become subject to reclassification under ASC Topic
815 are reclassified to liability at the fair value of the
instrument on the reclassification date.
Research
and Development
In accordance with ASC Topic 730, Research and
Development, expenditures for research and development of
the Companys products and services are expensed when
incurred, and are included in operating expenses. The Company
recognized research and development costs of $4,735 and $2,011
for the years ended December 31, 2009 and 2008,
respectively.
Codification
Update
In May 2009, the FASB issued an accounting standard that became
part of ASC Topic
855-10,
Subsequent Events which establishes general
standards of accounting for and disclosure of events that occur
after the balance sheet date but before financial statements are
issued or are available to be issued. ASC Topic 855 sets forth
(1) the period after the balance sheet date during which
management of a reporting entity should evaluate events or
transactions that may occur for potential recognition or
disclosure in the financial statements, (2) the
circumstances under which an entity should recognize events or
transactions occurring after the balance sheet date in its
financial statements and (3) the disclosures that an entity
should make about events or transactions that occurred after the
balance sheet date. ASC Topic 855 is effective for interim or
annual financial periods ending after June 15, 2009. The
adoption of ASC Topic 855 did not have a material effect on the
Companys financial statements.
F-13
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
In June 2009, the FASB issued an accounting standard
ASC 105, Generally Accepted Accounting
Principles, whereby the FASB Accounting Standards
Codification (ASC or Codification) will
be the single source of authoritative nongovernmental
U.S. GAAP. Rules and interpretive releases of the
Securities and Exchange Commission (the SEC) under
authority of federal securities laws are also sources of
authoritative GAAP for SEC registrants. ASC Topic 105 is
effective for interim and annual periods ending after
September 15, 2009. All existing accounting standards are
superseded as described in ASC Topic 105. All other accounting
literature not included in the Codification is
non-authoritative. The Codification is not expected to have a
significant impact on the Companys financial statements.
In August 2009, the FASB issued Accounting Standards Update
2009-05,
Fair Value Measurements and Disclosures (Topic 820):
Measuring Liabilities at Fair Value. ASU
2009-05
provided amendments to
ASC 820-10,
including clarification that in circumstances in which a quoted
price in an active market for the identical liability is not
available, a reporting entity is required to measure fair value
using certain techniques. ASU
2009-05 also
clarifies that when estimating the fair value of a liability, a
reporting entity is not required to include a separate input or
adjustment to other inputs relating to the existence of a
restriction that prevents the transfer of a liability. ASU
2009-05 also
clarifies that both a quoted price in an active market for the
identical liability at the measurement date and the quoted price
for the identical liability when traded as an asset in an active
market when no adjustments to the quoted price of the asset are
required are Level 1 fair value measurements. Adoption of
ASU 2009-05
did not have a material impact on the Companys
consolidated results of operations or financial condition.
In October 2009, the FASB issued ASU
2009-13,
Multiple-Deliverable Revenue Arrangements (amendments to
FASB ASC Topic 605, Revenue Recognition) (ASU
2009-13)
and ASU
2009-14,
Certain Arrangements That Include Software Elements,
(amendments to FASB ASC Topic 985, Software) (ASU
2009-14).
ASU 2009-13
requires entities to allocate revenue in an arrangement using
estimated selling prices of the delivered goods and services
based on a selling price hierarchy. The amendments eliminate the
residual method of revenue allocation and require revenue to be
allocated using the relative selling price method. ASU
2009-14
removes tangible products from the scope of software revenue
guidance and provides guidance on determining whether software
deliverables in an arrangement that includes a tangible product
are covered by the scope of the software revenue guidance. ASU
2009-13 and
ASU 2009-14
should be applied on a prospective basis for revenue
arrangements entered into or materially modified in fiscal years
beginning on or after June 15, 2010, with early adoption
permitted. The Company does not expect adoption of ASU
2009-13 or
ASU 2009-14
to have a material impact on the Companys consolidated
results of operations or financial condition.
In January 2010, the FASB issued ASU
2010-06,
Fair Value Measurements and Disclosures (Topic 820):
Improving Disclosures about Fair Value Measurements. This
update provides amendments to Topic 820 that will provide more
robust disclosures about (1) the different classes of
assets and liabilities measured at fair value, (2) the
valuation techniques and inputs used, (3) the activity in
Level 3 fair value measurements, and (4) the transfers
between Levels 1, 2, and 3. The Company does not expect
adoption of ASU
2010-06 to
have a material impact on the Companys consolidated
results of operations or financial condition.
In February 2010, the FASB issued ASU
2010-09,
Subsequent Events (Topic 855): Amendments to Certain
Recognition and Disclosure Requirements. This update
addresses both the interaction of the requirements of Topic 855,
Subsequent Events, with the SECs reporting
requirements and the intended breadth of the reissuance
disclosures provision related to subsequent events
(paragraph 855-10-50-4).
The amendments in this update have the potential to change
reporting by both private and public entities, however, the
nature of the change may vary depending on facts and
circumstances. The Company does not expect adoption of ASU
2010-09 to
have a material impact on the Companys consolidated
results of operations or financial condition.
F-14
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
As reflected in the accompanying consolidated financial
statements for the years ended December 31, 2009 and 2008,
the Company had net losses of $2,247,767 and $1,568,251, and
cash used in operations of $1,737,841 and $575,443,
respectively. At December 31, 2009, the Company had an
accumulated deficit of $6,217,899. In addition, the Company had
minimal revenue generating activities in 2009 and is
transitioning to a new business model. These matters raise
substantial doubt about the Companys ability to continue
as a going concern. During 2009, the Company raised
approximately $7.2 million from contributed capital, new
loans, and a private placement of its common stock and warrants,
net of offering costs. At December 31, 2009, the Company
had working capital of $3,232,419, which includes a warrant
derivative liability of $804,718. Management plans to utilize
its working capital to implement its business plan. The
financial statements do not include any adjustments relating to
the recovery of the recorded assets or the classification of the
liabilities that might be necessary should the Company be unable
to implement its business plan and continue as a going concern.
|
|
Note 4.
|
Costs In
Excess of Billings (Billings in Excess of Costs) On Uncompleted
Contracts
|
Costs in excess of billings on uncompleted contracts (calculated
on an individual contract basis) represent accumulated contract
costs that exceeded billings
and/or cash
received on uncompleted contracts.
At December 31, 2009 and 2008, costs in excess of billings
on uncompleted contracts consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Costs on uncompleted contracts
|
|
$
|
76,596
|
|
|
$
|
|
|
Less: Billings and/or cash receipts on uncompleted contracts
|
|
|
(17,090
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs in excess of billings on uncompleted contracts
|
|
$
|
59,506
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Billings in excess of costs on uncompleted contracts (calculated
on an individual contract basis) represents billings
and/or cash
received that exceed accumulated contract costs on uncompleted
contracts.
At December 31, 2009 and 2008, billings in excess of costs
on uncompleted contracts consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Billings and/or cash receipts on uncompleted contracts
|
|
$
|
215,000
|
|
|
$
|
215,000
|
|
Less: Costs on uncompleted contracts
|
|
|
(13,781
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billings in excess of costs on uncompleted contracts
|
|
$
|
201,219
|
|
|
$
|
215,000
|
|
|
|
|
|
|
|
|
|
|
F-15
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
|
|
Note 5.
|
Property
and Equipment
|
Property and equipment consisted of the following at
December 31, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Computer and office equipment
|
|
$
|
9,724
|
|
|
$
|
9,724
|
|
Equipment and tools
|
|
|
1,065,959
|
|
|
|
1,142,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,075,683
|
|
|
|
1,152,392
|
|
Accumulated depreciation
|
|
|
(356,214
|
)
|
|
|
(307,393
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$
|
719,469
|
|
|
$
|
844,999
|
|
|
|
|
|
|
|
|
|
|
Property and equipment held under capitalized leases of $258,991
and $258,991 at December 31, 2009 and 2008, respectively,
are included in Equipment and tools above. Depreciation expense
for the years ended December 31, 2009 and 2008 was $112,345
and $252,609, of which $25,899 and $25,899 pertained to the
capitalized lease discussed above, for the years ended
December 31, 2009 and 2008, respectively. Accumulated
depreciation amounted to $356,214 and $307,393, of which $62,589
and $36,690 pertained to capitalized leases, as of
December 31, 2009 and 2008, respectively.
During the year ended December 31, 2008, as a result of an
analysis by management, the Company determined that an
impairment charge and write off of certain pieces of RDS
equipment were appropriate. The Company recorded an impairment
reserve as of December 31, 2008 of $124,630, which is
included in operating expenses, and wrote off the net book value
of RDS equipment amounting to $174,125, which is included in
other income (expense). No other events or circumstances
occurred for which an evaluation of the recoverability of
long-lived assets was required.
During the year ended December 31, 2009, the Company
recognized an impairment loss of $61,107, which is included in
operating expenses, related to the net book value of RDS
equipment held by a third party that was not recoverable.
Patents consisted of the following at December 31, 2009 and
2008:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Patents
|
|
$
|
|
|
|
$
|
68,767
|
|
Patents pending
|
|
|
|
|
|
|
98,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
166,864
|
|
Accumulated amortization
|
|
|
|
|
|
|
(14,275
|
)
|
|
|
|
|
|
|
|
|
|
Intangible assets, net
|
|
$
|
|
|
|
$
|
152,589
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for the years ended December 31, 2009
and 2008 was $4,415 and $4,415, respectively.
For the year ended December 31, 2009, as a result of an
analysis by management, the Company recognized an impairment
loss of $50,077 and $119,896 relating to the net book value of
patents and patents pending, respectively. The charge is
included in selling, general and administrative expenses.
F-16
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
Accrued expenses consisted of the following at December 31,
2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2009
|
|
|
2008
|
|
|
Payroll and related benefits
|
|
$
|
288,945
|
|
|
$
|
536,782
|
|
Accrued interest
|
|
|
12,180
|
|
|
|
183,482
|
|
Sales tax payable
|
|
|
|
|
|
|
16,276
|
|
Other
|
|
|
175,675
|
|
|
|
35,000
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
476,800
|
|
|
$
|
771,540
|
|
|
|
|
|
|
|
|
|
|
The Company has accrued payroll and estimated related taxes,
including estimated penalties and interest, to various taxing
authorities, including the Internal Revenue Service, that
pertain to various years of service. At December 31, 2009
and 2008, estimated penalties and interest in the amounts of
$63,709 and $33,851, respectively, were included in payroll and
related benefits in the above table.
|
|
Note 8.
|
Fair
Value of Financial Instruments
|
The estimated fair value of certain financial instruments,
including cash and cash equivalents and current liabilities, are
carried at historical cost basis, which approximates their fair
values because of the short-term nature of these instruments.
On January 1, 2009, the Company adopted a newly issued
accounting standard for fair value measurements of all
nonfinancial assets and nonfinancial liabilities not recognized
or disclosed at fair value in the financial statements on a
recurring basis.
The accounting standard for fair value measurements provides a
framework for measuring fair value and requires expanded
disclosures regarding fair value measurements. Fair value is
defined as the price that would be received for an asset or the
exit price that would be paid to transfer a liability in the
principal or most advantageous market in an orderly transaction
between market participants on the measurement date. The
accounting standard established a fair value hierarchy which
requires an entity to maximize the use of observable inputs,
where available. This hierarchy prioritizes the inputs into
three broad levels as follows. Level 1 inputs are quoted
prices (unadjusted) in active markets for identical assets or
liabilities. Level 2 inputs are quoted prices for similar assets
and liabilities in active markets or inputs that are observable
for the asset or liability, either directly or indirectly
through market corroboration, for substantially the full term of
the financial instrument. Level 3 inputs are unobservable
inputs based on the Companys own assumptions used to
measure assets and liabilities at fair value. An asset or
liabilitys classification within the hierarchy is
determined based on the lowest level input that is significant
to the fair value measurement.
F-17
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
Assets and liabilities measured at fair value on a recurring and
non-recurring basis consisted of the following at
December 31, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Carrying
|
|
|
|
|
|
|
|
|
|
|
|
|
Value at
|
|
|
Fair Value Measurements at December 31, 2009
|
|
|
|
December 31, 2009
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patents
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Patents pending
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant derivative liability
|
|
$
|
804,718
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
804,718
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following is a summary of activity of Level 3 assets
for the year ended December 31, 2009:
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
152,589
|
|
Patent costs
|
|
|
21,799
|
|
Amortization expense
|
|
|
(4,415
|
)
|
Impairment loss recognized
|
|
|
(169,973
|
)
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
|
|
|
|
|
|
|
The following is a summary of activity of Level 3
liabilities for the year ended December 31, 2009:
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
|
|
Warrant liability upon issuance
|
|
|
826,678
|
|
Change in fair value
|
|
|
(21,960
|
)
|
|
|
|
|
|
Balance at December 31, 2009
|
|
$
|
804,718
|
|
|
|
|
|
|
Impairment losses recognized on patents and patents pending are
included in selling, general and administrative expenses.
Changes in fair value of the warrant derivative liability are
included in other income (expense) in the accompanying
consolidated statements of operations.
The Company used the discounted cash flows method to measure the
fair value of patents and patents pending. Due to minimal and
varied revenue producing activities, the Company cannot reliably
project positive cash flows for patents and patents pending.
The Company estimates the fair value of the warrant derivative
liability utilizing the Black-Scholes option pricing model,
which is dependent upon several variables such as the expected
warrant term, expected volatility of our stock price over the
expected warrant term, expected risk-free interest rate over the
expected warrant term, and the expected dividend yield rate over
the expected warrant term. The Company believes this valuation
methodology is appropriate for estimating the fair value of the
warrant derivative liability. The following table summarizes the
assumptions the Company utilized to estimate the fair value of
the warrant derivative liability at December 31, 2009:
|
|
|
|
|
Assumptions
|
|
December 31, 2009
|
|
Expected term (years)
|
|
|
1.8 - 3.0
|
|
Expected volatility
|
|
|
120.0%
|
|
Risk-free interest rate
|
|
|
1.14% - 1.70%
|
|
Dividend yield
|
|
|
0.00%
|
|
F-18
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
The expected warrant term is based on the remaining contractual
term. The expected volatility is based on historical volatility.
The risk-free interest rate is based on the U.S. Treasury
yields with terms equivalent to the expected term of the related
warrant at the valuation date. Dividend yield is based on
historical trends. While the Company believes these estimates
are reasonable, the fair value would increase if a higher
expected volatility was used, or if the expected dividend yield
increased.
There were no changes in the valuation techniques during the
three months ended December 31, 2009.
Loan payable at December 31, 2009 and 2008 consisted of an
unsecured, non-interest bearing loan in the amount of $68,076,
due on demand.
|
|
Note 10.
|
Equipment
Payable
|
On June 19, 2007, the Company entered into an agreement and
bill of sale with a third party vendor for the purchase of
certain RDS equipment in the amount of $110,000. The terms of
payment under the agreement were principal only payments of
$6,670 per month, commencing August 1, 2007, for a period
of seven months. On March 1, 2008, a final payment of
$70,000 was to be made by the Company. The Company made no
payments under the agreement during 2007 and went into default
under the agreement. During 2008, the Company made payments to
reduce the principal amount by $25,205. Upon default, 12%
interest applies to the unpaid balance. As of December 31,
2009 and 2008, the principal amount due under the agreement
amounted to $84,795, and is reflected as equipment payable in
the accompanying consolidated balance sheets.
|
|
Note 11.
|
Capital
Lease Obligations
|
Capital lease obligations consisted of the following at
December 31, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Capital lease obligations
|
|
$
|
59,216
|
|
|
$
|
261,250
|
|
Less: Current maturities
|
|
|
(59,216
|
)
|
|
|
(143,428
|
)
|
|
|
|
|
|
|
|
|
|
Amount due after one year
|
|
$
|
|
|
|
$
|
117,822
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 12.
|
Secured
Note Payable
|
Secured notes payable consisted of the following at
December 31, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
20% Secured promissory note payable
|
|
$
|
|
|
|
$
|
116,662
|
|
Less: Current maturities
|
|
|
|
|
|
|
(116,662
|
)
|
|
|
|
|
|
|
|
|
|
Amount due after one year
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
On July 30, 2008, the Company issued a secured promissory
note in the amount of $200,000 to a lender, who is the lessor of
the office space that the Company occupies for its operations,
for working capital purposes. The note bears interest at 20% per
year, was secured by all patents and other intellectual property
of the Company, and was personally guaranteed by the Chief
Executive Officer of the Company. The terms for repayment of the
note required payments of $16,667 per month for a period of
12 months, together with a balloon payment of $40,000 in
interest at the time the last payment was made. As part of the
secured promissory note, the Company granted to the lessor an
option to purchase, for a period of one year after the repayment
of the loan and interest, shares of common stock of the Company,
up to a total of the amount of the note, interest paid on the
note, and a premium of $40,000 (approximately $280,000 in
total), at a price of $1 per share. At December 31, 2008,
the principal balance of the
F-19
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
note remaining amounted to $116,662, all of which was current in
nature. The remaining balance of the note, including accrued
interest, was paid in full on August 31, 2009 and the lien
was subsequently released by the lender.
|
|
Note 13.
|
Convertible
Notes Payable
|
Convertible notes payable consisted of the following at
December 31, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Convertible notes payable
|
|
$
|
10,000
|
|
|
$
|
723,190
|
|
Less: Current maturities
|
|
|
(10,000
|
)
|
|
|
(723,190
|
)
|
|
|
|
|
|
|
|
|
|
Amount due after one year
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
The Company has entered into various secured and unsecured
convertible notes with third party lenders to fund its
operations. The notes are generally convertible into shares of
common stock at a fixed rate of $5.00 per share at the
discretion of the holder and mature over periods of less than
one year. As the conversion rate for all of the notes exceeded
the estimated fair value of the Companys common stock on
the date of issuance, the notes did not contain a beneficial
conversion feature. The notes bear interest at rates ranging
from 4.3% to 40%. Activities pertaining to convertible notes for
the years ended December 31, 2009 and 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Beginning balance
|
|
$
|
723,190
|
|
|
$
|
302,971
|
|
Issuance of convertible notes
|
|
|
773,500
|
|
|
|
595,330
|
|
Interest added to principal amounts
|
|
|
129,298
|
|
|
|
78,896
|
|
Principal payments
|
|
|
(158,179
|
)
|
|
|
(94,007
|
)
|
Conversions to common stock
|
|
|
(1,457,809
|
)
|
|
|
(160,000
|
)
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
10,000
|
|
|
$
|
723,190
|
|
|
|
|
|
|
|
|
|
|
The weighted average interest rate for convertible notes payable
outstanding as of December 31, 2009 was 40%.
|
|
Note 14.
|
Notes
Payable Related Party
|
Notes payable related party consisted of the
following at December 31, 2009 and 2008:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Notes payable related parties
|
|
$
|
14,575
|
|
|
$
|
50,819
|
|
Less: Current maturities
|
|
|
(14,575
|
)
|
|
|
(50,819
|
)
|
|
|
|
|
|
|
|
|
|
Amount due after one year
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
The Company has entered into various unsecured notes with
related parties to fund its operations. The notes are due on
demand or within one year from the date of the note. The notes
bear interest at rates ranging from 4.3% to 80%. Activities
pertaining to notes payable related parties for the
years ended December 31, 2009 and 2008, are described in
Note 19.
The weighted average interest rate for notes payable
related party outstanding as of December 31, 2009 was 13.5%.
F-20
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
|
|
Note 15.
|
Commitments
and Contingencies
|
Capital
Leases
The following is a schedule by years of future minimum lease
payments under capital leases together with the present value of
the net minimum lease payments as of December 31, 2009:
|
|
|
|
|
Year ending December 31, 2010
|
|
$
|
61,912
|
|
|
|
|
|
|
Total minimum lease payments
|
|
|
61,912
|
|
Less: Amount representing interest
|
|
|
(2,696
|
)
|
|
|
|
|
|
Present value of net minimum lease payments
|
|
$
|
59,216
|
|
|
|
|
|
|
Operating
Leases
The Company leases office facilities under a
month-to-month
lease, which is cancellable with 30 days notice by either
the Company or the landlord.
Rent expense for the years ended December 31, 2009 and 2008
was $14,971 and $14,219, respectively.
Settlement
Due to Vendor
On May 27, 2008, Eagle North America, Inc.
(Eagle), which provided certain equipment and
consulting services to the Company, filed suit against the
Company and Michael Hodges, Chief Executive Officer and
Director, for monies owed pursuant to an equipment lease
agreement between Eagle and the Company. Eagle claimed damages
of $152,103. The Company made counter claims against Eagle for
breach of certain representations and warranties, alleged
damages related to the performance and operation of certain
leased equipment and losses incurred as a result of its
inadequate operation and maintenance of approximately $280,000.
The Company and Eagle entered mediation in November 2008. On
June 26, 2009, the parties entered into a settlement
agreement pursuant to which Eagle dismissed its claims against
the Company, and the Company dismissed its claims against Eagle.
Pursuant to the settlement agreement, the Company is required to
pay Eagle the aggregate sum of $152,000, payable as follows:
(i) $25,000 within thirty days of the settlement, and
(ii) thereafter 15 equal installments of $8,467 commencing
August 26, 2009. As of December 31, 2009, the
remaining balance due under the settlement due to vendor was
$84,667, all of which is current in nature.
Registration
Rights
As part of a private placement, we have agreed to file a
resale registration statement with the SEC covering
all shares of our common stock included within the Units sold in
the Offering and underlying any warrants as well as the shares
underlying the Placement Agent warrants, on or before the date
which is 90 days after the final closing date of the
Private Placement or the termination date, whichever occurs
later (the Filing Deadline). We will maintain the
effectiveness of the resale registration statement
from the effective date through and until twelve
(12) months after the final closing date, unless all
securities registered under the registration statement have been
sold or are otherwise able to be sold pursuant to Rule 144.
We have agreed to use commercially reasonable efforts to have
the resale registration statement declared effective
by the SEC as soon as possible and, in any event, within
180 days after the final closing date of the Private
Placement or the termination date, whichever occurs later (the
Effectiveness Deadline). In addition, if the
registration statement is not effective, then the investors in
the Offering are permitted to piggy-back onto other
registration statements that are filed by the Company, with
certain exceptions. One of these exceptions is in connection
with a registration statement filed to register the sale of
certain shares held in escrow in connection with the Merger. We
are obligated to pay to investors in the Offering a fee of 1%
per month of the investors investment, payable in cash for
each month: (i) in excess of the Filing Deadline that the
registration statement has not been filed; and, (ii) in
excess of the Effectiveness Deadline that the
F-21
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
registration statement has not been declared effective;
provided, however, that the Company shall not be obligated to
pay any liquidated damages if the Company is unable to fulfill
its registration obligations as a result of rules, regulations,
positions or releases issued or actions taken by the SEC
pursuant to its authority with respect to
Rule 415, provided the Company registers at
that time the maximum number of shares of common stock
permissible upon consultation with the staff of the SEC. The
maximum potential penalty under the registration rights
agreement is 10%, which amounts $682,500. As of March 29,
2009, the Company was in default regarding the registration
rights agreement as the Company had not yet filed a registration
statement covering the securities issued in the private
placement.
Legal
Matters
From time to time, we may be involved in litigation relating to
claims arising out of our operations in the normal course of
business. As of December 31, 2009, other than what is
described in this section, Legal Matters, there were
no pending or threatened lawsuits that could reasonably be
expected to have a material effect on our results of operations.
In September 2006, the Company entered into a five-year
exclusive license agreement with an entity located in the
Netherlands (the Entity) to complete projects and
develop the revenues and marketing presence of the Company in
the Netherlands, France, and Germany. Though never consummated,
it was the intent of the parties to enter into a joint venture.
The parties completed one project, which has become the subject
of a dispute. Each party has alleged certain damages and
defenses as a result of the project. However, the parties are
working together to resolve the matter. In order to conduct the
project completed with the Entity, the Company relocated certain
RDS equipment from the United States to the Netherlands. The RDS
equipment transferred is currently under the control of the
Entity, and is part of the dispute between the parties described
above. During the year ended December 31, 2008, the Company
wrote off $174,125 in net book value of RDS equipment located in
the Netherlands, which management of the Company believes is not
in suitable operating condition, and provided a 50% reserve, in
the amount of $124,630, for impairment in the carrying value of
other RDS equipment, which is also under control of the Entity.
At December 31, 2009, the Company impaired the remaining
net book value of the equipment and recognized an impairment
loss of $61,107. The extent of any additional loss, contingent
or otherwise, was not determinable or probable of occurrence and
as a result, no general reserve for the dispute has been
recorded in the accompanying consolidated financial statements.
Further, as of December 31, 2009, no formal legal claim had
been filed with any jurisdiction by either party.
During 2009, the Company terminated a Reseller Agreement. The
reseller has contested this termination, however, no formal
legal claim had been filed as of December 31, 2009.
The former chief financial officer of the Company has claimed
breach of his separation agreement. The Company has made certain
counterclaims. As of December 31, 2009, no formal legal
claim had been filed with any jurisdiction by either party (See
Note 19).
|
|
Note 16.
|
Stockholders
Equity (Deficiency)
|
Recapitalization
On October 30, 2009, Genesis Ltd. entered into a merger
transaction with Holdings, an inactive publicly-held company.
This transaction was treated as a recapitalization of Genesis
Ltd. with 1,160,000 common shares deemed issued to the
pre-merger stockholders of Holdings. The accounting effects of
the recapitalization are reflected retroactively for all periods
presented in the accompanying consolidated financial statements
and footnotes (See Note 1).
F-22
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
As part of the Merger, 1,300,000 shares issuable to Michael
Hodges, the founder and Chief Executive Officer of the Company,
have been placed in escrow to be held for three years in order
to cover certain liabilities, including potential tax
liabilities of Genesis Ltd.
Upon completion of the Merger, on October 30, 2009, the
Company amended its Articles of Incorporation whereby it changed
its name to Genesis Fluid Solution Holdings, Inc. and revised
its authorized capital to consist of 100,000,000 common shares
at $0.001 par value and 25,000,000 preferred shares at
$0.001 par value.
Preferred
Stock
The Company is authorized to issue up to 25,000,000 shares
of preferred stock having a par value of $0.001 per share, of
which none was issued and outstanding at December 31, 2009
and December 31, 2008.
Common
Stock
The Company is authorized to issue up to 100,000,000 shares
of common stock having a par value of $0.001 per share, of which
17,668,500 and 10,000,000 shares were issued and
outstanding at December 31, 2009 and 2008, respectively.
During the year ended December 31, 2008, Michael Hodges,
the Companys Chief Executive Officer and a Director of the
Company, sold approximately 23,000 shares of Company common
stock owned personally by him to third-party investors for cash
proceeds of $68,360, which was then contributed to Company.
During the year ended December 31, 2008, Michael Hodges,
the Companys Chief Executive Officer and a Director of the
Company, gave approximately 32,960 shares of Company common
stock owned personally by him to certain creditors of the
Company to serve as repayment of notes payable and related
accrued interest of the note holders of $187,940. Such
conversions of the notes payable into common shares of the
Company did not result in any cash received by the Company.
For the purpose of recording certain equity transactions, the
Company obtained an independent certified valuation report of
the value of its common stock for May 11, 2009 of $0.01 per
share and for October 30, 2009 of $0.50 per share.
During the period from January 6, 2009 through
July 11, 2009, Michael Hodges, the Companys Chief
Executive Officer and a Director of the Company, sold
187,730 shares of Company common stock owned personally by
him to third-party investors for cash proceeds of $491,374,
which was then contributed to Company.
During the period from March 10, 2009 through
October 1, 2009, Michael Hodges, the Companys Chief
Executive Officer and a Director of the Company, gave
160,600 shares of Company common stock owned personally by
him to certain creditors of the Company upon conversion, at
their contractual conversion rate of $5.00 per share, of
convertible notes payable of $690,167 and related accrued
interest of $79,830. One creditor was given 6,700 additional
shares, resulting in convertible debt inducement expense of $66.
Such conversions of the notes payable into common shares of the
Company did not result in any cash received by the Company.
During the period from January 16, 2009 through
July 7, 2009, Michael Hodges, the Companys Chief
Executive Officer and a Director of the Company, gave
26,480 shares of Company common stock (having a fair value
of $265) owned personally by him to two individuals as loan
origination fees.
On October 30, 2009, Michael Hodges, the Companys
Chief Executive Officer and a Director of the Company, returned
to the Company 1,232,730 shares of common stock owned
personally by him. He received no compensation and the shares
were immediately cancelled. This transaction was recorded as an
increase in additional paid-in capital of $1,233 with a
corresponding decrease in common stock.
F-23
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
On October 30, 2009, several stockholders (comprised of a
director, an officer, and several employees of the Company)
agreed to return to the Company 1,972,000 shares of common
stock in exchange for options to purchase 1,972,000 shares
in the Company. The options have a term of ten years, of which
(i) 1,272,000 vested immediately and have an exercise price
of $0.90 per share and (ii) 700,000 options will vest on
April 30, 2010 and have an exercise price $0.99 per share.
Since the fair value of the common shares returned exceeded the
fair value of the stock options issued on the exchange date, no
additional expense was recognized. This transaction was recorded
as an increase in additional paid-in capital of $1,972 with a
corresponding decrease in common stock.
During the period from October 1, 2009 through
October 13, 2009, the Company issued 101,730 shares of
common stock upon conversion of convertible notes payable of
$92,642 and accrued interest of $9,079. The creditors
contractual conversion rate was $5.00 per share, however, the
creditors converted at $1.00 per share, resulting in convertible
debt inducement expense of $40,693.
During the year ended December 31, 2009, the Company issued
2,584,000 shares of common stock (having a fair value of
$25,840) in exchange for cash proceeds of $26 and services
rendered. Accordingly, the Company recognized stock-based
compensation expense of $25,814.
On October 30, 2009, prior to the Merger, stockholders of
the Company gave 50,000 shares of Company common stock
(having a fair value of $25,000) owned personally by them to a
vendor of the Company to serve as payment on behalf of the
Company for services rendered. The $25,000 was recorded as
contributed capital.
On October 30, 2009, prior to the Merger, stockholders of
the Company gave 250,000 shares of Company common stock
(having a fair value of $125,000) owned personally by them to a
vendor of the Company to serve as payment on behalf of the
Company to settle accounts payable of $243,910. Accordingly, the
Company recognized a gain on settlement of accounts payable of
$118,910.
In May and June 2009, pursuant to Note Purchase Agreements (the
Agreements), the Company sold $600,000 of
convertible notes (bridge notes) to lenders. In
September and October 2009, the Company sold an additional
$75,000 of bridge notes to lenders. The holders of $275,000 of
the bridge notes had the option and the holders of $400,000 of
the bridge notes had the obligation to convert on a
dollar-for-dollar
basis upon a Subsequent Financing (as defined in the Agreements)
on the same terms and conditions as the Subsequent Financing. In
addition, whether converted or not, upon the earlier of:
(i) a Subsequent Financing or (ii) six months, the
bridge note holders were entitled to additional interest in the
form of common shares of the Company equal to 30% of the face
value of the notes using a price per share based on:
(a) the same price per share of a Subsequent Financing or
(b) should the Subsequent Financing not have occurred
within six months of the date of the respective agreement, a
price per share based upon a $15 million total market value
of the Company. The bridge notes bore interest of 10% and were
due and payable on the earlier of the completion of a reverse
merger transaction (which occurred October 30,
2009) or November 9, 2009. All of the bridge note
holders converted to the private placement that occurred on
October 30, 2009. As a result, 675,000 common shares and
warrants (having the same terms as those issued to investors
under the private placement, as discussed below) to purchase
337,500 common shares were issued in exchange for the bridge
notes (an aggregate principal amount of $675,000) as payment in
full. Additionally, 202,500 common shares (representing 30% of
the face value of the bridge notes) (having a fair value of
$101,250), were issued and such value was included in interest
expense.
Following the closing of the Merger through December 29,
2009, the Company accepted subscriptions for an aggregate of
246 units in a private placement (each unit consisting of
25,000 shares of common stock and three-year warrants to
purchase 12,500 common shares at an exercise price of $2.00 per
share) at a price of $25,000 per unit for gross proceeds of
$6,150,000. As a result, the Company issued (i) 6,150,000
common shares and (ii) warrants to purchase 3,075,000
common shares. In connection with the private placement, the
Company paid $240,250 in offering costs and issued two-year
warrants to purchase an aggregate of 107,500 common shares,
exercisable at $1.25 per share, to placement agents. All of the
shares of common stock issued in the private placement as well
as the shares of common stock underlying the warrants issued in
the private placement and the shares of common stock
F-24
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
underlying the placement agents warrants are subject to a
registration rights agreement (See Note 15). In addition,
so long as the underlying shares of common stock are registered
in an effective registration statement, if and when shares of
the common stock are trading at or above $3.50 per share for 20
consecutive trading days, we will have the option to redeem the
three-year warrants from the investors for a purchase price of
$0.001 per share. A holder of three-year warrants will have
10 days following notice to convert their warrants or we
may retire the warrants upon the payment of $0.001 per share
underlying each warrant. All of the warrants contain a cashless
exercise provision whereby if at any time after twelve
(12) months from the issuance date of the warrants there is
no effective registration statement registering or no current
prospectus available, for the resale of the shares of warrant
stock issuable, then the holder may cashless exercise the
warrants. All of the warrants contain a price protection
provision whereby if from the warrant issuance date and through
the earlier to occur of: (i) first anniversary of the date
of issuance and (ii) the date there is an effective
registration statement on file with the Securities and Exchange
Commission covering the resale of all the shares of warrant
stock and all the shares of common stock issued in the offering
the Company issues or sells any shares of common stock or
securities convertible into common stock, other than an exempt
issuance, as defined in the warrant, for consideration per share
of common stock less than $1.00, then immediately after such
dilutive issuance, the warrant price then in effect shall be
reduced to an amount equal to the new issuance price multiplied
by two. Due to the price protection clause, the warrants are
deemed a derivative and, therefore, were reclassified from
equity to a warrant derivative liability on each date of
issuance resulting in an aggregate amount of $826,678 being
reclassified (See Note 8).
Common
Stock Warrants
A summary of the Companys warrant activity during the year
ended December 31, 2009 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
No. of
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Warrants
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
|
Balance Outstanding, December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
3,520,000
|
|
|
$
|
1.98
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Outstanding, December 31, 2009
|
|
|
3,520,000
|
|
|
$
|
1.98
|
|
|
|
2.9
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, December 31, 2009
|
|
|
3,520,000
|
|
|
$
|
1.98
|
|
|
|
2.9
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
Incentive Plan and Stock Option Grants to Employees and
Directors
On October 30, 2009, the Companys board of directors
and stockholders adopted the 2009 Equity Incentive Plan (the
2009 Plan). The purpose of the 2009 Plan is to
provide an incentive to attract and retain directors, officers,
consultants, advisors and employees whose services are
considered valuable, to encourage a sense of proprietorship and
to stimulate an active interest of such persons into our
development and financial success. Under the 2009 Plan, the
Company is authorized to issue incentive stock options intended
to qualify under Section 422 of the Code, non-qualified
stock options, stock appreciation rights, performance shares,
restricted stock and long-term incentive awards. The Company has
reserved for issuance an aggregate of 4,542,000 shares of
common stock under the 2009 Plan. The 2009 Plan will be
administered by the Companys board of directors until such
time as such authority has been delegated to a committee of the
board of directors.
The material terms of each option granted pursuant to the 2009
Plan by the Company shall contain the following terms:
(i) that the purchase price of each share purchasable under
an incentive option shall be determined
F-25
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
by the Committee at the time of grant, but shall not be less
than 100% of the Fair Market Value (as defined in the 2009 Plan)
of such common share on the date the option is granted,
(ii) the term of each option shall be fixed by the
Committee, but no option shall be exercisable more than
10 years after the date such option is granted and
(iii) in the absence of any option vesting periods
designated by the Committee at the time of grant, options shall
vest and become exercisable as to one-third of the total number
of shares subject to the option on each of the first, second and
third anniversaries of the date of grant.
On October 30, 2009, the Company issued, pursuant to the
2009 Plan, ten-year options to purchase 1,972,000 shares in
the Company in exchange for the return of 1,972,000 shares
of common stock (see above).
On October 30, 2009, the Company granted, pursuant to the
2009 Plan, ten-year stock options to purchase 1,250,000 common
shares of the Company, of which (i) 580,000 are exercisable
immediately at $0.90 per share, (ii) 70,000 are exercisable
on April 30, 2010 at $0.99 per share, and
(iii) 600,000 vest based on performance milestones, as
stipulated in the option, and are exercisable at $1.00 per share.
The total fair value of stock option awards (not including those
issued in exchange for common stock returned to the Company)
granted to employees during the year ended December 31,
2009 was $251,871, which is being recognized over the respective
vesting periods. The Company recorded compensation expense of
$233,900 for the year ended December 31, 2009 in connection
with these stock options.
As of December 31, 2009, 1,320,000 shares were
remaining under the 2009 Plan for future issuance.
The Company estimates the fair value of share-based compensation
utilizing the Black-Scholes option pricing model, which is
dependent upon several variables such as the expected option
term, expected volatility of our stock price over the expected
option term, expected risk-free interest rate over the expected
option term, expected dividend yield rate over the expected
option term, and an estimate of expected forfeiture rates. The
Company believes this valuation methodology is appropriate for
estimating the fair value of stock options granted to employees
and directors which are subject to ASC Topic 718 requirements.
These amounts are estimates and thus may not be reflective of
actual future results, nor amounts ultimately realized by
recipients of these grants. The Company recognizes compensation
on a straight-line basis over the requisite service period for
each award. The following table summarizes the assumptions the
Company utilized to record compensation expense for stock
options granted during the year ended December 31, 2009:
|
|
|
|
|
|
|
For the
|
|
|
Year Ended
|
Assumptions
|
|
December 31, 2009
|
|
Expected term (years)
|
|
|
5.0 - 10.0
|
|
Expected volatility
|
|
|
120.0%
|
|
Weighted-average volatility
|
|
|
120.0%
|
|
Risk-free interest rate
|
|
|
2.31% - 3.41%
|
|
Dividend yield
|
|
|
0.00%
|
|
Expected forfeiture rate
|
|
|
0.0%
|
|
The expected life is computed using the simplified method, which
is the average of the vesting term and the contractual term. The
expected volatility is based on historical volatility. The
risk-free interest rate is based on the U.S. Treasury
yields with terms equivalent to the expected term of the related
option at the time of the grant. Dividend yield is based on
historical trends. While the Company believes these estimates
are reasonable, the compensation expense recorded would increase
if the expected life was increased, a higher expected volatility
was used, or if the expected dividend yield increased.
F-26
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
A summary of the Companys stock option activity during the
year ended December 31, 2009 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
No. of
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Options
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
|
Balance Outstanding, December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
3,222,000
|
|
|
$
|
0.94
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Outstanding, December 31, 2009
|
|
|
3,222,000
|
|
|
$
|
0.94
|
|
|
|
9.8
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, December 31, 2009
|
|
|
1,852,000
|
|
|
$
|
0.90
|
|
|
|
9.8
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted-average grant-date fair value of options granted to
employees during the year ended December 31, 2009 was
$0.40. The Company expects all non-contingent outstanding
employee stock options to eventually vest.
As of December 31, 2009, there were total unrecognized
compensation costs related to nonvested share-based compensation
arrangements of $297,337, of which $17,972 is expected to be
recognized over a weighted-average period of 0.3 years and
$279,365 shall be recognized upon the satisfaction of a
contingency.
Other
Stock-Based Option Awards to Nonemployees
On July 30, 2008, as part of a secured promissory note, the
Company granted an option to purchase, for a period of one year
after the repayment of the loan and interest (which occurred on
August 31, 2009), shares of common stock of the Company, up
to a total of the amount of the note, interest paid on the note
and a premium of $40,000 (approximately $280,000 in total), at a
rate of $1 per share. As of December 31, 2009, the option
has not yet been exercised.
On September 30, 2009, an option to purchase up to 5,000
common shares at $5.00 expired unexercised.
The Company was originally formed in October 2005 as an
S corporation and filed its federal and state income
tax returns according to the rules and regulations of that
section of the Internal Revenue Code. On October 31, 2007,
the Company revoked its status as an S corporation
and converted to a C corporation.
F-27
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
The Company files a consolidated U.S. income tax return
that includes its U.S. subsidiary. The amounts provided for
income taxes are as follows:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
Year Ended
|
|
|
Year Ended
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Current (benefit) provision: federal
|
|
$
|
|
|
|
$
|
|
|
Current (benefit) provision: state
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current provision
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred (benefit) provision
|
|
|
|
|
|
|
|
|
Deferred (benefit) provision relating to reduction of valuation
allowance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred provision
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision (benefit) for income taxes from continuing
operations
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Significant items making up the deferred tax assets and deferred
tax liabilities as of December 31, 2009 and 2008 are as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31, 2009
|
|
|
December 31, 2008
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carryforward
|
|
|
1,315,280
|
|
|
|
588,181
|
|
Accrued severance
|
|
|
26,341
|
|
|
|
|
|
Impairment patents and patents pending
|
|
|
63,961
|
|
|
|
|
|
Stock-based compensation
|
|
|
88,017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,493,599
|
|
|
|
588,181
|
|
Less: valuation allowance
|
|
|
(1,473,655
|
)
|
|
|
(588,181
|
)
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
|
19,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
(11,680
|
)
|
|
|
|
|
Other temporary differences
|
|
|
(8,264
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
|
(19,944
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net deferred tax assets (liabilities)
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
A valuation allowance is established if it is more likely than
not that all or a portion of the deferred tax asset will not be
realized. Accordingly, a valuation allowance was established in
2009 and 2008 for the full amount of our deferred tax assets due
to the uncertainty of realization. Management believes that
based upon its projection of future taxable operating income for
the foreseeable future, it is more likely than not that the
Company will not be able to realize the benefit of the deferred
tax asset at December 31, 2009. The net change in the
valuation allowance during the years ended December 31,
2009 and 2008 was an increase of $885,474 and $521,696,
respectively.
At December 31, 2009, the Company had $3,495,295 of net
operating loss carryforwards which will expire in various years
through 2029. Under the provision of the Tax Reform Act of 1986,
when there has been a change in an entitys ownership of
50 percent or greater, utilization of net operating loss
carry forwards may be limited. As a result of the Companys
equity transactions, the Companys net operating losses may
be subject to such limitations and may not be available to
offset future income for tax purposes. Utilization of the net
operating losses and credits
F-28
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
may be subject to a substantial annual limitation due to the
ownership change provisions of the Internal Revenue Code of
1986, as amended. The annual limitation may result in the
expiration of net operating losses and credits before
utilization and in the event we have a change of ownership,
utilization of the carryforwards could be restricted.
The Companys effective income tax expense (benefit)
differs from the statutory federal income tax rate of 34% as
follows:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
For the
|
|
|
Year Ended
|
|
Year Ended
|
|
|
December 31, 2009
|
|
December 31, 2008
|
|
Federal tax rate applied to loss before income taxes
|
|
|
34.0
|
%
|
|
|
34.0
|
%
|
State income taxes, net of federal benefit
|
|
|
3.5
|
%
|
|
|
-3.3
|
%
|
Permanent differences
|
|
|
(0.9
|
)%
|
|
|
(2.0
|
)%
|
Change in valuation allowance
|
|
|
(39.4
|
)%
|
|
|
(28.7
|
)%
|
Other
|
|
|
2.8
|
%
|
|
|
0.0
|
%
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit)
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
|
|
|
|
|
|
|
Concentration
of Credit Risk
Financial instruments that potentially subject the Company to
concentration of credit risk consist of cash and cash
equivalents and accounts receivable. Cash and cash equivalents
are deposited in the local currency in three financial
institutions in the United States. The balance, at any given
time, may exceed Federal Deposit Insurance Corporation insurance
limits. As of December 31, 2009 and 2008, there was
$4,508,514 and $0, respectively, in excess of insurable limits.
|
|
Note 19.
|
Related
Party Transactions
|
On November 28, 2008, the Company entered into a loan
agreement with Maria Hodges, the wife of the Companys
Chief Executive Officer, Michael Hodges for $9,800. The note
bears an annual 4.29 percent interest rate and is due on
November 28, 2018. The note does not have any conversion
feature and is unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, no
principal or interest had been paid on the note. During 2009,
principal and accrued interest on this note was paid in full.
On September 29, 2008, the Company entered into a loan
agreement with Maria Hodges, wife of the Companys Chief
Executive Officer Michael Hodges for $9,000. The note bears an
annual 4.29 percent interest rate and is due on
September 29, 2019. The note does not have conversion
feature and is unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, no
principal interest had been paid on the note. During 2009,
principal and accrued interest on this note was paid in full.
On June 17, 2008, the Company entered into a loan agreement
with Jack Speer, who was then a member of the Genesis Ltd. board
of directors, for $5,000. The note bears an annual
4.29 percent interest rate and is due on June 17,
2018. The note does not have conversion feature and is
unsecured. Accrued and unpaid interest is due at the termination
of the loan. In September 2008, the Company paid Mr. Speer
$2,925 which was recorded as a reduction of the outstanding
principal balance.
On May 28, 2008, the Company entered into a loan agreement
with Jack Speer, who was then a member of the Genesis Ltd. board
of directors, for $1,075. The note had no stated interest rate
or maturity date. The note does not have any conversion feature
and is unsecured. In September 2008, the Company paid
Mr. Speer $1,075 and cancelled the note.
F-29
GENESIS
FLUID SOLUTIONS HOLDINGS, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2009 AND 2008
On February 4, 2008, the Company entered into a loan
agreement with Greg Rankin, who has provided legal services to
the Company, for $5,000. The note had no stated interest rate or
maturity date. The note does not have conversion feature and was
unsecured. On July 23, 2008, the principal balance plus
$600 of accrued and unpaid interest was converted into
1,120 shares of common stock.
On August 9, 2007, the Company entered into a loan
agreement with Michael Whaley, the former Chief Financial
Officer of the Company, for $50,000. The note originally bore an
annual interest rate of 20 percent, which was later amended
to 80 percent, and subsequently, in combination with his
separation, was revised to a 15 percent interest rate and
was due on November 5, 2007. The note does not have a
conversion feature and is unsecured. Accrued and unpaid interest
is due at maturity date of the loan. At December 31, 2008,
$37,500, respectively, had been repaid under the note. At
December 31, 2009, $12,500 of principal plus accrued
interest was due on the note. On September 17, 2009,
Michael Whaley, the former chief financial officer of the
Company, resigned. As part of his separation agreement and in
exchange for mutual releases, the Company is required to deliver
the following to Mr. Whaley after completion of the Merger:
(i) $40,000 in cash, (ii) $30,000 shares of
common stock of the Company, and (iii) payment of all
amounts due under his loan agreement. As of December 31,
2009, all of the amounts due under the separation agreement were
outstanding as the separation agreement is in dispute (See
Note 15).
On August 9, 2007, the Company entered into a loan
agreement with Larry McCurry, who was then a member of the
Genesis Ltd. board of directors, for $25,000. The note bears an
annual 40 percent interest rate and was due on
November 10, 2007. The note does not have conversion
feature and was unsecured. Accrued and unpaid interest is due at
the termination of the loan. At December 31, 2008, the
Company had made payments of $22,500 of which approximately
$13,000 had been applied against principal and the remaining
amount recognized as interest. During 2009, principal and
accrued interest on this note was paid in full.
On January 5, 2009, the Company entered into a loan
agreement with Larry McCurry, who was then a member of the
Genesis Ltd. board of directors, for $50,000. The note was
unsecured, bore 40% interest and was due on February 3,
2009. During 2009, principal and accrued interest on this note
was paid in full.
|
|
Note 20.
|
Subsequent
Events
|
On February 15, 2010, the Company entered into an agreement
with a vendor for the vendor to perform marketing services. On
March 2, 2010, the Company terminated its agreement with
the vendor. On March 23, 2010, the vendor filed suit for
breach of contract claiming amounts owed of approximately
$41,000. The Company disputes this claim and intends to
rigorously defend its position.
On March 19, 2010, the Company entered into a settlement
agreement with an individual that had been engaged May 11,
2009 to perform financial advisory services for the Company. As
a result of the settlement, the Company issued
83,000 shares of the Companys common stock.
As of March 29, 2009, the Company was in default regarding
the registration rights agreement as the Company had not yet
filed a registration statement covering the securities issued in
the private placement.
In preparing these consolidated financial statements, the
Company has evaluated events and transactions for potential
recognition or disclosure through the date the consolidated
financial statements were issued.
F-30
GENESIS FLUID SOLUTIONS
HOLDINGS, INC.
11,847,500 Shares
Common Stock
PROSPECTUS
,
2010
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
|
|
ITEM 13.
|
OTHER
EXPENSES OF ISSUANCE AND DISTRIBUTION.
|
The following table sets forth the costs and expenses payable by
us in connection with the issuance and distribution of the
securities being registered. None of the following expenses are
payable by the selling stockholders. All of the amounts shown
are estimates, except for the SEC registration fee.
|
|
|
|
|
SEC registration fee
|
|
$
|
2,872.07
|
|
Legal fees and expenses
|
|
$
|
50,000
|
|
Accounting fees and expenses
|
|
$
|
15,000
|
|
Miscellaneous
|
|
$
|
20,000
|
|
|
|
|
|
|
TOTAL
|
|
$
|
87,872.07
|
|
|
|
ITEM 14.
|
INDEMNIFICATION
OF DIRECTORS AND OFFICERS.
|
Section 145 of the Delaware General Corporation Law (the
DGCL) provides, in general, that a corporation
incorporated under the laws of the State of Delaware, as we are,
may indemnify any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed
action, suit or proceeding (other than a derivative action by or
in the right of the corporation) by reason of the fact that such
person is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the
corporation as a director, officer, employee or agent of another
enterprise, against expenses (including attorneys fees),
judgments, fines and amounts paid in settlement actually and
reasonably incurred by such person in connection with such
action, suit or proceeding if such person acted in good faith
and in a manner such person reasonably believed to be in or not
opposed to the best interests of the corporation and, with
respect to any criminal action or proceeding, had no reasonable
cause to believe such persons conduct was unlawful. In the
case of a derivative action, a Delaware corporation may
indemnify any such person against expenses (including
attorneys fees) actually and reasonably incurred by such
person in connection with the defense or settlement of such
action or suit if such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed
to the best interests of the corporation, except that no
indemnification will be made in respect of any claim, issue or
matter as to which such person will have been adjudged to be
liable to the corporation unless and only to the extent that the
Court of Chancery of the State of Delaware or any other court in
which such action was brought determines such person is fairly
and reasonably entitled to indemnity for such expenses.
Our Certificate of Incorporation and Bylaws provide that we will
indemnify our directors, officers, employees and agents to the
extent and in the manner permitted by the provisions of the
DGCL, as amended from time to time, subject to any permissible
expansion or limitation of such indemnification, as may be set
forth in any stockholders or directors resolution or
by contract. In addition, our director and officer
indemnification agreements with each of our directors and
officers provide, among other things, for the indemnification to
the fullest extent permitted or required by Delaware law,
provided that no indemnitee will be entitled to indemnification
in connection with any claim initiated by the indemnitee against
us or our directors or officers unless we join or consent to the
initiation of the claim, or the purchase and sale of securities
by the indemnitee in violation of Section 16(b) of the
Exchange Act.
Any repeal or modification of these provisions approved by our
stockholders will be prospective only and will not adversely
affect any limitation on the liability of any of our directors
or officers existing as of the time of such repeal or
modification.
We are also permitted to apply for insurance on behalf of any
director, officer, employee or other agent for liability arising
out of his actions, whether or not the DGCL would permit
indemnification.
II-1
|
|
ITEM 15.
|
RECENT
SALES OF UNREGISTERED SECURITIES.
|
Explanatory Note: At the closing of the
Merger, each share of Genesis Fluid Solutions common stock
was exchanged for the right to receive 10 shares of our
common stock. All Genesis Fluid Solutions share and
per-share information contained below retroactively reflects the
effect of the 10:1 exchange.
Sales by
Genesis Fluid Solutions, Ltd.
On October 1, 2005, Genesis Fluid Solutions issued an
aggregate of 10,000,000 shares of its common stock to 16
individuals, including 500,000 shares to Michael Hodges,
its then chief executive officer, and 450,000 shares to
Larry Campbell, its then senior vice president and director of
field operations. The aggregate purchase price for these shares
was $396,800. The shares were issued in a transaction that was
exempt from the registration requirements of the Securities Act
pursuant to Section 4(2) of the Securities Act, which
exempts transactions by an issuer not involving a public
offering.
From May 2009 through October 13, 2009, Genesis Fluid
Solutions sold an aggregate of $675,000 principal amount of 10%
secured promissory notes (Bridge Notes) in a private
placement transaction. The purchasers of Bridge Notes paid an
aggregate gross purchase price of $675,000 for the Bridge Notes.
The Bridge Notes are due and payable upon the earlier of
November 3, 2009 and the date that Genesis Fluid Solutions,
or an affiliate such as the Company, consummates an offering or
offerings raising gross proceeds of at least $2.5 million
(a Subsequent Financing). The Private Placement
resulted in the Bridge Notes becoming due. The Bridge Notes also
provide that, upon the consummation of a Subsequent Financing,
the holders shall have the right to exchange the Bridge Notes
for an amount of securities that could be purchased in the
Subsequent Financing for a purchase price equal to the
outstanding principal, and accrued interest on the Bridge Notes.
The private placement was made solely to accredited
investors, as that term is defined in Regulation D
under the Securities Act. The securities sold in the private
placement were not registered under the Securities Act, or the
securities laws of any state, and were offered and sold in
reliance on the exemption from registration afforded by
Section 4(2) and Regulation D
(Rule 506) under the Securities Act and corresponding
provisions of state securities laws, which exempt transactions
by an issuer not involving a public offering.
In addition, according to the terms of the Bridge Notes, in the
event Genesis Fluid Solutions enters into a reverse merger
transaction that has a capital raising transaction in connection
therewith (the Reverse Merger Financing),
(i) the holders of $275,000 of Bridge Notes will have the
option and (ii) the holders of $400,000 of Bridge Notes
will have the obligation, to exchange the Bridge Notes for an
amount of securities that could be purchased in the Reverse
Merger Financing for a purchase price equal to the outstanding
principal and accrued interest on the Bridge Notes. The Private
Placement constitutes a Reverse Merger Financing and, therefore,
each holder of Bridge Notes will either be entitled or
obligated, as the case may be, to exchange the outstanding
principal and interest amount of its Bridge Notes for units sold
in the Private Placement. If the holders of all of the Bridge
Notes elect to exchange the Bridge Notes for units in the
Private Placement, then the Company will be required to issue an
aggregate of 675,000 shares of common stock and warrants to
purchase an aggregate of 337,500 shares of common stock
(plus additional shares in respect of any accrued but unpaid
interest on the Bridge Notes) to the holders of the Bridge
Notes. Upon the closing of the Merger, Bridge Notes in the
principal amount of $675,000 converted in the Private Placement.
On May 11, 2009, Genesis Fluid Solutions sold an aggregate
of 2,584,000 shares of its common stock to eight parties
who provided services to it, for an aggregate purchase price of
$25.80. The shares were issued in a transaction that was exempt
from the registration requirements of the Securities Act
pursuant to Section 4(2) of the Securities Act, which
exempts transactions by an issuer not involving a public
offering.
Sales by
Genesis Fluid Solutions Holdings, Inc.
On April 15, 2007, we issued 1,000,000 shares of our
common stock to Sharone Perlstein, our founder and sole director
at that time, in consideration for their par value. On
April 15, 2007, we issued 900,000 shares of our common
stock to Dr. Reuven Gepstein, our then president, chief
executive officer and director, in consideration of their par
value. The shares were issued in a transaction that was exempt
from the registration requirements of the Securities Act
pursuant to Regulation S of the SEC.
II-2
On April 15, 2007, we issued 3,777,000 shares of our
common stock to four other individuals in consideration of their
par value. The shares were issued in a transaction that was
exempt from the registration requirements of the Securities Act
pursuant to Regulation S of the SEC.
On June 18, 2007, we issued 962,500 shares of our
common stock to Yael Alush, our then Secretary, Treasurer and
Director, in consideration of their par value. The shares were
issued in a private transaction that was exempt from the
registration requirements of the Securities Act pursuant to
Regulation S of the SEC.
On June 18, 2007, we issued 3,940,500 shares of our
common stock to six other individuals in consideration of their
par value. The shares were issued in a transaction that was
exempt from the registration requirements of the Securities Act
pursuant to Regulation S of the SEC.
In July 2007 through October of 2007, we issued
2,000,000 shares of common stock to 46 investors in a
private placement pursuant to the exemption from the
registration requirements of the Securities Act provided by
Regulation S. The aggregate consideration paid for these
shares was $50,000. All investors in the private placement were
non-US persons (as defined under SEC Regulations). The Company
provided all investors in the private placement with a
subscription agreement.
On December 9, 2007, we raised $225,000 by selling
1,125,000 shares of our common stock to two investors in a
transaction that was exempt from registration pursuant to the
exemption from the registration requirements of the Securities
Act provided by Regulation S. Both investors in the private
placement were non-US persons (as defined under SEC Regulations)
and were provided with subscription agreements.
On October 30, 2009, we accepted subscriptions for a total
of 142.6 units in the Private Placement, consisting of an
aggregate of 3,707,500 shares of the our common stock and
warrants to purchase an aggregate of 1,782,500 shares of
common stock at an exercise price of $2.00 per share, for a per
unit purchase price of $25,000. We received net proceeds from
this closing of the Private Placement of $2,946,000, which does
not include the $475,000 of Bridge Notes that were converted in
the Private Placement. The Private Placement was made solely to
accredited investors, as that term is defined in
Regulation D under the Securities Act. The securities sold
in the Private Placement were not registered under the
Securities Act, or the securities laws of any state, and were
offered and sold in reliance on the exemption from registration
afforded by Section 4(2) and Regulation D
(Rule 506) under the Securities Act and corresponding
provisions of state securities laws, which exempt transactions
by an issuer not involving a public offering.
WFG Investments, Inc. and Colorado Financial Service Corporation
acted as our Placement Agents and received (i) cash fees of
$56,000 and $52,000, respectively, equal to 8% of the gross
proceeds of the Private Placement from units sold through these
Placement Agents, and (ii) two-year warrants to purchase an
aggregate of 14,000 and 13,000 shares of common stock,
respectively, equal to 2% of the number of shares of common
stock included in the units sold through these Placement Agents,
for an exercise price of $1.25 per share. GarWood Securities LLC
received two-year warrants to purchase an aggregate of
50,000 shares of common stock for an exercise price of
$1.25 per share.
On November 19, 2009, we accepted subscriptions for a total
of 22.9 units in the Private Placement, consisting of an
aggregate of 372,500 shares of the our common stock and
warrants to purchase an aggregate of 186,250 shares of
common stock at an exercise price of $2.00 per share, for a per
unit purchase price of $25,000. We received net proceeds from
this closing of the Private Placement of $364,500, which does
not include the $200,000 of Bridge Notes that were converted in
the Private Placement. The Private Placement was made solely to
accredited investors, as that term is defined in
Regulation D under the Securities Act. The securities sold
in the Private Placement were not registered under the
Securities Act, or the securities laws of any state, and were
offered and sold in reliance on the exemption from registration
afforded by Section 4(2) and Regulation D
(Rule 506) under the Securities Act and corresponding
provisions of state securities laws, which exempt transactions
by an issuer not involving a public offering.
Legend Merchant Group acted as our Placement Agent and received
(i) a cash fee of $8,000, equal to 8% of the gross proceeds
of the Private Placement from units sold through the Placement
Agent, and (ii) two-year warrants to purchase an aggregate
of 2,000 shares of common stock, equal to 2% of the number
of shares of common stock included in the units sold through the
Placement Agent, for an exercise price of $1.25 per share.
II-3
On December 29, 2009, we accepted subscriptions for a total
of 107.5 units in the Private Placement, consisting of an
aggregate of 2,687,500 shares of the our common stock and
warrants to purchase an aggregate of 1,343,750 shares of
common stock at an exercise price of $2.00 per share, for a per
unit purchase price of $25,000. We received net proceeds from
the final closing of the Private Placement of $2,573,500. The
Private Placement was made solely to accredited
investors, as that term is defined in Regulation D
under the Securities Act. The securities sold in the Private
Placement were not registered under the Securities Act, or the
securities laws of any state, and were offered and sold in
reliance on the exemption from registration afforded by
Section 4(2) and Regulation D
(Rule 506) under the Securities Act and corresponding
provisions of state securities laws, which exempt transactions
by an issuer not involving a public offering.
Colorado Financial Service Corporation, Legend Merchant Group,
and Jesup & Lamont Securities Corp. acted as our
Placement Agents and received (i) cash fees of $80,000,
$24,000 and $10,000, respectively, equal to 8% of the gross
proceeds of the Private Placement from units sold through these
Placement Agents, and (ii) two-year warrants to purchase an
aggregate of 20,000, 6000 and 2,500 shares of common stock,
respectively, equal to 2% of the number of shares of common
stock included in the units sold through these Placement Agents,
for an exercise price of $1.25 per share.
On March 17, 2010, we issued 83,000 shares of our
common stock to an individual who had provided certain
consulting services to the Company. The shares were issued in a
transaction that was exempt from the registration requirements
of the Securities Act pursuant to Section 4(2) of the
Securities Act, which exempts transactions by an issuer not
involving a public offering.
|
|
ITEM 16.
|
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES.
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
2
|
.1
|
|
Agreement and Plan of Merger, dated as of October 30, 2009,
by and among Genesis Fluid Solutions Holdings, Inc., Genesis
Fluid Solutions, Ltd. and Genesis Fluid Solutions Acquisition
Corp.(1)
|
|
2
|
.2
|
|
Certificate of Merger, dated October 30, 2009 merging
Genesis Fluid Solutions Acquisition Corp. with and into Genesis
Fluid Solutions, Ltd.(1)
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation(1)
|
|
3
|
.2
|
|
Amended and Restated Bylaws(1)
|
|
5
|
.1*
|
|
Opinion of Sichenzia Ross Friedman Ference LLP
|
|
10
|
.1
|
|
Form of Subscription Agreement(1)
|
|
10
|
.2
|
|
Form of Investor Warrant(1)
|
|
10
|
.3
|
|
Form of Registration Rights Agreement(1)
|
|
10
|
.4
|
|
Form of Lockup Agreement(1)
|
|
10
|
.5
|
|
Placement Agent Agreement, dated July 15, 2009, between
Genesis Fluid Solutions, Ltd. and WFG(1)
|
|
10
|
.6
|
|
Placement Agent Agreement, dated June 28, 2009, between
Genesis Fluid Solutions, Ltd. and Chadbourn Securities(1)
|
|
10
|
.7
|
|
Form of Placement Agent Warrant(1)
|
|
10
|
.8
|
|
Form of Directors and Officers Indemnification Agreement(1)
|
|
10
|
.9
|
|
Genesis Fluid Solutions Holdings, Inc. 2009 Equity Incentive
Plan(1)
|
|
10
|
.10
|
|
Form of 2009 Incentive Stock Option Agreement(1)
|
|
10
|
.11
|
|
Form of 2009 Non-Qualified Stock Option Agreement(1)
|
|
10
|
.12
|
|
Agreement of Conveyance, Transfer and Assignment of Assets and
Assumption of Obligations, dates as of October 30, 2009, by
and between Genesis Fluid Solutions Holdings, Inc. and Cherry
Tankers Holdings, Inc.(1)
|
|
10
|
.13
|
|
Stock Purchase Agreement, dated as of October 30, 2009, by
and between Genesis Fluid Solutions Holdings, Inc. and the
shareholders listed therein(1)
|
|
10
|
.14
|
|
Consulting Agreement, dated May 11, 2009, between Genesis
Fluid Solutions and Liviakis Financial Communications, Inc.(1)
|
II-4
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
10
|
.15
|
|
Amendment to Consulting Agreement, dated October 20, 2009,
between Genesis Fluid Solutions and Liviakis Financial
Communications, Inc.(1)
|
|
10
|
.16
|
|
Assignment of Patents Agreement, dated as of August 16,
2009, between Michael Hodges, Larry Campbell and Genesis Fluid
Solutions, Ltd.(1)
|
|
10
|
.17
|
|
Assignment of Patents Agreement, dated as of September 30,
2009, between Michael Hodges, Larry Campbell and Genesis Fluid
Solutions, Ltd.(1)
|
|
10
|
.18
|
|
Form of Voting Agreement between Michael Hodges and the
stockholders signatory thereto(1)
|
|
10
|
.19
|
|
Escrow Agreement, dated October 30, 2009, among Genesis
Fluid Solutions Holdings, Inc., Michael Hodges and Sichenzia
Ross Friedman Ference LLP, as escrow agent(1)
|
|
10
|
.20
|
|
Consulting Agreement dated December 14, 2009 by and between
Genesis Fluid Solutions Holdings, Inc. and Sharp Resources,
Inc.(2)
|
|
10
|
.21
|
|
Consulting Agreement dated December 15, 2009 by and between
Genesis Fluid Solutions Holdings, Inc. and SFL3 LLC(3)
|
|
10
|
.22
|
|
Director and Officer Indemnification Agreement dated
December 15, 2009 by and between Genesis Fluid Solutions
Holdings, Inc. and Selby F. Little, III(3)
|
|
10
|
.23
|
|
Engagement Letter between Genesis Fluid Solutions and GarWood
Securities LLC dated November 10, 2009(5)
|
|
10
|
.24
|
|
Amendment to Engagement Letter between Genesis Fluid Solutions
and GarWood Securities LLC dated March 23, 2010(5)
|
|
16
|
.1
|
|
Letter from Davis Accounting Group P.C.(4)
|
|
21
|
|
|
List of Subsidiaries(1)
|
|
23
|
.1
|
|
Consent of Davis Accounting Group P.C.
|
|
23
|
.2
|
|
Consent of Salberg & Company, P.A.
|
|
23
|
.3*
|
|
Consent of Sichenzia Ross Friedman Ference LLP (included in
Exhibit 5.1)
|
|
24
|
.1
|
|
Powers of Attorney (included on signature page)
|
|
|
|
* |
|
To be filed by amendment |
|
(1) |
|
Incorporated herein by reference to the copy of such document
included as an exhibit to our Current Report on
Form 8-K
filed on November 5, 2009, as amended on November 16,
2009 and December 14, 2009. |
|
(2) |
|
Incorporated herein by reference to the copy of such document
included as Exhibit 10.1 to our Current Report on
Form 8-K
filed on December 21, 2009. |
|
(3) |
|
Incorporated herein by reference to the copy of such documents
included as Exhibit 10.1 and Exhibit 10.2 to our
Current Report on
Form 8-K
filed on December 24, 2009. |
|
(4) |
|
Incorporated herein by reference to the copy of such document
included as Exhibit 16.1 to our Current Report on
Form 8-K
filed on January 28, 2010 |
|
(5) |
|
Incorporated herein by reference to the copy of such document
included as an exhibit to our Annual Report on
Form 10-K
filed on April 15, 2010 |
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) To include any prospectus required by Section 10(a)(3)
of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding
II-5
the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would
not exceed that which was registered) and any deviation from the
low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission
pursuant to Rule 424(b) if, in the aggregate, the changes
in volume and price represent no more than a 20 percent
change in the maximum aggregate offering price set forth in the
Calculation of Registration Fee table in the
effective registration statement;
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser, each prospectus
filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration
statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part
of and included in the registration statement as of the date it
is first used after effectiveness. Provided, however, that no
statement made in a registration statement or prospectus that is
part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of
contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or
prospectus that was part of the registration statement or made
in any such document immediately prior to such date of first use.
(5) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is
against public policy as expressed in the Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be
governed by the final adjudication of such issue.
II-6
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Colorado Springs, State of Colorado
on the 14th day of April 2010.
GENESIS FLUID SOLUTIONS HOLDINGS, INC.
Name: Michael Hodges
|
|
|
|
Title:
|
Chairman and Interim Chief Executive Officer
|
POWER OF
ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
signature appears below hereby constitutes and appoints Michael
Hodges his true and lawful attorneys-in-fact and agents, with
full power of substitution and resubstitution, for such person
and in his name, place and stead, in any and all capacities, to
sign any or all further amendments or supplements (including
post-effective amendments filed pursuant to Rule 462(b) of
the Securities Act of 1933) to this registration statement
and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the SEC, granting unto
said attorneys-in-fact and agents full power and authority to do
and perform each and every act and thing requisite and necessary
to be done in and about the premises, as fully as to all intents
and purposes as he might or could do in person, hereby ratifying
and confirming all that each of said attorneys-in-fact and
agents, or their substitutes, may lawfully do or cause to be
done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Michael
Hodges
Michael
Hodges
|
|
Chairman and
Interim Chief Executive Officer
|
|
April 15, 2010
|
|
|
|
|
|
/s/ Mary
Losty
Mary
Losty
|
|
Director
|
|
April 15, 2010
|
|
|
|
|
|
/s/ John
Freshman
John
Freshman
|
|
Director
|
|
April 15, 2010
|
|
|
|
|
|
/s/ Robert
Stempel
Robert
Stempel
|
|
Director
|
|
April 15, 2010
|
II-7
EXHIBITS
AND FINANCIAL STATEMENT SCHEDULES
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
2
|
.1
|
|
Agreement and Plan of Merger, dated as of October 30, 2009,
by and among Genesis Fluid Solutions Holdings, Inc., Genesis
Fluid Solutions, Ltd. and Genesis Fluid Solutions Acquisition
Corp.(1)
|
|
2
|
.2
|
|
Certificate of Merger, dated October 30, 2009 merging
Genesis Fluid Solutions Acquisition Corp. with and into Genesis
Fluid Solutions, Ltd.(1)
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation(1)
|
|
3
|
.2
|
|
Amended and Restated Bylaws(1)
|
|
5
|
.1*
|
|
Opinion of Sichenzia Ross Friedman Ference LLP
|
|
10
|
.1
|
|
Form of Subscription Agreement(1)
|
|
10
|
.2
|
|
Form of Investor Warrant(1)
|
|
10
|
.3
|
|
Form of Registration Rights Agreement(1)
|
|
10
|
.4
|
|
Form of Lockup Agreement(1)
|
|
10
|
.5
|
|
Placement Agent Agreement, dated July 15, 2009, between
Genesis Fluid Solutions, Ltd. and WFG(1)
|
|
10
|
.6
|
|
Placement Agent Agreement, dated June 28, 2009, between
Genesis Fluid Solutions, Ltd. and Chadbourn Securities(1)
|
|
10
|
.7
|
|
Form of Placement Agent Warrant(1)
|
|
10
|
.8
|
|
Form of Directors and Officers Indemnification Agreement(1)
|
|
10
|
.9
|
|
Genesis Fluid Solutions Holdings, Inc. 2009 Equity Incentive
Plan(1)
|
|
10
|
.10
|
|
Form of 2009 Incentive Stock Option Agreement(1)
|
|
10
|
.11
|
|
Form of 2009 Non-Qualified Stock Option Agreement(1)
|
|
10
|
.12
|
|
Agreement of Conveyance, Transfer and Assignment of Assets and
Assumption of Obligations, dates as of October 30, 2009, by
and between Genesis Fluid Solutions Holdings, Inc. and Cherry
Tankers Holdings, Inc.(1)
|
|
10
|
.13
|
|
Stock Purchase Agreement, dated as of October 30, 2009, by
and between Genesis Fluid Solutions Holdings, Inc. and the
shareholders listed therein(1)
|
|
10
|
.14
|
|
Consulting Agreement, dated May 11, 2009, between Genesis
Fluid Solutions and Liviakis Financial Communications, Inc.(1)
|
|
10
|
.15
|
|
Amendment to Consulting Agreement, dated October 20, 2009,
between Genesis Fluid Solutions and Liviakis Financial
Communications, Inc.(1)
|
|
10
|
.16
|
|
Assignment of Patents Agreement, dated as of August 16,
2009, between Michael Hodges, Larry Campbell and Genesis Fluid
Solutions, Ltd.(1)
|
|
10
|
.17
|
|
Assignment of Patents Agreement, dated as of September 30,
2009, between Michael Hodges, Larry Campbell and Genesis Fluid
Solutions, Ltd.(1)
|
|
10
|
.18
|
|
Form of Voting Agreement between Michael Hodges and the
stockholders signatory thereto(1)
|
|
10
|
.19
|
|
Escrow Agreement, dated October 30, 2009, among Genesis
Fluid Solutions Holdings, Inc., Michael Hodges and Sichenzia
Ross Friedman Ference LLP, as escrow agent(1)
|
|
10
|
.20
|
|
Consulting Agreement dated December 14, 2009 by and between
Genesis Fluid Solutions Holdings, Inc. and Sharp Resources,
Inc.(2)
|
|
10
|
.21
|
|
Consulting Agreement dated December 15, 2009 by and between
Genesis Fluid Solutions Holdings, Inc. and SFL3 LLC(3)
|
|
10
|
.22
|
|
Director and Officer Indemnification Agreement dated
December 15, 2009 by and between Genesis Fluid Solutions
Holdings, Inc. and Selby F. Little, III(3)
|
|
10
|
.23
|
|
Engagement Letter between Genesis Fluid Solutions and Garwood
Securities LLC dated November 20, 2009(5)
|
II-8
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
10
|
.24
|
|
Amendment to Engagement Letter between Genesis Fluid Solutions
and Garwood Securities LLC dated March 23, 2010(5)
|
|
16
|
.1
|
|
Letter from Davis Accounting Group P.C.(4)
|
|
21
|
|
|
List of Subsidiaries(1)
|
|
23
|
.1
|
|
Consent of Davis Accounting Group P.C.
|
|
23
|
.2
|
|
Consent of Salberg & Company, P.A.
|
|
23
|
.3*
|
|
Consent of Sichenzia Ross Friedman Ference LLP (included in
Exhibit 5.1)
|
|
24
|
.1
|
|
Powers of Attorney (included on signature page)
|
|
|
|
* |
|
To be filed by amendment |
|
(1) |
|
Incorporated herein by reference to the copy of such document
included as an exhibit to our Current Report on
Form 8-K
filed on November 5, 2009, as amended on November 16,
2009 and December 14, 2009. |
|
(2) |
|
Incorporated herein by reference to the copy of such document
included as Exhibit 10.1 to our Current Report on
Form 8-K
filed on December 21, 2009. |
|
(3) |
|
Incorporated herein by reference to the copy of such documents
included as Exhibit 10.1 and Exhibit 10.2 to our
Current Report on
Form 8-K
filed on December 24, 2009. |
|
(4) |
|
Incorporated herein by reference to the copy of such document
included as Exhibit 16.1 to our Current Report on
Form 8-K
filed on January 28, 2010 |
|
(5) |
|
Incorporated herein by reference to the copy of such document
included as an exhibit to our Annual Report on
Form 10-K
filed on April 15, 2010 |
II-9